DPM Results Final Complete
,Title,Authors,DOI,DOI link,Journal / Venue,Year,Filename,Study Type,Number of cases,Study_Type_narrative,Patient_Demographics_narrative,Age,Female_count,Male_count,Non-smoker,Assoc_Pulmonary CA,Assoc_Extrapulmonary CA,Assoc_pulmonaryEmbolism,Assoc_GERD,Assoc_CAD,Assoc_Metabolic disease,Assoc_Hypersensitivity pneumonitis,Assoc_Cryptococcus,Assoc_Autoimmune dz,Assoc_hypoThyroid,Assoc_Turner syndrome,Assoc_HRT,Exposure_Birds,Exposure_rabbits,Exposure_other,Associated_Conditions_narrative,Symptom_narrative,Symptom_asymptomatic,Symptom_Dyspnea,Symptom_Cough_dry,Symptom_Chest_pressure,Symptom_Wheezing,Symptom_Fever,Symptom_Progression,Symptom_Persistence,Exam_SpO2,PhysicalExam_narrative,Discovery reason,Results_Spirometry,Results_FEV1,Results_FVC,Results_FEV1/FVC,Results_DLCO mL/min/mmHg (%predicted),Pulmonary_Function_Testing_Spirometry_Narrative,Bronchoscopy findings,Results_BAL,Results_transbronchial_biopsy,Results_negative_narrative,Laboratory Fetures,Clinical Features,Radiological Characteristics,CT_narrative,CT_size,CT_groundGlass,CT_solidnodules,CT_centralCavitation,CT_cystic_micronodules,CT_random,CT_cheerio,CT_upperLobePredominance,CT_lowerLobePredominance,CT_central_perihilarPredominance,CT_subpleural_predominance,CT_assoc_emphyema,CT_assoc_fibrosis,CT_thickenedIntraLobularSeptum,Pathological_Features_narrative,Gross_features,Gross_subpleural_predominance,Histology_narrative,Histo_perivascular_distribution,Primary_histologic_pattern,Ultrastructure_electronmicroscope_features,Diagnostic Approach,Biopsy_TBLB,Biopsy_endobronchial,Biopsy_TTNB,Biopsy_surgical,Biopsy_cryobiopsy,Biopsy_autopsy,Biopsy_TBLB_diagnostic,Biopsy_endobronchial_diagnostic,Biopsy_TTNB_diagnostic,Biopsy_surgical_diagnostic,Biopsy_cryobiopsy_diagnostic,Method of Diagnosis,Immunohistochemistry_narrative,IHC_EMA_pos,IHC_EMA_neg,IHC_PR_pos,IHC_PR_neg,IHC_vimentin_pos,IHC_vimentin_neg,IHC_TTF1_pos,IHC_TTF1_neg,IHC_cytokeratin_pos,IHC_cytokeratin_neg,IHC_S100_pos,IHC_S100_neg,IHC_SMA_pos,IHC_SMA_neg,IHC_Ki67_high,IHC_Ki67_neg,IHC_profile_summary,Management_narrative,Mgmt_observation,Mgmt_no_followup_data,Mgmt_hormone_therapy_withdrawal,Mgmt_lung_transplant_referral,Outcomes,Outcome_followup_available,Followup_duration_unit_raw,Followup_interval_imaging_months,Followup_interval_clinical_months,Outcome_DPM_stable,Outcome_DPM_improved,Outcome_DPM_progressed,Outcome_DPM_died,Authors_followup_recommendation_narrative
Case Report,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,Diffuse Pulmonary Meningotheliomatosis: A Rare Lung Disease Presenting with Diffuse Ground-Glass Opacities and Cavitation,Alkurashi et al.,10.12659/AJCR.926172,http://doi.org/10.12659/AJCR.926172,American Journal of Case Reports,2020,amjcaserep-21-e926172.pdf,Case Report,1,,,55,1,0,1,0,0,0,1,0,1,0,0,0,1,0,0,0,0,0,"- Concurrent malignancies: 44% of patients have a history of or active malignancy at the time of DPM diagnosis.
- Other systemic associations: History of hypertension, hypercholesterolemia, hypothyroidism, gastroesophageal reflux disease, and impaired fasting blood glucose.",Non-exertional chest pressure and dry cough of 4-month duration,0,1,1,1,0,0,0,1,NULL,NULL,Incidental,Normal,Normal,Normal,Normal,Normal,"- PFTs or spirometry at diagnosis: No abnormalities
- FEV1, FVC, FEV/FVC, DLCO, TLC, RV: Not mentioned
- Did these get worse or were stable or improved: Stable
- Comparison of DPM vs MPMN values: Not mentioned",,,,"Laboratory tests, including complete blood count, inflammatory markers, antinuclear antibody (ANA), anti-dsDNA, anti-scl-70 and RNA polymerase III antibodies, rheumatoid factor, and anti-cyclic citrullinated peptide (CCP) antibody, in addition to antineutrophil cytoplasmic antibodies (ANCA) and extractable nuclear antibody panels, were all negative. Hypersensitivity pneumonitis panel, cystic fibrosis genetic mutation testing, and fungal serologies were all negative as well.","- Complete blood count (CBC): Negative
- Autoimmune workup: Negative (ANA, anti-dsDNA, anti-scl-70, RNA polymerase III antibodies, rheumatoid factor, anti-CCP antibody, ANCA, extractable nuclear antibody panels)
- Infectious workup: Negative (hypersensitivity pneumonitis panel, cystic fibrosis genetic mutation testing, fungal serologies)
- Pulmonary function tests: No abnormalities",x,"- Imaging modalities used: High-resolution chest computed tomography (CT)
- Nodule characteristics:
  - Size: Small
  - Number/innumerable: Innumerable
  - Distribution: Diffuse bilateral
  - Appearance: Ground-glass opacity, some with central cavitation
- Temporal changes on follow-up imaging: Stable findings
- Visibility on CT: Visible",High-resolution chest computed tomography (CT) showed innumerable diffuse small ground-glass nodules.,Null,1,0,1,0,1,1,0,0,0,0,0,0,Null,"- Macroscopic/Gross features: Not mentioned
- Gross anatomic location: Interstitial, perivenular
- Microscopic/Histological features and morphology: Multiple well-circumscribed interstitial meningothelial-like nodules with occasional whorling of cells
- Microscopic location: Interstitial, perivenular
- Immunohistochemical markers tested and results: Not mentioned
- Molecular or genetic findings: Not mentioned
- Ultrastructural features: Resemblance to meningothelial cells
- Pathological criteria used for diagnosis: Not mentioned",,,Multiple well-circumscribed interstitial meningothelial-like nodules with occasional whorling of cells,1,Typical DPM,,"- Diagnostic criteria used: Radiographic features include diffuse innumerable bilateral pulmonary nodules on chest CT, some with central cavitation.
- Differential diagnoses considered: Benign neoplasms (e.g., hamartomas, pulmonary papillomatosis), malignant neoplasms (e.g., metastases, bronchoalveolar cell carcinoma), infections (e.g., miliary tuberculosis), inflammatory disorders (e.g., granulomatosis with polyangiitis).
- Diagnostic methods employed: Lung biopsy (typically established with a lung biopsy), transbronchial or surgical (VATS or open) lung biopsies.
- Challenges in distinguishing from malignancy or metastatic meningioma: DPM has a strong female preponderance and is classically seen in middle-aged females; malignancy can be seen in a significant number of patients.
- Recommendations for diagnosis: Consider DPM in the differential diagnosis for patients with diffuse bilateral pulmonary nodules; use lung biopsies for confirmation.",,,,,,,,,,,,VATS (video-assisted thoracoscopic surgery) - Right lung (no specific lobe mentioned),Not mentioned (the paper does not provide specific immunohistochemistry results),,,,,,,,,,,,,,,,,,"- Management strategies: Surgical lung biopsy (VATS) for diagnosis
- Monitoring intervals: Follow-up chest CT scan at least one year after diagnosis
- Recommendations for management: Consider DPM in differential diagnosis for diffuse bilateral pulmonary nodules
- Other: Clinical significance is unclear; further research needed",,,,,"- Follow-up duration and methods: 1 year, repeat high-resolution chest CT scan
- Disease progression/stability: Stable
- Radiological stability or progression: Stable
- Symptomatic or asymptomatic: Symptomatic with non-exertional chest pressure
- Clinical outcomes and patient status: Patient remained symptomatic with non-exertional chest pressure
- Survival/outcome at last follow up: Not mentioned
- Treatment effectiveness if interventions performed: Not mentioned
- Long-term prognosis: Not mentioned",,,,,,,,,
,A Rare Case Of Diffuse Pulmonary Meningotheliomatosis,Siddiqui et al.,-,-,American Journal of Respiratory and Critical Care Medicine,2017,Siddiqui and Ahmad - A Rare Case Of Diffuse Pulmonary Meningotheliomatosis.pdf,Case Report,1,,,54,1,0,1,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,"- History of hypothyroidism and gastroesophageal disease
- No exposure to tobacco, asbestosis, birds, and animals
- Negative for fungal, viral, acid-fast bacillus, and immunologic workup
- No mention of other associations","Shortness of breath of one year duration that gradually progressed and was associated with cough. She denied fever, chest pain, sputum production and wheezing.",0,1,1,0,0,0,1,,90,"Diffuse rhonchi posterior chest bilaterally",Symptomatic workup,Normal,Normal,Normal,Normal,8.13 (40%),"- PFTs or spirometry at diagnosis: Normal spirometry; DLCO: 8.13 ml/min/mmHg (40% predicted)
- FEV1, FVC, FEV/FVC, TLC, RV: Not mentioned
- Did these get worse or were stable or improved: Not mentioned
- Comparison of DPM vs MPMN values: Not mentioned",,"Not diagnostic; negative cultures, viral studies, AFB",Not diagnostic,,"- Pulmonary function test: Normal spirometry, significantly reduced DLCO (8.13 ml/min/mmHg, 40% predicted)
- Bronchoalveolar lavage (BAL): Not diagnostic
- Infectious workup: Negative blood cultures, BAL cultures (fungal, viral, acid-fast bacillus), negative serum and urine tests for Histoplasmosis and Coccidioidomycosis
- Autoimmune workup: Negative","- Disease course and natural history: Progressive symptoms, worsening lung function
- Progression over time: Persistent symptoms, referral for lung transplant evaluation
- Complications: Need for oxygen supplementation, referral for lung transplant evaluation
- Pulmonary function testing: Normal spirometry, significantly reduced DLCO","- Imaging modalities used: CT
- Nodule characteristics:
  - Distribution: Centrilobular
  - Appearance: Not specified
- Other unique lung findings on CT: Not specified
- SUV values if PET performed: Not mentioned
- Temporal changes on follow-up imaging: Not mentioned
- Visibility on CT: Visible (implied)
- Other radiology studies: Not mentioned",,Null,,,,,NULL,,Centrilobular,,,,,,Null,"- Macroscopic/Gross features: Not mentioned
- Gross anatomic location: Not explicitly mentioned, but implied to be within the lung interstitium
- Microscopic/Histological features and morphology: Multiple pulmonary meningothelial-like nodules
- Microscopic location: Interstitial
- Immunohistochemical markers tested and results: Not mentioned
- Molecular or genetic findings: Not mentioned
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Not mentioned",,,,,,,"- Diagnostic criteria used: Not explicitly mentioned
- Differential diagnoses considered: Unexplained dyspnea and diffuse interstitial nodules
- Misdiagnosis rates and types: Not mentioned
- Diagnostic methods employed: CT chest imaging, pulmonary function tests (DLCO), bronchoscopy with BAL and transbronchial biopsies, wedge resection
- Challenges in distinguishing from malignancy or metastatic meningioma: Not addressed
- Recommendations for diagnosis: Consider DPM in differential diagnosis for unexplained dyspnea and diffuse interstitial nodules",,,,,,,,,,,,"- Method: Surgical Biopsy (wedge resection)
- Biopsy site: Left lower lobe
- Bronchoscopic biopsy: Not diagnostic (BAL and transbronchial biopsies)
- Surgical Biopsy: Diagnostic (wedge resection of left lower lobe)",Not mentioned (the paper does not provide immunohistochemistry results),,,,,,,,,,,,,,,,,,"- Management strategies: Surgical intervention (wedge resection), oxygen supplementation, referral for lung transplant evaluation.
- Monitoring intervals: Not mentioned.
- Recommendations for management: Lung transplant may be considered for symptomatic patients with hypoxemia and reduced DLCO <40%.
- Other: Treatment is not well defined.",,,,,"- Follow-up duration and methods: Not mentioned
- Disease progression/stability: Disease progression; patient remained symptomatic
- Radiological stability or progression: Not mentioned
- Symptomatic or asymptomatic: Symptomatic; cough and shortness of breath
- Clinical outcomes and patient status: Required oxygen supplementation; referred for lung transplant evaluation
- Survival/outcome at last follow up: Not mentioned
- Treatment effectiveness if interventions performed: Not well defined
- Long-term prognosis: Not mentioned",,,,,,,,,
,Diffuse pulmonary meningotheliomatosis,Nadrous et al.,-,https://doi.org/10.1002/rcr2.1183,Respirology Case Reports,2023,Respirology Case Reports - 2023 - Nadrous - Diffuse pulmonary meningotheliomatosis.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Symptomatic presentation",,49,1,0,1,0,0,0,0,0,1,0,0,0,0,0,1,NULL,NULL,NULL,Concurrent lung malignancies: Lung adenocarcinoma,Nonproductive cough and dyspnea.,0,1,1,0,0,0,0,,,,,,,,,,Not mentioned (no information on pulmonary function testing is included in the paper),Not mentioned (no information on bronchoscopy findings or related procedures is included in the paper),,,,Not mentioned (no specific laboratory features are included in the paper),"- Symptoms at presentation: Asymptomatic, nonproductive cough, dyspnea
- Lung complications: Not mentioned
- Physical examination findings: Not mentioned
- Circumstances of discovery: Not specified
- Disease course and natural history: Stable, no progression
- Progression over time: Stable for the last 2 years
- Complications or adverse outcomes: Not mentioned
- Pulmonary function testing: Not mentioned","- Imaging modality: Chest computed tomography (CT)
- Nodule characteristics:
  - Size: 2-4 mm
  - Number: Innumerable
  - Distribution: Randomly distributed, bilateral
  - Appearance: Solid and ground glass
  - Unique feature: ""Cheerio-sign"" with central lucency
- Temporal changes: Nodules remained stable over two years","Chest computed tomography showed numerous, randomly distributed, bilateral, solid and ground glass micronodules of 2–4 mm..  Several nodules exhibited the characteristic ‘cheerio-sign’ marked by central lucency.",2-4mm,1,,1,0,Random,1,,,,,,,,"- Macroscopic/Gross features: Innumerable bilateral minute pulmonary meningothelial-like nodules
- Gross anatomic location: Not explicitly mentioned
- Microscopic/Histological features and morphology: Nests of bland cells with moderate cytoplasm, round to oval nuclei, finely granular chromatin
- Microscopic location: Perivenular
- Immunohistochemical markers tested and results: Immunoreactive with progesterone receptors
- Molecular or genetic findings: Not mentioned
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Not mentioned",,,,,,,"- Diagnostic criteria used: 'Cheerio-sign' on imaging, characteristic micronodules on CT.
- Differential diagnoses considered: Lung adenocarcinoma.
- Diagnostic methods employed: Chest computed tomography, wedge biopsy.
- Challenges in distinguishing from malignancy or metastatic meningioma: Association with lung adenocarcinoma.
- Recommendations for diagnosis: Use of 'cheerio-sign' and imaging for identification, biopsy for confirmation.",,,,,,,,,,,,Wedge biopsy (surgical resection); specific lung lobe not mentioned,Not mentioned (the paper does not provide specific immunohistochemistry results),,,,,,,,,,,,,,,,,,"- Management strategies: Withdrawal of hormone replacement therapy (HRT)
- Monitoring intervals: Not specified
- Recommendations for management: Not specified
- Other: Observation of nodules",,,,,"- Follow-up duration and methods: Not explicitly mentioned beyond 2 years of stability.
- Disease progression/stability: Most patients are asymptomatic with no disease progression; specific case showed stability for 2 years.
- Radiological stability or progression: Nodules remained stable for 2 years.
- Symptomatic or asymptomatic: Most patients are asymptomatic; specific case had symptoms that improved after stopping HRT.
- Clinical outcomes and patient status: Symptoms improved after stopping HRT.
- Survival/outcome at last follow up: Not explicitly mentioned.
- Treatment effectiveness if interventions performed: Withdrawal of HRT led to symptom improvement.
- Long-term prognosis: Not explicitly discussed.",,,,,,,,,
,A Rare Case Diagnosed by Videothoracoscopic Lung Biopsy: Diffuse Pulmonary Meningotheliomatosis,Dzian et al.,-,-,,2021,CRIPU2021-1990433.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding",,60,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,,,,"- Concurrent lung malignancies: Lung adenocarcinoma
- Other concurrent conditions: Chronic ischemic heart disease, pulmonary thromboembolism
- Other systemic associations: Hormonal imbalance with progesterone stimulation, chronic lung diseases with inducing hypoxia and ischemia
- Frequency of associations: Not specified
- Temporal relationship: Not specified",,,,,,,,,,,,,,,,,,"- PFTs or spirometry at diagnosis: Normal spirometry, lung volumes, and diffusion capacity
- FEV1, FVC, FEV/FVC, DLCO, TLC, RV: Not mentioned
- Did these get worse or were stable or improved: Not mentioned
- Comparison of DPM vs MPMN values: Not mentioned","- Bronchoscopy findings: Normal endobronchial finding
- Bronchoalveolar lavage (BAL) analysis: No tumor cells; CD4/CD8 ratio = 7.5
- Cell count and predominance: Not mentioned
- CD4/CD8 ratio: 7.5
- Was a Transbronchial lung biopsy performed? Yes; results: Normal peribronchial lung parenchyma with a micronodule of benign neuroendocrine hyperplasia, no granulomatous inflammation
- Was a Transbronchial lung cryobiopsy performed? No
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? Yes",,,,"- Tuberculin skin test: Negative
- Bronchoalveolar lavage: No tumor cells, CD4/CD8 ratio = 7.5","- Symptoms at presentation: Asymptomatic
- Lung complications: Not mentioned
- Physical examination findings: Normal
- Circumstances of discovery: Incidental during routine medical examination
- Disease course and natural history: Usually asymptomatic, can coexist with other conditions
- Progression over time: Not mentioned
- Complications or adverse outcomes: Not mentioned
- Pulmonary function testing: Normal spirometry, lung volumes, and diffusion capacity","- Imaging modalities used: HRCT
- Nodule characteristics:
  - Size: 1-5 mm
  - Number/innumerable: Multiple
  - Distribution: Diffuse with slight upper lobe predominance
  - Appearance: Tiny nodules or ground-glass opacity
- Other radiology studies: PET mentioned but not used for small nodules like DPM",,1-5mm,Ground-glass opacity with central cavitation,,,,Diffuse,,Upper Lobe,,,,,,,"- Macroscopic/Gross features: Small nodules ranging from 1 to 5 mm in size.
- Gross anatomic location: Perivascular.
- Microscopic/Histological features and morphology: Epithelioid cell nests or whorls in a zellballen-like arrangement centered on small veins; cells have round to oval nuclei and abundant eosinophilic cytoplasm.
- Microscopic location: Perivascular.
- Immunohistochemical markers tested and results: Positive for vimentin, CD56, and progesterone receptor; negative for synaptophysin, chromogranin A, InsM1, CK7, TTF-1, p40, CK5/6, HMB45, AE1/AE3, S100, and des-min.
- Molecular or genetic findings: Not mentioned.
- Ultrastructural features: Not mentioned.
- Pathological criteria used for diagnosis: Histopathological examination and immunohistochemical studies.",,,,,,,"- Diagnostic criteria used: Histopathology through videothoracoscopic lung biopsy.
- Differential diagnoses considered: Various lung malignancies, infections, and interstitial lung diseases.
- Diagnostic methods employed: Videothoracoscopic lung biopsy, transbronchial biopsy, PET imaging for larger nodules.
- Challenges in distinguishing from malignancy or metastatic meningioma: DPM can mimic serious lung malignancies and other conditions.
- Recommendations for diagnosis: Multidisciplinary team approach, routine diagnostic work-up, and definitive diagnosis through histopathology.",,,,,,,,,,,,Videothoracoscopic lung biopsy (right upper lobe),"- Positive: vimentin, CD56, progesterone receptor, epithelial membrane antigen
- Negative: synaptophysin, chromogranin A, InsM1, CK7, TTF-1, p40, CK5/6, HMB45, AE1/AE3, S100, des-min, cytokeratin, actin, CD34",,,,,,,,,,,,,,,,,,"- Management strategies: Conservative treatment with observation and follow-up chest computed tomography imaging.
- Monitoring intervals: Not mentioned.
- Recommendations for management: Conservative approach with observation and follow-up imaging.
- Other: Videothoracoscopic lung biopsy is used for diagnosis, not typically part of management.",,,,,Not mentioned (the paper does not provide specific follow-up data or outcomes beyond the initial diagnosis and management),,,,,,,,,
,A 48-Year-Old Woman With a History of Severe Asthma and Bilateral Minute Pulmonary Nodules,Bottet et al.,10.1016/j.chpulm.2025.100198,-,CHEST Pulmonary,2025,Bottet et al. - 2025 - A 48-Year-Old Woman With a History of Severe Asthma and Bilateral Minute Pulmonary Nodules.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: 1
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned (1-year follow-up)
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding during evaluation for other symptoms",,48,1,0,1,0,,0,0,0,0,0,0,0,0,0,0,1,1,0,"- History of nonallergic asthma and sleep apnea syndrome
- Potential association with hypersensitivity pneumonitis (ruled out)
- Differential diagnoses included granulomatosis and metastatic disease
- No intracranial meningioma identified
- No other genetic disorders, concurrent malignancies, ulcerative colitis, cardiac disease, or systemic associations mentioned",,,,,,,,,,,,,,,,,,Not mentioned (the paper does not provide specific pulmonary function testing values or comparisons between DPM and MPMN),"- Bronchoscopy findings: Not mentioned
- Bronchoalveolar lavage (BAL) analysis: Did not support hypersensitivity pneumonitis
- Cell count and predominance: Not mentioned
- CD4/CD8 ratio: Not mentioned
- Was a Transbronchial lung biopsy performed? If yes, describe results: Not mentioned
- Was a Transbronchial lung cryobiopsy performed? If yes, describe results: Not mentioned
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? Yes",,,,"- Autoimmune workup: Positive serum precipitins to moldy hay
- Bronchoalveolar lavage (BAL): Findings did not support hypersensitivity pneumonitis","- Symptoms at presentation: Asymptomatic, respiratory symptoms (increased when handling hay)
- Lung complications: None mentioned
- Physical examination findings: Macroscopic examination showed benign-appearing diffuse millimetric nodules
- Circumstances of discovery: Incidental during symptomatic workup for asthma
- Disease course and natural history: Typically asymptomatic and incidental, but can cause cardiorespiratory symptoms; stable condition with no progression over 1 year
- Progression over time: No progression over 1 year
- Complications or adverse outcomes: None mentioned
- Pulmonary function testing: Not mentioned","- Imaging modalities used: CT, HRCT
- Nodule characteristics:
  - Appearance: Rounded ground-glass opacity with clear edges and central lucencies
  - Distribution: Random with mild subpleural predominance
- Temporal changes on follow-up imaging: No progression at 1-year follow-up",,NULL,"Rounded ground-glass opacity with clear edges and central lucencies",,,,Random,,Subpleural,,,,,,,"- Macroscopic/Gross features: Numerous benign-appearing diffuse millimetric nodules with a whitish appearance.
- Gross anatomic location: Not explicitly mentioned.
- Microscopic/Histological features and morphology: Multiple foci of meningothelial cell proliferation with a perivenular pattern of growth and ill-defined borders.
- Microscopic location: Perivenular.
- Immunohistochemical markers tested and results: SSTR2+, PS100-, HMB45-, RO-, RP+, actin smooth muscle-, ERG-, CD31-, melan A-, AE1/AE3-, MNF116-, chromogranin-, synaptophysin-, CD56+, TTF1-, and P40-.
- Molecular or genetic findings: Not mentioned.
- Ultrastructural features: Not mentioned.
- Pathological criteria used for diagnosis: Characteristic microscopic features and immunohistochemical profile.",,,,,,,"- Diagnostic criteria used: High-resolution CT imaging for detection and characterization; histopathologic confirmation through lung biopsies.
- Differential diagnoses considered: Meningioma of the lung, hypersensitivity pneumonitis, granulomatosis, metastatic disease.
- Diagnostic methods employed: High-resolution CT imaging, lung biopsies (transparietal or surgical via video-assisted thoracoscopic surgery).
- Challenges in distinguishing from malignancy or metastatic meningioma: DPM can be mistaken for other diseases, especially metastatic cancer and infections; specific features like ill-defined borders and small size help distinguish DPM.
- Recommendations for diagnosis: Conservative management with surveillance imaging to monitor nodule stability; awareness of DPM to avoid misdiagnosis with other diseases.",,,,,,,,,,,,Surgical Biopsy: Video-assisted thoracoscopic surgery; Biopsy site: Right lobe,"- Positive: SSTR2, RP, CD56
- Negative: PS100, HMB45, RO, actin smooth muscle, ERG, CD31, melan A, AE1/AE3, MNF116, chromogranin, synaptophysin, TTF1, P40",,,,,,,,,,,,,,,,,,"- Management strategies: Conservative management involving surveillance imaging to monitor the stability of the nodules.
- Monitoring intervals: 1-year follow-up.
- Recommendations for management: Awareness of DPM to avoid misdiagnosis with other conditions.
- Other: No specific active treatment interventions mentioned.",,,,,"- Follow-up duration and methods: 1-year follow-up with surveillance imaging.
- Disease progression/stability: No progression of the disease.
- Radiological stability or progression: Not specifically mentioned.
- Symptomatic or asymptomatic: Asymptomatic; no specific symptoms or scales mentioned.
- Clinical outcomes and patient status: Recovered well from postoperative phase.
- Survival/outcome at last follow-up: No progression of the disease.
- Treatment effectiveness if interventions performed: Conservative management with surveillance imaging.
- Long-term prognosis: Benign nature of the disease.",,,,,,,,,
,Diffuse Cavitating Pulmonary Meningotheliomatosis: A Rare and Elusive Pathology,Santos et al.,-,-,C73. CHEST DISEASE CLINICAL CASES,2023,Torrech Santos et al. - 2023 - Diffuse Cavitating Pulmonary Meningotheliomatosis A Rare and Elusive Pathology.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding due to abnormal radiologic imaging findings",,45,1,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,"- History of hypothyroidism and hyperlipidemia
- Association with malignancy (type not specified)
- Nonsmoker, no overt exposure or occupational risk factors
- No other specific associations mentioned",,,,,,,,,,,,,,,,,,"- FEV1/FVC: Normal
- Air trapping: Moderate
- Airway resistance: Increased
- No information on DLCO, TLC, RV, or changes over time
- No comparison with MPMN values",Not mentioned (no information on bronchoscopy findings or related procedures is included in the paper),,,,"- VEGF levels: nondiagnostic
- Rheumatoid panel: nondiagnostic
- Pulmonary function testing: normal FEV1/FVC, moderate air trapping, increased airway resistance","- Symptoms at presentation: Asymptomatic, dyspnea, cough
- Lung complications: Not mentioned
- Physical examination findings: Not mentioned
- Circumstances of discovery: Incidental due to asymptomatic course
- Disease course and natural history: Not detailed
- Progression over time: Not detailed
- Complications or adverse outcomes: Not mentioned
- Pulmonary function testing: Normal FEV1/FVC, moderate air trapping, increased airway resistance","- Imaging modality: High-resolution chest CT scan
- Nodule characteristics:
  - Size: Minute
  - Number: Innumerable
  - Distribution: Bilateral
  - Appearance: Thin-walled pulmonary cysts with thickened interlobular septa
- Other unique lung findings on CT: Thickened interlobular septa",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Rare parenchymal lung disease
- Gross anatomic location: Bilateral
- Microscopic/Histological features and morphology: Extensive bilateral minute pulmonary meningothelial-like nodules (MPMNs)
- Microscopic location: Likely interstitial
- Immunohistochemical markers tested and results: Not mentioned
- Molecular or genetic findings: Not mentioned
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Tissue biopsy necessary due to wide differential diagnosis",,,,,,,"- Diagnostic criteria used: Tissue biopsy is strictly necessary for diagnosis.
- Differential diagnoses considered: Lymphangioleiomyomatosis (LAM).
- Diagnostic methods employed: High-resolution chest CT scan, open biopsy of the lung.
- Challenges in distinguishing from malignancy or metastatic meningioma: Some cases display an association with malignancy.
- Recommendations for diagnosis: Tissue biopsy is necessary due to wide differential diagnosis.",,,,,,,,,,,,Surgical Biopsy: Open biopsy of the right lung,Not mentioned (the paper does not provide specific immunohistochemistry results),,,,,,,,,,,,,,,,,,"- Management strategies: Use of budesonide/formoterol as needed for symptom relief.
- Monitoring intervals: Not mentioned.
- Recommendations for management: Not mentioned.
- Other: The paper highlights the need to establish treatment options and correlations with other manifestations.",,,,,Not mentioned (the paper does not provide specific follow-up data or outcomes for the patient),,,,,,,,,
,Diffuse pulmonary meningotheliomatosis with pan-TRK expression by immunohistochemistry: a novel finding and potential pitfall,Karakas et al.,10.1186/s13000-023-01292-1,https://doi.org/10.1186/s13000-023-01292-1,Diagnostic Pathology,2023,s13000-023-01292-1.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: 1
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Symptomatic presentation",,59,1,0,1,1,0,0,1,0,1,0,0,0,0,0,0,0,0,0,"- Concurrent lung malignancies: Higher incidence in malignant pulmonary tumors, particularly adenocarcinoma.
- Other pulmonary disease: Thromboembolic disease, respiratory bronchiolitis-associated interstitial lung disease, desquamative interstitial pneumonia, atypical adenomatous hyperplasia of the lungs.
- History of active malignancy: 44% of patients with DPM have a history of active malignancy.
- Temporal relationship: DPM can be concurrent with other conditions.",,,,,,,,,,,,,,,,,,"- PFTs or spirometry at diagnosis: Spirometry results were within normal ranges.
- FEV1, FVC, FEV/FVC, DLCO, TLC, RV: Not mentioned.
- Did these get worse or were stable or improved: Stable (no progression in nodule size or number).
- Comparison of DPM vs MPMN values: Not mentioned.","- Bronchoscopy findings: Not mentioned
- Bronchoalveolar lavage (BAL) analysis: Not mentioned
- Cell count and predominance: Not mentioned
- CD4/CD8 ratio: Not mentioned
- Was a Transbronchial lung biopsy performed? Yes, results were diagnostic for diffuse pulmonary meningotheliomatosis
- Was a Transbronchial lung cryobiopsy performed? Not mentioned
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? No",,,,"- Spirometry results: within normal ranges
- Autoimmune workup: negative
- Infectious workup: negative","- Symptoms at presentation: Chronic cough, night sweats, fatigue, productive cough, occasional shortness of breath
- Lung complications: Not mentioned
- Physical examination findings: Unremarkable
- Circumstances of discovery: Symptomatic workup for chronic cough
- Disease course and natural history: Stable condition with no progression in nodule size or number
- Progression over time: No progression
- Complications or adverse outcomes: Not mentioned
- Pulmonary function testing: Spirometry results were within normal ranges","- Imaging modality: CT
- Nodule characteristics:
  - Size: 100 μm to 3 mm
  - Number: Multiple
  - Distribution: Randomly distributed throughout the lung interstitium
  - Appearance: Some with central cavitation
- Temporal changes: No progression in nodule size or number on follow-up imaging",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Not specifically mentioned in the paper.
- Gross anatomic location: Not specifically mentioned in the paper.
- Microscopic/Histological features and morphology: Nodular interstitial proliferations composed of epithelioid to spindled cells in a vague whorled pattern.
- Microscopic location: Interstitial.
- Immunohistochemical markers tested and results: EMA (positive), progesterone receptor (positive), pan-TRK (positive), INSM1 (negative).
- Molecular or genetic findings: Negative for NTRK gene rearrangements involving NTRK1, NTRK2, and NTRK3.
- Ultrastructural features: Cells with cytoplasmic interdigitating junctions, desmosomes, and intracytoplasmic filaments.
- Pathological criteria used for diagnosis: Histological appearance and immunohistochemical marker expression.",,,,,,,"- Diagnostic criteria used: Immunohistochemical stains for EMA, progesterone receptor, and pan-TRK; RNA-based next-generation sequencing for NTRK fusions.
- Differential diagnoses considered: Metastatic carcinomas, pulmonary meningiomas, pulmonary carcinoid tumorlets.
- Misdiagnosis rates and types: Not explicitly mentioned.
- Diagnostic methods employed: Transbronchial biopsies, surgical biopsies (VATS or open).
- Challenges in distinguishing from malignancy or metastatic meningioma: Cytological differences; need for specific markers like INSM1.
- Recommendations for diagnosis: Use of transbronchial or surgical biopsies; careful histological examination to avoid misdiagnosis.",,,,,,,,,,,,Transbronchial biopsy (frequency: multiple samples) - Biopsy site: Left lung and contralateral lung,"- Positive: EMA, progesterone receptor, pan-TRK
- Negative: INSM1",,,,,,,,,,,,,,,,,,"- Management strategies: Transbronchial biopsies for diagnosis, observation through follow-up imaging.
- Monitoring intervals: Not specified.
- Recommendations for management: Not mentioned.
- Other: No specific treatment or therapeutic management strategies mentioned.",,,,,"- Follow-up duration and methods: Follow-up imaging showed no progression in nodule size or number.
- Disease progression/stability: Stable, with no progression in nodule size or number.
- Radiological stability or progression: No progression in nodule size or number.
- Symptomatic or asymptomatic: Non-specific pulmonary symptoms; no detailed information on symptomatic or asymptomatic status or scales used.
- Clinical outcomes and patient status: Stable, with no progression in nodule size or number.
- Survival/outcome at last follow-up: Not mentioned.
- Treatment effectiveness if interventions performed: Not mentioned.
- Long-term prognosis: Not mentioned.",,,,,,,,,
,Diffuse Pulmonary Meningotheliomatosis: A Rare Case With Long-term Radiographic Stability,Lefebvre et al.,,-,American Journal of Respiratory and Critical Care Medicine,2025,Lefebvre et al. - Diffuse Pulmonary Meningotheliomatosis A Rare Case With Long-term Radiographic Stability.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: 1
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Seven years
- Institution/geographic location: Not mentioned
- Method of patient identification: Symptomatic presentation",,89,1,0,1,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,"- Other pulmonary disease: bibasilar bronchiectasis
- History of cardiac disease: coronary artery disease, aortic and mitral regurgitation
- Other systemic associations: iron deficiency anemia, hypothyroidism
- Temporal relationship: Concurrent with DPM",,,,,,,,,,,,,,,,,,"- PFTs or spirometry at diagnosis: Not explicitly mentioned for initial diagnosis in 2017; in 2024: TLC at 90% predicted, FVC at 81% predicted, DLCO at 90% predicted
- Did these get worse or were stable or improved: Minimal changes in lung function over seven years
- Comparison of DPM vs MPMN values: Not mentioned",Not mentioned (no information on bronchoscopy findings or related procedures is included in the paper),,,,Iron deficiency anemia,"- Symptoms at presentation: Progressive dyspnea on exertion (DOE)
- Lung complications: Bibasilar bronchiectasis
- Circumstances of discovery: Incidental finding on abdominal imaging in 2008
- Disease course and natural history: Stable radiographic findings over seven years with minimal changes in lung function
- Progression over time: Progressive DOE despite stable imaging
- Pulmonary function testing: TLC at 90% predicted, FVC at 81% predicted, DLCO at 90% predicted","- Imaging modalities used: Not specified
- Nodule characteristics:
  - Size: Small
  - Number/innumerable: Numerous
  - Distribution: Bilateral
  - Centrilobular, panlobar, or paraseptal predominance: Mostly centrilobular
  - Upper or lower predominance: Not specified
  - Left or Right predominance: Not specified
  - Appearance: Ground glass, central lucencies
  - Other unique lung findings on CT: Not specified
  - SUV values if PET performed: Not specified
  - Temporal changes on follow-up imaging: Unchanged over at least seven years
  - Visibility on CT: Visible
  - Other radiology studies: Not specified",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Numerous, bilateral minute pulmonary meningothelial-like nodules (MPMNs)
- Gross anatomic location: Not explicitly mentioned
- Microscopic/Histological features and morphology: Not mentioned
- Microscopic location: Not mentioned
- Immunohistochemical markers tested and results: Not mentioned
- Molecular or genetic findings: Not mentioned
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Determined based on imaging findings after multidisciplinary discussion",,,,,,,"- Diagnostic methods employed: Imaging (chest imaging showing numerous bilateral small nodules with ground glass appearance and central lucencies)
- Challenges: Difficulty in attributing symptoms solely to DPM due to other contributing factors (worsening anemia and valvular disease)
- Recommendations for diagnosis: Not mentioned
- Diagnostic criteria used: Not mentioned
- Differential diagnoses considered: Not mentioned
- Misdiagnosis rates and types: Not mentioned
- Challenges in distinguishing from malignancy or metastatic meningioma: Not mentioned",,,,,,,,,,,,Not mentioned (the paper does not specify the method of diagnosis beyond radiographic findings and multidisciplinary discussion),Not mentioned (no information on immunohistochemistry is included in the paper),,,,,,,,,,,,,,,,,,"- Management strategies: Continued monitoring
- Monitoring intervals: Not mentioned
- Recommendations for management: Continued monitoring is essential
- Other: No specific treatments or interventions mentioned",,,,,"- Follow-up duration and methods: Seven years; pulmonary function testing (PFT) and radiographic imaging.
- Disease progression/stability: Stable with minimal changes in lung function.
- Radiological stability or progression: Stable; nodules unchanged since 2008.
- Symptomatic or asymptomatic: Symptomatic; progressive dyspnea on exertion (DOE).
- Clinical outcomes and patient status: Stable lung function with minimal changes; patient has multiple contributing factors.
- Survival/outcome at last follow up: Stable with no significant changes.
- Treatment effectiveness if interventions performed: Not mentioned.
- Long-term prognosis: Not mentioned.",,,,,,,,,
,A Rare Case of Diffuse Bilateral Minute Pulmonary Meningothelial-like Nodules Increasing over the Short Term and Resembling Metastatic Lung Cancer,Murata et al.,10.2169/internalmedicine.0343-22,https://doi.org/10.2169/internalmedicine.0343-22,Internal Medicine,2023,62_0343-22.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: Not mentioned
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not explicitly mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding during a health checkup",,54,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,"- History of cholelithiasis and hypercholesterolemia
- Concurrent lung malignancies: 10% of patients have complicated lung adenocarcinoma
- Other concurrent malignancies: Not mentioned
- Intracranial meningioma: Not mentioned
- Other pulmonary disease: Not mentioned
- History of ulcerative colitis: Not mentioned
- History of cardiac disease or infective endocarditis: Not mentioned
- Other systemic associations: Female hormones and genetic background may be involved; normal biochemical examination results for collagen disease
- Frequency of associations: 10% for lung adenocarcinoma
- Temporal relationship: Not specified",,,,,,,,,,,,,,,,,,"- PFTs or spirometry at diagnosis: No respiratory failure; specific values not provided.
- FEV1, FVC, FEV/FVC, DLCO, TLC, RV: Not mentioned.
- Did these get worse or were stable or improved: Stable; no worsening or improvement mentioned.
- Comparison of DPM vs MPMN values: Not applicable; paper focuses on MPMNs.","- Bronchoscopy findings: No visible airway abnormalities.
- Bronchoalveolar lavage (BAL) analysis: Not mentioned.
- Cell count and predominance: Not mentioned.
- CD4/CD8 ratio: Not mentioned.
- Was a Transbronchial lung biopsy performed? Yes, results showed no malignant cells.
- Was a Transbronchial lung cryobiopsy performed? Not mentioned.
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? Yes.",,,,"- Complete blood count (CBC): WBC: 6.8×10³ /μL, Neut: 70.6%, Ly: 22.7%, Eo: 2.9%, Baso: 0.3%, Mono: 3.5%, RBC: 5.08×10⁶ /μL, Hb: 14.4 g/dL, Plt: 312×10³ /μL
- Metabolic panel: Na: 141 mEq/L, K: 4.1 mEq/L, Cl: 102 mEq/L, AST: 25 U/L, ALT: 29 U/L, LDH: 210 U/L, T-Bil: 0.6 mg/dL, BUN: 9 mg/dL, Cre: 0.51 mg/dL, UA: 4.8 mg/dL, TP: 8.2 g/dL, Alb: 4.7 g/dL, CRP: 0.14 mg/dL
- Autoimmune workup: ANA: 40 nX, Anti-Scl70: 1.6 U/mL, Anti-SSA: <1.0 U/mL, Anti-SSB: <1.0 U/mL, Anti-ARS: <1.0 U/mL, Anti-CCP: <5.0 U/mL, RF: 7 IU/mL, MPO-ANCA: <1.0 U/mL, PR3-ANCA: <1.0 U/mL
- Infectious workup: IGRA: Negative","- Symptoms at presentation: Asymptomatic
- Lung complications: None reported
- Physical examination findings: Normal
- Circumstances of discovery: Incidental during health checkup
- Disease course and natural history: Increase in nodule numbers over time, but patient remained asymptomatic
- Progression over time: Increase in nodule numbers, slight enlargement in size
- Complications or adverse outcomes: None reported
- Pulmonary function testing: Normal pulmonary function test results","- Imaging modalities used: Thin-section chest CT
- Nodule characteristics:
  - Size: Up to 5 mm in diameter
  - Number: Innumerable
  - Distribution: Randomly distributed throughout both lungs, no significant differences between lobes
  - Appearance: Ground-glass attenuation, some with central lucency and ring-shaped
- Temporal changes: Increase in number of nodules over time",,,,,,,,,,,,,,,,"- Microscopic/Histological features and morphology: Small nests of spindle cells with eosinophilic cytoplasm.
- Microscopic location: Within the interstitium of the lung, along the alveolar septum.
- Immunohistochemical markers tested and results: Negative for cytokeratin AE1/AE3, positive for vimentin and progesterone receptors.",,,,,,,"- Diagnostic criteria used: Histological findings of spindle-shaped cells with lightly acidic vesicles and round nuclei; immunohistochemical staining negative for cytokeratin AE1/AE3 and positive for vimentin and progesterone receptors.
- Differential diagnoses considered: Metastatic lung cancer.
- Diagnostic methods employed: Thin-section CT for initial detection; transbronchial lung biopsy and surgical lung biopsy for definitive diagnosis.
- Challenges in distinguishing from malignancy or metastatic meningioma: Differentiation from metastatic lung cancer is crucial due to similar radiographic findings; biopsies are necessary to confirm diagnosis.
- Recommendations for diagnosis: Use thin-section CT for detection; perform biopsies to rule out malignancy, especially in cases with increasing nodules.",,,,,,,,,,,,"- Method: Transbronchial lung biopsy (initial), Surgical lung biopsy (definitive)
- Biopsy site: Right middle lobe S4, Right lower lobe S6","- Positive: vimentin, progesterone receptors
- Negative: cytokeratin AE1/AE3",,,,,,,,,,,,,,,,,,"- Management strategies: Observation, surgical lung biopsy
- Monitoring intervals: Four months and twelve months after diagnosis
- Recommendations for management: Perform lung biopsy to rule out malignant disease if nodules increase
- Other: No treatment required beyond biopsy; patient remained asymptomatic with stable pulmonary function",,,,,"- Follow-up duration and methods: Follow-up at 4 months, 6 months, and 12 months; methods included chest radiograph, spirometry, and thin-section CT.
- Disease progression/stability: Initially increased in number and size at 6 months, then stable at 12 months.
- Radiological stability or progression: Increased number and slight enlargement at 6 months, stable at 12 months.
- Symptomatic or asymptomatic: Asymptomatic throughout.
- Clinical outcomes and patient status: Stable condition, normal pulmonary function tests.
- Survival/outcome at last follow-up: Stable condition, no treatment required.
- Treatment effectiveness: No treatment required.
- Long-term prognosis: Stable condition, no treatment required.",,,,,,,,,
,Diffuse Pulmonary Meningotheliomatosis Presenting as Innumerable Pulmonary Micronodules: A Case Report,"Eitetsu Koh, Yasuo Sekine, Hodaka Oeda, | Tadao Nakazawa",-,-,,-,TCA-16-e70172.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: 2019 to 2022
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding during routine chest CT",,44,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"- History of turner syndrome or other genetic/inheritable disorder: Not mentioned
- Concurrent lung malignancies: Not mentioned
- Other concurrent malignancies: Not mentioned
- Intracranial meningioma: No intracranial lesion detected postoperatively
- Other pulmonary disease: Not mentioned
- History of ulcerative colitis: Not mentioned
- History of cardiac disease or infective endocarditis: Not mentioned
- Other systemic associations: Not mentioned
- Frequency of associations: Not mentioned
- Temporal relationship between DPM and associated conditions: Not mentioned",,1,0,0,0,0,0,,,NULL,NULL,,Normal,Normal,Normal,Normal,Normal,"- PFTs or spirometry at diagnosis: Normal
- FEV1, FVC, FEV/FVC, DLCO, TLC, RV: Not mentioned
- Did these get worse or were stable or improved: Stable (no new lesions or growth over 3 years)
- Comparison of DPM vs MPMN values: Not mentioned","- Bronchoscopy findings: Not mentioned (bronchoscopic biopsy was not feasible)
- Bronchoalveolar lavage (BAL) analysis: Not mentioned
- Cell count and predominance: Not mentioned
- CD4/CD8 ratio: Not mentioned
- Was a Transbronchial lung biopsy performed? No
- Was a Transbronchial lung cryobiopsy performed? No
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? Yes",,,,"- Complete blood count (CBC): Within normal limits
- Metabolic panel: Within normal limits
- Tumor markers: CEA 0.9 ng/mL, SCC 1.2 ng/mL, CYFRA 0.9 ng/mL, proGRP 31.2 pg/mL (all within normal limits)","- Symptoms at presentation: Asymptomatic
- Lung complications: None reported
- Physical examination findings: Normal
- Circumstances of discovery: Incidental during screening CT
- Disease course and natural history: No progression over 3 years; remained asymptomatic
- Progression over time: No radiologic progression
- Complications or adverse outcomes: None reported
- Pulmonary function testing: Spirometry was unremarkable","- Imaging modalities used: CT
- Nodule characteristics:
  - Size: 1-2 mm
  - Number/innumerable: Innumerable
  - Distribution: Predominantly peripheral/subpleural
  - Appearance: Micronodular
- Temporal changes on follow-up imaging: No new lesions or growth over 3 years",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Multiple small, firm subpleural nodules
- Gross anatomic location: Subpleural
- Microscopic/Histological features and morphology: Spindle-to-ovoid cells in whorled arrangements without atypia or mitoses
- Microscopic location: Not specified
- Immunohistochemical markers tested and results: Vimentin (positive), EMA (negative), cytokeratin AE1/AE3 (negative), SMA (negative), chromogranin (negative)
- Molecular or genetic findings: Not tested; recurrent alterations in NF2, TRAF7, KLF4, AKT1, and SMO are characteristic of meningiomas
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Not specified beyond histological and immunohistochemical findings",,,,,,,"- Diagnostic criteria used: Histological examination showing spindle-to-ovoid cells in whorled arrangements without atypia or mitoses; immunohistochemistry revealing vimentin positivity and negativity for epithelial and neuroendocrine markers.
- Differential diagnoses considered: Miliary tuberculosis, sarcoidosis, hematogenous metastases, lymphoproliferative disorders.
- Diagnostic methods employed: Diagnostic video-assisted thoracoscopic wedge resection due to infeasibility of bronchoscopic biopsy.
- Challenges in distinguishing from malignancy or metastatic meningioma: Radiological mimicry of other conditions; need for histopathologic confirmation.
- Recommendations for diagnosis: Histopathologic confirmation through surgical resection; use of PR and SSTR2A immunostains for further support; consideration of molecular testing in ambiguous cases.",,,,,,,,,,,,"- Method: Video-assisted thoracoscopic wedge resection
- Biopsy site: Right upper lobe
- Bronchoscopic biopsy: Not feasible due to minute and peripheral distribution of nodules","- Positive: Vimentin
- Negative: EMA, cytokeratin AE1/AE3, SMA, chromogranin",,,,,,,,,,,,,,,,,,"- Management strategies: Diagnostic video-assisted thoracoscopic wedge resection
- Monitoring intervals: Surveillance CTs at regular intervals over 3 years
- Recommendations for management: Histopathologic confirmation when bronchoscopic sampling is impracticable
- Other: No additional treatments mentioned beyond surgery and follow-up imaging",,,,,"- Follow-up duration and methods: 3 years, regular surveillance CT scans
- Disease progression/stability: Stable, no radiologic progression
- Radiological stability or progression: No new lesions or growth
- Symptomatic or asymptomatic: Asymptomatic
- Clinical outcomes and patient status: Discharged without complications, asymptomatic
- Survival/outcome at last follow up: Asymptomatic, no new lesions or growth
- Treatment effectiveness: Successful diagnostic video-assisted thoracoscopic wedge resection
- Long-term prognosis: Favorable, stable disease and asymptomatic",,,,,,,,,
,Diffuse Pulmonary Meningotheliomatosis Presenting as Innumerable Pulmonary Micronodules: A Case Report,Koh et al.,10.1111/1759-7714.70172,https://doi.org/10.1111/1759-7714.70172,Thoracic Cancer,2025,TCA-16-e70172.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: 2019 to 2022
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding during routine chest CT","- Age: 44 years old
- Sex distribution: Female
- Smoking status: Not mentioned
- E-cigarette/vape use: Not mentioned
- Relevant medical history: Asymptomatic
- History of pulmonary thromboemboli: Not mentioned
- History of pulmonary cryptococcus: Not mentioned
- History of hypersensitivity pneumonitis: Not mentioned
- History of ulcerative colitis: Not mentioned
- History of infective endocarditis: Not mentioned
- Social history: Not mentioned
- Environment exposures: Not mentioned
- Incidence/prevalence data: Not mentioned
- Other demographic characteristics: Not mentioned",,,,,,,,,,,,,,,,,,,,"Not mentioned (the paper does not provide information on associated conditions such as history of genetic disorders, concurrent malignancies, intracranial meningioma, or other systemic diseases)",,,,,,,,,,,,,,,,,,"- PFTs or spirometry at diagnosis: Normal
- FEV1, FVC, FEV/FVC, DLCO, TLC, RV: Not mentioned
- Did these get worse or were stable or improved: Stable
- Comparison of DPM vs MPMN values: Not mentioned","- Bronchoscopy findings: Not mentioned (bronchoscopy was not performed due to technical feasibility)
- Bronchoalveolar lavage (BAL) analysis: Not mentioned
- Cell count and predominance: Not mentioned
- CD4/CD8 ratio: Not mentioned
- Was a Transbronchial lung biopsy performed? No
- Was a Transbronchial lung cryobiopsy performed? No
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? Yes",,,,"- Complete blood count (CBC): Normal
- Metabolic panel: Normal
- Tumor markers: Normal (CEA 0.9 ng/mL, SCC 1.2 ng/mL, CYFRA 0.9 ng/mL, proGRP 31.2 pg/mL)
- ECG: Unremarkable
- Spirometry: Unremarkable","- Symptoms at presentation: Asymptomatic
- Lung complications: None reported
- Physical examination findings: Normal
- Circumstances of discovery: Incidental during routine chest CT
- Disease course and natural history: Stable with no progression over 3 years
- Progression over time: No radiologic progression
- Complications or adverse outcomes: None reported
- Pulmonary function testing: Spirometry was unremarkable","- Imaging modalities used: CT
- Nodule characteristics:
  - Size: 1-2 mm
  - Number/innumerable: Innumerable
  - Distribution: Bilateral, predominantly peripheral/subpleural
  - Appearance: Micronodules
- Temporal changes on follow-up imaging: No new lesions or growth over 3 years
- Other radiology studies: Postoperative brain MRI showed no intracranial lesions",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Multiple small, firm subpleural nodules
- Gross anatomic location: Subpleural
- Microscopic/Histological features and morphology: Spindle-to-ovoid cells in whorled arrangements without atypia or mitoses
- Microscopic location: Not specified
- Immunohistochemical markers tested and results: Vimentin (positive), EMA (negative), cytokeratin AE1/AE3 (negative), SMA (negative), chromogranin (negative)
- Molecular or genetic findings: Not tested; recurrent alterations in NF2, TRAF7, KLF4, AKT1, and SMO are characteristic of meningiomas
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Not specified beyond histological and immunohistochemical findings",,,,,,,"- Diagnostic criteria used: Histological examination showing spindle-to-ovoid cells in whorled arrangements; immunohistochemistry with vimentin positivity and negativity for epithelial and neuroendocrine markers.
- Differential diagnoses considered: Miliary tuberculosis, sarcoidosis, hematogenous metastases, lymphoproliferative disorders.
- Diagnostic methods employed: Video-assisted thoracoscopic wedge resection due to infeasibility of bronchoscopic biopsy.
- Challenges in distinguishing from malignancy or metastatic meningioma: Requires careful differential diagnosis and histopathologic confirmation.
- Recommendations for diagnosis: Use of PR and SSTR2A immunostains when available; molecular testing for ambiguous cases.",,,,,,,,,,,,"- Method: Video-assisted thoracoscopic wedge resection
- Biopsy site: Right upper lobe
- Surgical Biopsy: Yes","- Positive: Vimentin
- Negative: EMA, cytokeratin AE1/AE3, SMA, chromogranin",,,,,,,,,,,,,,,,,,"- Management strategies: Diagnostic video-assisted thoracoscopic wedge resection for histopathologic confirmation; observation with regular CT scans for surveillance.
- Monitoring intervals: Regular CT scans over a 3-year period.
- Recommendations for management: Histopathologic confirmation when bronchoscopic sampling is impracticable; surveillance with regular CT scans.
- Other: Molecular testing may aid in ambiguous cases or provide prognostic context, but it is not mandatory.",,,,,"- Follow-up duration and methods: 3 years, surveillance CT scans at regular intervals
- Disease progression/stability: No radiologic progression; asymptomatic
- Radiological stability or progression: No new lesions or growth
- Symptomatic or asymptomatic: Asymptomatic
- Clinical outcomes and patient status: Discharged on postoperative Day 3; no intracranial lesions on postoperative brain MRI
- Survival/outcome at last follow up: Asymptomatic with no radiologic progression
- Treatment effectiveness if interventions performed: Successful surgical intervention without immediate complications
- Long-term prognosis: Stable with no progression over 3 years",,,,,,,,,
,Diffuse Pulmonary Meningotheliomatosis: A Diagnostically Challenging Entity on Fine-Needle Aspiration Cytology,Huang et al.,10.1111/1759-7714.70172,https://doi.org/10.1111/1759-7714.70172,Thoracic Cancer,2015,huang2015.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding during CT evaluation","- Age: 57 years
- Sex distribution: Female
- Smoking status: Nonsmoker
- Relevant medical history: Obesity, hypertension, asthma, hypercholesterolemia, history of pulmonary embolus
- History of pulmonary thromboemboli: Yes",,,,,,,,,,,,,,,,,,,,"- History of obesity
- History of hypertension
- History of asthma
- History of hypercholesterolemia
- Pulmonary embolism (treated with Coumadin)
- Mild obstructive changes
- Normal lung volume
- Preserved diffusing capacity for carbon monoxide
- Allergic symptoms",,,,,,,,,,,,,,,,,,"- PFTs or spirometry at diagnosis: Mild obstructive changes, normal lung volume, preserved DLCO
- FEV1, FVC, FEV/FVC, DLCO, TLC, RV: Not specifically mentioned
- Did these get worse or were stable or improved: Not mentioned
- Comparison of DPM vs MPMN values: Not mentioned","- Bronchoscopy findings: Normal appearing airways
- Bronchoalveolar lavage (BAL) analysis: Benign appearing bronchial columnar cells and alveolar macrophages
- Cell count and predominance: Not mentioned
- CD4/CD8 ratio: Not mentioned
- Was a Transbronchial lung biopsy performed? No
- Was a Transbronchial lung cryobiopsy performed? No
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? No",,,,"- Pulmonary function test: mild obstructive changes, normal lung volume, preserved diffusing capacity for carbon monoxide
- Bronchoalveolar lavage: benign appearing bronchial columnar cells and alveolar macrophages","- Symptoms at presentation: Asymptomatic for respiratory symptoms; history of obesity, hypertension, asthma, and hypercholesterolemia.
- Lung complications: Pulmonary embolus.
- Physical examination findings: Not mentioned.
- Circumstances of discovery: Incidental during follow-up CT evaluation.
- Disease course and natural history: Increase in number and size of nodules over time.
- Progression over time: Increased and diffuse bilateral pulmonary nodules.
- Complications or adverse outcomes: Pulmonary embolus.
- Pulmonary function testing: Mild obstructive changes, normal lung volume, preserved diffusing capacity for carbon monoxide.","- Imaging modality: CT
- Nodule characteristics:
  - Size: 2 to 9 mm
  - Number: Innumerable
  - Distribution: Bilateral and diffuse
  - Appearance: Ground glass, solid, with few containing calcifications
  - Distribution tendency: Peripheral zone",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Not mentioned
- Gross anatomic location: Not mentioned
- Microscopic/Histological features and morphology: Whorled/nested clusters of elongated cells with oval nuclei, clear pseudonuclear inclusions, nuclear grooves/indentations, smooth nuclear contours, fine granular chromatin, inconspicuous nucleoli, and abundant fibrillary cytoplasm with indistinct cell borders.
- Microscopic location: Interstitial
- Immunohistochemical markers tested and results: Positive for vimentin, EMA, PR; negative for cytokeratin (AE1/AE3), smooth muscle actin, S-100, HMB-45, CD31, and CD34.
- Molecular or genetic findings: Not mentioned
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Not specifically mentioned beyond histological and immunohistochemical characteristics.",,,,,,,"- Diagnostic criteria used: Cytologic features include whorled/nested clusters of elongated cells with oval nuclei, clear pseudonuclear inclusions, nuclear grooves/indentations, smooth nuclear contours, fine granular chromatin, inconspicuous nucleoli, and abundant fibrillary cytoplasm with indistinct cell borders.
- Differential diagnoses considered: Pulmonary Langerhans cell histiocytosis (PLCH), inflammatory process.
- Diagnostic methods employed: CT-guided fine-needle aspiration cytology, pulmonary wedge resections, immunohistochemical profiling.
- Challenges in distinguishing from malignancy or metastatic meningioma: Radiographic findings mimic metastatic tumors.
- Recommendations for diagnosis: Familiarity with cytologic features, awareness of this entity in the context of multiple pulmonary micronodules.",,,,,,,,,,,,"- Method: Fine-needle aspiration (FNA) and surgical biopsy (pulmonary wedge resections)
- Frequency: FNA was performed once; surgical biopsy involved multiple resections
- Biopsy site: FNA from left upper lobe; surgical biopsy from right upper, middle, and lower lobes
- Bronchoscopic biopsy: Performed but did not provide diagnostic material for DPM","- Positive: vimentin, epithelial membrane antigen (EMA), progesterone receptor (PR), CD56
- Negative: cytokeratin (AE1/AE3), smooth muscle actin, S-100, HMB-45, CD31, CD34",,,,,,,,,,,,,,,,,,"- Management strategies: Treatment of pulmonary embolus with Coumadin; CT-guided FNA biopsy; pulmonary wedge resections.
- Monitoring intervals: Not mentioned.
- Recommendations for management: Early recognition and accurate diagnosis to prevent unnecessary procedures.
- Other: No specific other management strategies or recommendations mentioned.",,,,,"- Follow-up duration and methods: Follow-up CT scans at 3 months showed increased and diffuse bilateral pulmonary nodules.
- Disease progression/stability: Disease progression with increased nodules.
- Radiological stability or progression: Radiological progression with increased nodules.
- Symptomatic or asymptomatic: Asymptomatic except for usual allergic symptoms.
- Clinical outcomes and patient status: Mild obstructive changes on pulmonary function tests; asymptomatic.
- Survival/outcome at last follow-up: Not mentioned.
- Treatment effectiveness if interventions performed: Not explicitly mentioned.
- Long-term prognosis: Not mentioned.",,,,,,,,,
,Bilateral pulmonary nodules: A case of meningotheliomatosis,Jesus et al.,10.18332/pne/163185,https://doi.org/10.18332/pne/163185,Pneumon,2023,Bilateral pulmonary.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: 1
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: 2 years follow-up
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding during routine chest CT for follow-up","- Age: 81 years old
- Sex: Female
- Smoking status: Non-smoker
- Relevant medical history: Stage IA lung adenocarcinoma",81,1,0,1,1,0,0,0,0,0,0,0,0,0,,0,,,,"- Concurrent lung malignancies: Lung adenocarcinoma
- Other pulmonary disease: Pulmonary thromboembolic disease, smoking-related interstitial lung disease
- Temporal relationship: DPM diagnosed after lung adenocarcinoma",,,,,,,,,,,,,,,,,,Not mentioned (no information on pulmonary function testing or spirometry results is included in the paper),Not mentioned (the paper does not provide any information on bronchoscopy findings or related procedures),,,,"Not mentioned (no specific laboratory features such as CBC, metabolic panel, etc., are mentioned in the paper)","- Symptoms at presentation: Asymptomatic or non-specific cardiorespiratory symptoms
- Lung complications: Not mentioned
- Physical examination findings: Not mentioned
- Circumstances of discovery: Incidental during routine follow-up chest CT scan
- Disease course and natural history: Clinically innocuous with conservative management
- Progression over time: Stable over a 2-year follow-up period
- Complications or adverse outcomes: Not mentioned
- Pulmonary function testing: Not mentioned","- Imaging modalities used: Chest CT, 18-FDG PET scan
- Nodule characteristics:
  - Size: 2-5 mm
  - Number: Multiple
  - Distribution: Diffuse and bilateral
  - Basal predominance
  - Appearance: Ground-glass opacity
- Other unique lung findings on CT: Central lucency ('cheerio sign')
- SUV values if PET performed: Not mentioned
- Temporal changes on follow-up imaging: Not mentioned
- Visibility on CT: Visible
- Other radiology studies: Not mentioned",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Diffuse and bilateral, randomly distributed nodules.
- Gross anatomic location: Throughout the lung tissue.
- Microscopic/Histological features and morphology: Epithelioid cell proliferation within the interstitium.
- Microscopic location: Within the interstitium.
- Immunohistochemical markers tested and results: Not mentioned.
- Molecular or genetic findings: Not mentioned.
- Ultrastructural features: Not mentioned.
- Pathological criteria used for diagnosis: Definitive diagnosis requires lung biopsy, typically surgical.",,,,,,,"- Diagnostic criteria used: Ground-glass appearance on chest CT scans, often with central lucency.
- Differential diagnoses considered: Infections, inflammatory disorders, metastatic malignancy (as listed in Table 1).
- Misdiagnosis rates and types: Not mentioned.
- Diagnostic methods employed: Chest CT scans, 18-FDG PET scans, video-assisted thoracoscopic (VATS) biopsy.
- Challenges in distinguishing from malignancy or metastatic meningioma: Difficulty in distinguishing DPM from other conditions, especially in patients with a history of malignancy.
- Recommendations for diagnosis: Correlation with clinical and radiological findings, along with lung biopsy for definitive diagnosis.",,,,,,,,,,,,"- Method: Video-assisted thoracoscopic (VATS) biopsy
- Biopsy site: Not specified (bilateral micronodules)",Not mentioned (the paper does not provide immunohistochemistry results),,,,,,,,,,,,,,,,,,"- Management strategies: Conservative management
- Monitoring intervals: Not specified
- Recommendations for management: Correlation with clinical and radiological findings, lung biopsy for definitive diagnosis
- Other: The patient is asymptomatic and under follow-up",,,,,"- Follow-up duration and methods: 2 years since detection
- Disease progression/stability: Asymptomatic, no signs of malignancy
- Radiological stability or progression: Not mentioned
- Symptomatic or asymptomatic: Asymptomatic
- Clinical outcomes and patient status: Clinically innocuous, conservative management
- Survival/outcome at last follow up: Asymptomatic, no signs of malignancy
- Treatment effectiveness if interventions performed: Conservative management
- Long-term prognosis: Not mentioned",,,,,,,,,
,Case 323: Minute Pulmonary Meningothelial-like Nodules,Ufuk et al.,10.1148/radiol.222512,https://doi.org/10.1148/radiol.222512,Radiology,2024,Ufuk et al. - 2024 - Case 323 Minute Pulmonary Meningothelial-like Nodules.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: 1
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: 5 years
- Institution/geographic location: Not mentioned
- Method of patient identification: Symptomatic presentation","- Age: 70 years
- Sex: Female
- Smoking status: Non-smoker
- Relevant medical history: Asthma (6 years), diabetes mellitus (12 years)
- Family history: Maternal endometrial cancer",70,1,0,1,0,0,0,0,0,1,0,0,0,0,,0,,,,"- History of asthma
- History of diabetes mellitus
- Family history of maternal endometrial cancer",,,,,,,,,,,,,,,,,,"- FEV1: 108% predicted
- FVC: 101% predicted
- TLC: 72% predicted
- DLCO: 69% predicted
- Forced midexpiratory flow: 85% predicted
- No information on changes over time or comparison to DPM values",Not mentioned (the paper does not provide any information on bronchoscopy findings or related procedures),,,,"- Complete blood count (CBC): Within normal limits
- Erythrocyte sedimentation rate (ESR): Within normal limits
- C-reactive protein (CRP) level: Within normal limits
- Rheumatoid factor: Within normal limits
- Antinuclear antibody (ANA) levels: Within normal limits","- Symptoms at presentation: Dyspnea and cough
- Lung complications: None mentioned
- Physical examination findings: Normal breath sounds, partial oxygen saturation of 98%, respiratory rate of 18 breaths per minute, heart rate of 77 beats per minute
- Circumstances of discovery: Presented to the pulmonology clinic with symptoms
- Disease course and natural history: Stable over 5 years, suggesting a benign process
- Progression over time: No change in pulmonary nodules over 5 years
- Complications or adverse outcomes: None reported
- Pulmonary function testing: Forced expiratory volume in 1 second, 108% predicted; total lung capacity, 72% predicted; forced vital capacity, 101% predicted; diffusing capacity for carbon monoxide, 69% predicted; forced midexpiratory flow, 85% predicted","- Imaging modalities used: Unenhanced chest CT, High-resolution CT (HRCT)
- Nodule characteristics:
  - Size: ≤6 mm
  - Number: Numerous
  - Distribution: Randomly distributed in both lungs
  - Appearance: Ground-glass opacity with central lucencies (Cheerio sign)
- Temporal changes on follow-up imaging: Stable over 5 years
- Visibility on CT: Visible",,,,,,,,,,,,,,,,"- Microscopic/Histological features and morphology: Numerous bland spindle cell proliferations expanding the alveolar septa and resembling meningothelial cells with a whorl formation.
- Microscopic location: Within the lung interstitium, specifically expanding the alveolar septa.
- Immunohistochemical markers tested and results: Positive for progesterone receptors and epithelial membrane antigen; negative for synaptophysin.",,,,,,,"- Diagnostic criteria used: Thin-section CT of the chest to identify ground-glass nodules with central lucencies; histopathologic examination and immunohistochemical staining to confirm meningothelial-like cells.
- Differential diagnoses considered: PLCH, multifocal lung adenocarcinoma, metastases, rheumatoid nodule, granulomatous polyangiitis, MMPH, DIPNECH, nonfibrotic hypersensitivity pneumonitis, cavitary sarcoidosis.
- Diagnostic methods employed: Thin-section CT of the chest; surgical lung biopsy for histopathology and immunohistochemical staining.
- Challenges in distinguishing from malignancy or metastatic meningioma: Clinical findings alone are insufficient; imaging and histopathology are necessary for accurate diagnosis.
- Recommendations for diagnosis: Use thin-section CT and histopathological examination to confirm diagnosis.",,,,,,,,,,,,Surgical lung biopsy (site not specified),"- Positive: progesterone receptors, epithelial membrane antigen
- Negative: synaptophysin",,,,,,,,,,,,,,,,,,The management strategy for this case was observation without any additional treatment recommendations.,,,,,"- Follow-up duration and methods: 5 years, volumetric thin-section CT
- Disease progression/stability: Stable
- Radiological stability or progression: Stable
- Symptomatic or asymptomatic: Nonspecific respiratory symptoms
- Clinical outcomes and patient status: Observed without additional treatment
- Survival/outcome at last follow-up: Not mentioned
- Treatment effectiveness: Not applicable
- Long-term prognosis: Benign",,,,,,,,,
,Diffuse pulmonary meningotheliomatosis,Yun et al.,10.1016/j.clinimag.2020.10.007,https://doi.org/10.1016/j.clinimag.2020.10.007,Clinical Imaging,2021,Yun et al. - 2021 - Diffuse pulmonary meningotheliomatosis.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Symptomatic presentation","- Age: 80 years (individual age)
- Sex distribution: Female
- Smoking status: Non-smoker
- Relevant medical history: Hypertension, type 2 diabetes mellitus, chronic kidney disease, gastroesophageal reflux disease, surgical history of benign colon polyp resection
- Social history: No smoking, no known lung disease",80,,,,,,,,,,,,,,,,,,,"- Potential associations: thromboembolism, smoking-related interstitial lung disease, neoplasm
- Concurrent lung malignancies: potential confusion with metastatic disease
- Other conditions: not mentioned
- Frequency and temporal relationship: not mentioned",,,,,,,,,,,,,,,,,,"- PFTs or spirometry at diagnosis: FEV1 of 1.55 L (84%), FVC of 1.89 L (70%), FEV1/FVC ratio of 0.82, DLCO of 15.70 mL/mmHg/min (79%)
- Did these get worse or were stable or improved: Stable in the 6-month follow-up
- Comparison of DPM vs MPMN values: Not directly compared in the paper","- Bronchoscopy findings: Not mentioned
- Bronchoalveolar lavage (BAL) analysis: Not mentioned
- Cell count and predominance: Not mentioned
- CD4/CD8 ratio: Not mentioned
- Was a Transbronchial lung biopsy performed? If yes, describe results: Not mentioned
- Was a Transbronchial lung cryobiopsy performed? If yes, describe results: Not mentioned
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? Yes, a surgical lung biopsy was performed for definitive diagnosis.",,,,"- Complete blood count (CBC): Normal
- Metabolic panel: Normal (electrolytes, kidney and liver function profiles)
- Autoimmune workup: Positive for ANA and SSA, but no clinical signs or symptoms of autoimmune disorder
- Infectious workup: Negative for infectious disease","- Symptoms at presentation: Dry cough, progressive dyspnea
- Lung complications: None mentioned
- Physical examination findings: Unremarkable, hemodynamically stable, well-nourished
- Circumstances of discovery: Symptomatic workup
- Disease course and natural history: Stable in 6-month follow-up
- Progression over time: No progression mentioned
- Complications or adverse outcomes: None reported
- Pulmonary function testing: Restrictive ventilatory defect with FEV1 of 1.55 L (84%), FVC of 1.89 L (70%), FEV1/FVC ratio of 0.82, diffusing capacity for CO2 of 15.70 mL/mmHg/min (79%)","- Imaging modalities used: High-resolution chest CT (HRCT)
- Nodule characteristics:
  - Size: 2-4 mm
  - Number: Multiple
  - Distribution: Random
  - Centrilobular, panlobar, or paraseptal predominance: Random distribution
  - Upper or lower predominance: Mild predilection for lower lobes
  - Appearance: Predominantly ground-glass opacity
  - Other unique lung findings on CT: None mentioned
  - SUV values if PET performed: Not mentioned
  - Temporal changes on follow-up imaging: Not specifically mentioned
  - Visibility on CT: Visible
  - Other radiology studies: Not mentioned",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Not mentioned
- Gross anatomic location: Not mentioned
- Microscopic/Histological features and morphology: Numerous nodules measuring 0.5 mm to 3 mm in a random distribution, composed of bland epithelioid cells forming small nests within the interstitium with associated variable amount of fibrosis.
- Microscopic location: Within the interstitium
- Immunohistochemical markers tested and results: Not mentioned
- Molecular or genetic findings: Not mentioned
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Presence of small nodules with bland epithelioid cells in a random distribution within the interstitium",,,,,,,"- Diagnostic criteria used: Surgical biopsy, imaging characteristics (distribution and appearance of nodules)
- Differential diagnoses considered: RB-ILD, HP, vasculitis, infection, metastatic disease, miliary tuberculosis or fungal infection
- Diagnostic methods employed: Surgical biopsy (VATS lung wedge biopsy), imaging
- Challenges in distinguishing from malignancy or metastatic meningioma: Difficulty in differentiating from metastatic disease, especially in patients with a history of malignancy
- Recommendations for diagnosis: Tissue confirmation through surgical biopsy, correlation with clinical and radiologic findings",,,,,,,,,,,,Surgical Biopsy: VATS lung wedge biopsy of right upper and lower lobes,"- Positive: Meningothelial origin
- Negative: Neuroendocrine differentiation",,,,,,,,,,,,,,,,,,"- Management strategies: Conservative management with surveillance imaging.
- Monitoring intervals: 6-month follow-up after VATS biopsy.
- Recommendations for management: Conservative approach with surveillance imaging.
- Other: No additional treatments mentioned beyond diagnostic VATS biopsy.",,,,,"- Follow-up duration and methods: 6 months, surveillance imaging
- Disease progression/stability: Stable
- Radiological stability or progression: Stable
- Symptomatic or asymptomatic: Asymptomatic
- Clinical outcomes and patient status: Stable
- Survival/outcome at last follow-up: Stable
- Treatment effectiveness: Conservative management with surveillance imaging
- Long-term prognosis: Generally favorable",,,,,,,,,
,Minute Pulmonary Meningothelial-Like Nodules: A Case of Incidentally Detected Diffuse Cystic Micronodules on Thin-Section Computed Tomography,Kraushaar et al.,-,-,Journal of Computer Assisted Tomography,2010,kraushaar2010.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: 1
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding during screening for iron deficiency anemia","- Age: 54 years old
- Sex: Female
- Smoking status: Nonsmoker
- Relevant medical history: Hypertension, gastroesophageal reflux
- Incidence/prevalence data: Most frequent in the sixth decade; female-to-male ratio of 1.8:9:1",54,,,,,,,,,,,,,,,,,,,"- Concurrent lung malignancies: Pulmonary adenocarcinoma (9% to 10% association)
- Other concurrent malignancies: Uterine cancer, breast cancer
- Other pulmonary disease: Pulmonary thromboembolism (24% to 42% association), smoking-related interstitial lung disease, atypical adenomatous hyperplasia
- History of cardiac disease: Suggested association
- Frequency of associations: Pulmonary thromboembolism (24% to 42%), pulmonary adenocarcinoma (9% to 10%)
- Temporal relationship: Not specifically detailed in the paper",,,,,,,,,,,,,,,,,,Not mentioned (the paper does not provide specific pulmonary function testing values or comparisons between DPM and MPMN),Not mentioned (the paper does not provide any information on bronchoscopy findings or related procedures),,,,"- Complete blood count (CBC): Iron deficiency anemia
- Metabolic panel: Not mentioned
- Bronchoalveolar lavage: Not mentioned
- Autoimmune workup: Not mentioned
- Infectious workup: Not mentioned","- Symptoms at presentation: Asymptomatic (denied fatigue, shortness of breath, or other respiratory symptom)
- Lung complications: Not mentioned
- Physical examination findings: Not mentioned
- Circumstances of discovery: Incidental (found during routine office visit for iron deficiency anemia)
- Disease course and natural history: Patient was generally well; anemia responded to iron therapy
- Progression over time: Not mentioned
- Reported complications or adverse outcomes: Not mentioned
- Pulmonary function testing, spirometry, or walking tests: Not mentioned","- Imaging modalities used: CT (CT enteroclysis, spiral chest CT with 1-mm reformations)
- Nodule characteristics:
  - Size: 1 to 4 mm
  - Number: Multiple
  - Distribution: Bilateral, randomly distributed
  - Appearance: Thin-walled cavities
  - Other unique lung findings on CT: No other parenchymal, hilar, mediastinal, or pleural abnormality",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Multiple indistinct, pale, tan, small nodules with central tissue loss.
- Gross anatomic location: Subpleural.
- Microscopic/Histological features and morphology: Interstitial proliferation of cytologically bland oval to blunted spindle cells.
- Microscopic location: Interstitial, juxtaposed to pleura, interlobular septa, and perilobular venous tributaries.
- Immunohistochemical markers tested and results: Positive for vimentin, epithelial membrane antigen, progesterone receptor, and CD56; negative for pankeratin, synaptophysin, S-100 protein, bombesin, CD34.
- Molecular or genetic findings: Suggests a reactive origin; increased genetic instability in cases with multiple MPMNs.
- Ultrastructural features: Not mentioned.
- Pathological criteria used for diagnosis: Not specifically mentioned beyond microscopic and immunohistochemical characteristics.",,,,,,,"- Diagnostic criteria used: Microscopic examination showing interstitial proliferation of cytologically bland oval to blunted spindle cells; immunohistochemical profile consistent with previous descriptions.
- Differential diagnoses considered: Metastatic disease, atypical infections, pulmonary Langerhans cell histiocytosis.
- Diagnostic methods employed: CT enteroclysis, spiral chest CT with thin-section reformations, minimally invasive thoracoscopic lung biopsy.
- Challenges in distinguishing from malignancy or metastatic meningioma: MPMNs can be mistaken for neoplastic processes due to their appearance on imaging.
- Recommendations for diagnosis: Awareness of imaging manifestations; importance of tissue diagnosis to avoid misdiagnosis and ensure appropriate management.",,,,,,,,,,,,"- Method: Minimally invasive thoracoscopic lung biopsy
- Frequency: Single-wedge biopsy
- Biopsy site: Right upper lobe
- Surgical Biopsy: Yes","- Positive: vimentin, epithelial membrane antigen, progesterone receptor, CD56, rare cells positive for MIB1
- Negative: pankeratin, synaptophysin, S-100 protein, bombesin, CD34",,,,,,,,,,,,,,,,,,"- Management strategies: Minimally invasive thoracoscopic lung biopsy for tissue diagnosis.
- Monitoring intervals: Not mentioned.
- Recommendations for management: Accurate diagnosis to avoid misinterpretation as metastatic disease.
- Other: Anemia was managed with iron therapy.",,,,,"- Follow-up duration and methods: Not mentioned
- Disease progression/stability: Not mentioned
- Radiological stability or progression: Not mentioned
- Symptomatic or asymptomatic: Asymptomatic; no respiratory symptoms
- Clinical outcomes and patient status: Generally well; anemia responded to iron therapy
- Survival/outcome at last follow up: Not mentioned
- Treatment effectiveness if interventions performed: Not mentioned
- Long-term prognosis: Not mentioned",,,,,,,,,
,Mimicry of Minute Pulmonary Meningothelial-like Nodules to Metastatic Deposits in a Patient with Infiltrating Lobular Carcinoma: A Case Report and Review of the Literature,Kfoury et al.,10.4132/KoreanJPathol.2012.46.1.87,https://doi.org/10.4132/KoreanJPathol.2012.46.1.87,Korean Journal of Pathology,2012,kjpathol-46-87.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not applicable
- Number of single MPMN patients excluded: Not applicable
- Study period/duration: Not specified
- Institution/geographic location: Not specified
- Method of patient identification: Incidental finding during thin-section CT scan","- Age: 65 years old
- Sex: Female
- Smoking status: Regular smoker for 30 years
- Relevant medical history: Diabetic, hypertensive, positive family history of breast cancer",65,,,,,,,,,,,,,,,,,,,"- Concurrent lung malignancies: Not mentioned
- Other concurrent malignancies: Invasive lobular carcinoma of the breast
- Intracranial meningioma: Not mentioned
- Other pulmonary disease: Pulmonary thromboembolism, respiratory bronchiolitis-associated interstitial lung disease/desquamative interstitial pneumonia
- History of ulcerative colitis: Not mentioned
- History of cardiac disease or infective endocarditis: Congestive heart failure
- Other systemic associations: Atypical adenomatous hyperplasia
- Frequency of associations: Not specified
- Temporal relationship: MPMNs found incidentally during investigations for other conditions",,,,,,,,,,,,,,,,,,Not mentioned (no information on pulmonary function testing or spirometry is included in the paper),Not mentioned (the paper does not provide any information on bronchoscopy findings or related procedures),,,,"Not mentioned (no specific laboratory features such as CBC, metabolic panel, etc., are mentioned in the paper)","- Symptoms at presentation: Asymptomatic for MPMNs
- Lung complications: Small pneumothorax during thoracoscopy
- Physical examination findings: Firm, ill-defined 2-cm mass in the upper inner quadrant of the right breast
- Circumstances of discovery: Incidental during staging work-up for breast cancer
- Disease course and natural history: Benign, curative with surgical excision
- Progression over time: Not mentioned
- Complications or adverse outcomes: Small pneumothorax
- Pulmonary function testing: Not mentioned","- Imaging modality: Thin-section CT scan (HRCT)
- Nodule characteristics:
  - Size: Small
  - Number: Two
  - Distribution: Right lung, middle and lower lobes
  - Appearance: Ground-glass opacities",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Minute nodules, largest measuring 0.4 cm.
- Gross anatomic location: Within the pulmonary interstitium and around small veins.
- Microscopic/Histological features and morphology: Nests of cells in a ""zellballen""-like arrangement; oval to epithelioid cells with pale eosinophilic cytoplasm and indistinct cellular borders; nuclei are round to oval, uniform, and centrally located with a fine granular chromatin pattern.
- Microscopic location: Within the pulmonary interstitium and around small veins.
- Immunohistochemical markers tested and results: Vimentin (strong cytoplasmic positivity), E-cadherin (strong membranous positivity), EMA (moderate membranous positivity), PR (moderate to strong nuclear positivity).
- Ultrastructural features: Interdigitating cellular junctions, desmosomes, scattered intracytoplasmic filaments.
- Pathological criteria used for diagnosis: Microscopic and ultrastructural features, immunohistochemical profile.",,,,,,,"- Diagnostic criteria used: Microscopic features (nests of cells in a ""zellballen""-like arrangement), immunohistochemical markers (vimentin, E-cadherin, EMA, progesterone receptor positivity)
- Differential diagnoses considered: Metastatic carcinoma, pulmonary carcinoid tumors, paraganglioma, pulmonary meningioma, metastasis of primary intracranial malignant meningioma
- Misdiagnosis rates and types: Not mentioned
- Diagnostic methods employed: Imaging (thin-section CT scans), biopsy (coil-localization excision), surgical resection
- Challenges in distinguishing from malignancy or metastatic meningioma: Requires pathological correlation and specific immunohistochemical stains
- Recommendations for diagnosis: Maintain high suspicion for MPMNs, especially with other neoplasms; use microscopic morphology, immunohistochemical stains, and clinical/radiological findings",,,,,,,,,,,,"- Method: Open lung excisional biopsy
- Frequency: Two lung wedge biopsies
- Biopsy site: Right lower and middle lobes
- Surgical Biopsy: Coil-localization excision","- Positive:
  - Vimentin: strong cytoplasmic positivity
  - E-cadherin: strong membranous positivity
  - Epithelial membrane antigen (EMA): moderate membranous positivity
  - Progesterone receptor (PR): moderate to strong nuclear positivity
- Negative:
  - Neuroendocrine markers
  - Vascular markers
  - Melanocytic markers
  - Other epithelial markers
  - Estrogen receptor
  - Human epidermal growth factor receptor 2 (HER2)
  - GCDFP15",,,,,,,,,,,,,,,,,,"- Management strategies: Surgical excision of lung nodules
- Monitoring intervals: Follow-up at the oncology clinic
- Recommendations for management: Pathological correlation is essential for proper staging and treatment
- Other: Surgical excision is curative for MPMNs; management of complications such as pneumothorax with chest tube insertion",,,,,"- Follow-up duration and methods: Patient was discharged on the fourth day post-operatively and was to be followed up at the oncology clinic.
- Disease progression/stability: Not mentioned.
- Radiological stability or progression: Not mentioned.
- Symptomatic or asymptomatic: Patients with MPMNs are usually asymptomatic.
- Clinical outcomes and patient status: Successful surgical excision of lung nodules; no evidence of metastatic carcinoma.
- Survival/outcome at last follow-up: Not mentioned.
- Treatment effectiveness: Successful surgical excision.
- Long-term prognosis: Not mentioned.",,,,,,,,,
,"Diffuse Pulmonary Meningotheliomatosis Presenting as Multiple Peribronchial Consolidations Containing Patent Air Bronchogram, Not Small Nodules: A Rare Manifestation for a Rare Disease",Lee et al.,10.5812/iranjradiol.61395,https://doi.org/10.5812/iranjradiol.61395,Iranian Journal of Radiology,2018,61395.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: 1
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Symptomatic presentation","- Age: 45 years old
- Sex: Female
- Smoking status: Not mentioned
- E-cigarette/vape use: Not mentioned
- Relevant medical history: No past history of surgery or underlying chronic medical disease
- Incidence/prevalence data: 0.07% to 13.8% at autopsy or surgical resection",45,,,,,,,,,,,,,,,,,,,"- Concurrent lung malignancies: Pulmonary adenocarcinoma
- Other pulmonary disease: Pulmonary thromboembolism, respiratory bronchiolitis-associated interstitial lung disease, desquamative interstitial pneumonia, atypical adeno-matous hyperplasia
- History of cardiac disease: Congestive heart failure
- Frequency of associations: Not specified
- Temporal relationship: Not specified",,,,,,,,,,,,,,,,,,Not mentioned (the paper does not provide specific pulmonary function testing results or comparisons),"- Bronchoscopy findings: Bronchoscopic washing and brushing cytology were performed.
- Bronchoalveolar lavage (BAL) analysis: Not mentioned.
- Cell count and predominance: Not mentioned.
- CD4/CD8 ratio: Not mentioned.
- Was a Transbronchial lung biopsy performed? Yes, microscopic features revealed multiple small meningothelioid nests in peribronchial interstitium.
- Was a Transbronchial lung cryobiopsy performed? No.
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? No.",,,,"- Laboratory exam: No specific findings
- Culture of sputum and blood: No specific findings
- Infectious workup: Pneumonia excluded due to lack of pneumonic symptoms and laboratory findings","- Symptoms at presentation: Dyspnea (atypical symptom)
- Lung complications: Not mentioned
- Physical examination findings: Not mentioned
- Circumstances of discovery: Symptomatic workup
- Disease course and natural history: Stable disease course in this case
- Progression over time: No significant changes on follow-up CT scan
- Complications or adverse outcomes: Not mentioned
- Pulmonary function testing: Not mentioned","- Imaging modalities used: Chest-computed tomography (CT)
- Nodule characteristics:
  - Size: Not specified
  - Number/innumerable: Multiple
  - Distribution: Lower lung predominance
  - Centrilobular, panlobar, or paraseptal predominance: Not specified
  - Upper or lower predominance: Lower
  - Left or Right predominance: Not specified
  - Appearance: Patchy and nodular areas with patent air bronchogram
  - Other unique lung findings on CT: Peribronchial consolidations
- SUV values if PET performed: Not performed
- Temporal changes on follow-up imaging: No significant interval change
- Visibility on CT: Visible
- Other radiology studies: Not mentioned",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Not mentioned
- Gross anatomic location: Peribronchial
- Microscopic/Histological features and morphology: Multiple small meningothelioid nests
- Microscopic location: Peribronchial interstitium
- Immunohistochemical markers tested and results: Positive for EMA and vimentin; negative for CK, synaptophysin, CD56, CD1a, TTF-1, CD68, and S-100
- Molecular or genetic findings: Not mentioned
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Not mentioned",,,,,,,"- Diagnostic criteria used: Chest CT scans showing multiple peribronchial consolidations with patent air bronchogram.
- Differential diagnoses considered: Cryptogenic organizing pneumonia, multicentric consolidative primary lung malignancies (adenocarcinomas, lymphomas), multifocal bronchopneumonias.
- Diagnostic methods employed: Bronchoscopic washing and brushing cytology, transbronchial lung biopsy.
- Challenges in distinguishing from malignancy or metastatic meningioma: Overlapping radiological findings.
- Recommendations for diagnosis: Consider DPM in differential diagnosis for peribronchial consolidations with patent air bronchogram; use histological confirmation through biopsy.",,,,,,,,,,,,Transbronchial lung biopsy at anterior and posterior basal segments of the right lower lobe of the lung; Bronchoscopic washing and brushing cytology,"- Positive: Epithelial membrane antigen (EMA), Vimentin
- Negative: Cytokeratin (CK), Synaptophysin, CD56, CD1a, Thyroid transcription factor -1 (TIF -1), CD68, S -100",,,,,,,,,,,,,,,,,,"- Management strategies: Initial treatment with antibiotic medication for 20 days.
- Monitoring intervals: Follow-up chest CT scan after 20 days.
- Recommendations for management: Consideration of MPMNs in differential diagnosis to prevent diagnostic pitfalls.
- Other: No specific therapeutic interventions or effectiveness mentioned.",,,,,"- Follow-up duration and methods: 20 days, follow-up chest CT scan
- Disease progression/stability: Radiological stability
- Radiological stability or progression: No significant interval change
- Symptomatic or asymptomatic: Symptomatic with dyspnea
- Clinical outcomes and patient status: Persistent dyspnea
- Survival/outcome at last follow up: Not mentioned
- Treatment effectiveness if interventions performed: No improvement with antibiotics
- Long-term prognosis: Not mentioned",,,,,,,,,
,Diffuse Pulmonary Meningotheliomatosis and Turner's Syndrome: A Growing Area of Literature,Cooper et al.,-,-,American Thoracic Society 2025 International Conference,2025,Cooper et al. - Diffuse Pulmonary Meningotheliomatosis and Turner's Syndrome A Growing Area of Literature.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Follow-up at 2 years
- Institution/geographic location: Not mentioned
- Method of patient identification: Symptomatic presentation (chronic cough)","- Age: 57 years old
- Sex distribution: Female
- Smoking status: Non-smoker
- Relevant medical history: Turner syndrome, aortic coarctation, bicuspid aortic valve status post replacement, left vocal cord paralysis, heart failure with reduced ejection fraction",57,,,,,,,,,,,,,,,,,,,"- History of Turner syndrome: Yes
- Concurrent lung malignancies: Not mentioned
- Other concurrent malignancies: Not mentioned
- Intracranial meningioma: Not mentioned
- Other pulmonary disease: Not mentioned
- History of ulcerative colitis: Not mentioned
- History of cardiac disease: Yes (aortic coarctation, bicuspid aortic valve, heart failure with reduced ejection fraction)
- Other systemic associations: Not mentioned
- Frequency of associations: Third reported case of Turner syndrome associated with DPM
- Temporal relationship: Turner syndrome present before DPM diagnosis",,,,,,,,,,,,,,,,,,"- PFTs or spirometry at diagnosis: Mild obstructive ventilatory defect, no significant response to bronchodilators, air trapping, hyperinflation, mildly reduced diffusion capacity.
- FEV1, FVC, FEV/FVC, DLCO, TLC, RV: Not mentioned.
- Did these get worse or were stable or improved: Not mentioned.
- Comparison of DPM vs MPMN values: Not mentioned.","- Bronchoscopy findings: Bronchoscopic cultures demonstrated mixed respiratory flora; biopsy showed no malignant cells, mild acute inflammation, and pulmonary macrophages.
- Bronchoalveolar lavage (BAL) analysis: Not mentioned
- Cell count and predominance: Not mentioned
- CD4/CD8 ratio: Not mentioned
- Was a Transbronchial lung biopsy performed? Yes, results showed no malignant cells, mild acute inflammation, and pulmonary macrophages.
- Was a Transbronchial lung cryobiopsy performed? Not mentioned
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? Not explicitly mentioned, but thoracic surgery was consulted and wedge resections were performed.",,,,"- Pulmonary function testing: mild obstructive ventilatory defect, no significant response to bronchodilators, air trapping, hyperinflation, mildly reduced diffusion capacity
- Bronchoalveolar lavage: mixed respiratory flora, no malignant cells, mild acute inflammation, pulmonary macrophages","- Symptoms at presentation: Chronic cough
- Lung complications: Ground glass nodules bilaterally with central clearing or cavitation
- Circumstances of discovery: Incidental during evaluation for chronic cough
- Disease course and natural history: No significant increase in lung nodules over two years; no malignancy diagnosed
- Progression over time: Minimal; no significant increase in nodule size or number
- Pulmonary function testing: Mild obstructive ventilatory defect, air trapping, hyperinflation, mildly reduced diffusion capacity","- Imaging modality: CT
- Nodule characteristics:
  - Size: Largest nodule was five millimeters
  - Distribution: Bilateral
  - Appearance: Ground glass opacities with some having central clearing or cavitation
- Temporal changes: Increase in number of nodules on follow-up CT, but maximum size remained the same",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Minute pulmonary meningothelial-like nodules; ground glass nodules bilaterally on CT scans.
- Gross anatomic location: Bilateral.
- Microscopic/Histological features and morphology: No malignant cells; mild acute inflammation; pulmonary macrophages.
- Microscopic location: Not specified.
- Immunohistochemical markers tested and results: Positive for Vimentin, EMA, PR, CD163; negative for S100, CD1a, desmin, chromogranin, cytokeratin, HMB-45.
- Molecular or genetic findings: Not mentioned.
- Ultrastructural features: Not mentioned.
- Pathological criteria used for diagnosis: Immunohistochemical and pathological findings.",,,,,,,"- Diagnostic criteria used: Histopathologic review of lung tissue, immunohistochemical staining (positive for Vimentin, EMA, PR, CD163; negative for S100, CD1a, desmin, chromogranin, cytokeratin, HMB-45).
- Differential diagnoses considered: Malignancy, other conditions presenting with similar symptoms or imaging findings.
- Diagnostic methods employed: Chest CT scans, pulmonary function testing, bronchoscopy with bronchoalveolar lavage and transbronchial lung biopsy.
- Challenges in distinguishing from malignancy or metastatic meningioma: Ruling out malignancy through biopsy results.
- Recommendations for diagnosis: Use of comprehensive diagnostic methods including imaging, pulmonary function tests, bronchoscopy, and immunohistochemical staining.",,,,,,,,,,,,"- Bronchoscopic biopsy: Bronchoalveolar lavage and transbronchial lung biopsy
- Surgical Biopsy: Right upper and right lower lobe wedge resections","- Positive: Vimentin, EMA, PR, CD163
- Negative: S100, CD1a, desmin, chromogranin, cytokeratin, HMB-45",,,,,,,,,,,,,,,,,,"- Management strategies: Observation, use of fluticasone-salmeterol inhaler, bronchoscopy with bronchoalveolar lavage and transbronchial lung biopsy, prescription of Amoxicillin-Clavulanate, thoracic surgery (wedge resections).
- Monitoring intervals: Repeat CT scan in three months.
- Recommendations for management: Consideration of DPM in patients with diffuse ground glass pulmonary nodules.
- Other: Stable disease course at two years post-diagnosis.",,,,,"- Follow-up duration and methods: Two years post-diagnosis; CT scans at three months and two years.
- Disease progression/stability: No significant increase in lung nodules; no malignancy diagnosed.
- Radiological stability or progression: More ground-glass nodules scattered throughout the lungs; maximum nodule size remained at five millimeters.
- Symptomatic or asymptomatic: Patient felt better initially; no specific scales or symptoms detailed.
- Clinical outcomes and patient status: Prescribed fluticasone-salmeterol inhaler; underwent thoracic surgery (wedge resections).
- Survival/outcome at last follow-up: No significant increase in nodules; no malignancy.
- Treatment effectiveness: Patient felt better initially; radiological progression despite treatment.
- Long-term prognosis: Not mentioned.",,,,,,,,,
,An Alternative Approach of Diagnosing Diffuse Pulmonary Meningotheliomatosis (DPMs) with Transbronchial Cryobiopsy,Seo et al.,10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A6302,https://doi.org/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A6302,"American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX",2019,Seo et al. - 2019 - An Alternative Approach of Diagnosing Diffuse Pulmonary Meningotheliomatosis (DPMs) with Transbronch.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding on chest imaging and symptomatic presentation","- Age: 75 years old
- Sex: Female
- Relevant medical history: Late-onset asthma, giant cell arteritis on chronic low dose prednisone
- History of pulmonary thromboemboli: Ruled out",75,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,,,"- History of late-onset asthma
- History of giant cell arteritis
- On chronic low-dose prednisone
- No mention of genetic disorders, concurrent malignancies, intracranial meningioma, or other systemic associations",,,,,,,,,,,,,,,,,,"- PFTs or spirometry at diagnosis: Mild obstruction and moderately reduced diffusion capacity
- FEV1, FVC, FEV/FVC, DLCO, TLC, RV: Not mentioned
- Did these get worse or were stable or improved: Not mentioned
- Comparison of DPM vs MPMN values: Not mentioned","- Bronchoscopy findings: Bronchoscopy with lavage was negative for infection.
- Bronchoalveolar lavage (BAL) analysis: Negative for infection.
- Cell count and predominance: Not mentioned.
- CD4/CD8 ratio: Not mentioned.
- Was a Transbronchial lung biopsy performed? No.
- Was a Transbronchial lung cryobiopsy performed? Yes, results showed meningothelial-like nodules consistent with DPM.
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? No.",,,,"- Pulmonary function test: mild obstruction and moderately reduced diffusion capacity
- Bronchoalveolar lavage: negative for infection","- Symptoms at presentation: Mild exertional dyspnea and cough
- Lung complications: Moderate postoperative endobronchial bleeding
- Circumstances of discovery: Incidental finding on chest imaging
- Pulmonary function testing: Mild obstruction and moderately reduced diffusion capacity
- Complications: Moderate postoperative endobronchial bleeding
- Disease course and natural history: Not mentioned
- Progression over time: Not mentioned
- Physical examination findings: Not mentioned","- Imaging modalities used: CT
- Nodule characteristics:
  - Size: Micronodules
  - Number/innumerable: Numerous
  - Distribution: Bilateral
  - Appearance: Micronodular
  - Temporal changes on follow-up imaging: Unchanged from prior imaging
  - Visibility on CT: Visible",,,,,,,,,,,,,,,,"- Microscopic/Histological features and morphology: Meningothelial-like nodules occurring in close proximity consistent with diffuse minute pulmonary meningothelial-like nodules (MPMNs).
- Immunohistochemical markers tested and results: Positive for epithelial membrane antigen (EMA), negative for synaptophysin and chromogranin.",,,,,,,"- Diagnostic criteria used: Histological findings of meningothelial-like nodules; immunohistochemical profile positive for epithelial membrane antigen and negative for synaptophysin and chromogranin.
- Diagnostic methods employed: Transbronchial lung cryobiopsy (TBLCB) as a safer alternative to surgical lung biopsy (SLB).
- Challenges in distinguishing from malignancy or metastatic meningioma: Not explicitly discussed, but implies the need for histopathologic evaluation.
- Recommendations for diagnosis: TBLCB as the first-attempt diagnostic modality for asymptomatic or mildly symptomatic DPLD.",,,,,,,,,,,,Transbronchial lung cryobiopsy (TBLCB) of the right middle and lower lobes,"- Positive: Epithelial membrane antigen
- Negative: Synaptophysin, Chromogranin",,,,,,,,,,,,,,,,,,"- Management strategies: Transbronchial lung cryobiopsy (TBLCB) is suggested as a first-attempt diagnostic modality for asymptomatic or mildly symptomatic DPLD.
- Monitoring intervals: Not mentioned.
- Recommendations for management: TBLCB is recommended as a safer alternative to surgical lung biopsy (SLB).
- Other: Moderate postoperative endobronchial bleeding was managed with endobronchial blockade for 24 hours.",,,,,"- Follow-up duration and methods: Not mentioned
- Disease progression/stability: Radiological stability (no change in pulmonary micronodules)
- Radiological stability or progression: Stable (no change in pulmonary micronodules)
- Symptomatic or asymptomatic: Symptomatic (mild exertional dyspnea and cough)
- Clinical outcomes and patient status: Mild obstruction and moderately reduced diffusion capacity; moderate postoperative endobronchial bleeding
- Survival/outcome at last follow-up: Not mentioned
- Treatment effectiveness if interventions performed: Not applicable (diagnostic procedure)
- Long-term prognosis: Not mentioned",,,,,,,,,
,Meningotheliomatosis: A Rare Cause of Diffuse Miliary Pattern Pulmonary Opacities,Gleason,10.7860/JCDR/2016/22345.8354,https://doi.org/10.7860/JCDR/2016/22345.8354,JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH,2016,22345_CE(EK)_F(AK)_PF1(EKAK)_PFA(NC_AK)_PF2(EkGH).pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding","- Age: 63 years old
- Sex distribution: Female
- Smoking status: Smoker with 10 pack-year history
- E-cigarette/vape use: Not mentioned
- Relevant medical history: 10 pack-year smoking history, occupational chemical fume exposure
- History of pulmonary thromboemboli: Not mentioned
- History of pulmonary cryptococcus: Not mentioned
- History of hypersensitivity pneumonitis: Not mentioned
- History of ulcerative colitis: Not mentioned
- History of infective endocarditis: Not mentioned
- Social history: Born in Paraguay, moved to the United States in early 30s
- Environment exposures: Occupational chemical fume exposure from working in a compounding pharmacy
- Incidence/prevalence data: Exceedingly rare, typically occurs in women near the sixth decade of life
- Other demographic characteristics: Occupation - worker in a compounding pharmacy",63,,,,,,,,,,,,,,,,,,,- Concurrent lung malignancies: Associated with an increased prevalence of pulmonary malignancy; no specific malignancy type mentioned.,,,,,,,,,,,,,,,,,,"- Spirometry: Normal
- DLCO: Decreased
- FEV1, FVC, FEV/FVC, TLC, RV: Not mentioned
- Did these get worse or were stable or improved: Not mentioned
- Comparison of DPM vs MPMN values: Not mentioned","- Bronchoscopy findings: Cultures were negative.
- Bronchoalveolar lavage (BAL) analysis: Not mentioned.
- Cell count and predominance: Not mentioned.
- CD4/CD8 ratio: Not mentioned.
- Was a Transbronchial lung biopsy performed? Yes, revealed many meningothelial like bodies.
- Was a Transbronchial lung cryobiopsy performed? No.
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? No.",,,,"- Infectious workup: HIV, Tuberculosis - negative
- Autoimmune workup: negative
- Spirometry: normal
- DLCO: decreased
- Bronchoscopy cultures: negative","- Symptoms at presentation: Asymptomatic
- Lung complications: Not mentioned
- Physical examination findings: No mediastinal or hilar adenopathy
- Circumstances of discovery: Incidental
- Disease course and natural history: Typically asymptomatic, occurring in women near the sixth decade of life
- Progression over time: Not mentioned
- Complications or adverse outcomes: Not mentioned
- Pulmonary function testing: Spirometry normal, DLCO decreased","- Imaging modalities used: CT with contrast, PET/CT
- Nodule characteristics:
  - Size: up to 4mm
  - Number/innumerable: innumerable
  - Distribution: diffusely distributed
  - Appearance: military type pattern
- Other unique lung findings on CT: no mediastinal or hilar adenopathy",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Innumerable and diffusely distributed nodules up to 4mm in a military type pattern.
- Gross anatomic location: Diffuse distribution.
- Microscopic/Histological features and morphology: Presence of many meningothelial like bodies.
- Microscopic location: Not explicitly mentioned, but implied to be within lung tissue.
- Immunohistochemical markers tested and results: Not mentioned.
- Molecular or genetic findings: Not mentioned.
- Ultrastructural features: Not mentioned.
- Pathological criteria used for diagnosis: Not explicitly mentioned.",,,,,,,"- Diagnostic criteria used: Presence of meningothelial-like bodies in transbronchial biopsies.
- Differential diagnoses considered: HIV, tuberculosis, autoimmune diseases.
- Diagnostic methods employed: CT scan with contrast, PET/CT scan, transbronchial biopsy.
- Challenges in distinguishing from malignancy or metastatic meningioma: Associated with increased prevalence of pulmonary malignancy; PET/CT scan used to rule out malignancy.
- Recommendations for diagnosis: Consider DPM in differential for miliary pattern nodules; use transbronchial biopsy as a diagnostic method.",,,,,,,,,,,,Transbronchial biopsy (frequency not specified); no specific lung lobe mentioned,Not mentioned (the paper does not provide specific immunohistochemistry results),,,,,,,,,,,,,,,,,,"- Management strategies: Diagnosis via transbronchial biopsy, potentially alleviating the need for surgical lung biopsy.
- Monitoring intervals: Not mentioned.
- Recommendations for management: Not mentioned.
- Other: Focus on diagnostic approaches rather than treatment or follow-up.",,,,,"- Follow-up duration and methods: Not mentioned
- Disease progression/stability: Not mentioned
- Radiological stability or progression: Not mentioned
- Symptomatic or asymptomatic: Asymptomatic
- Clinical outcomes and patient status: Normal spirometry, decreased DLCO
- Survival/outcome at last follow up: Not mentioned
- Treatment effectiveness if interventions performed: Not mentioned
- Long-term prognosis: Not mentioned",,,,,,,,,
,Diffuse Pulmonary Meningotheliomatosis in a Patient With Neurodermatitis With Prurigo Nodularis,Kim et al.,10.1097/LBR.0000000000000902,https://doi.org/10.1097/LBR.0000000000000902,Journal of Bronchology & Interventional Pulmonology,2023,Kim et al. - 2023 - Diffuse Pulmonary Meningotheliomatosis in a Patient With Neurodermatitis With Prurigo Nodularis.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: 1 year follow-up
- Institution/geographic location: Not mentioned
- Method of patient identification: Symptomatic presentation","- Age: Individual age - 55 years; Median age for DPM cases - 59.5 years; Mean age in pilot study - 61 years
- Sex distribution: Individual case - Female; Pilot study - 50% female
- Smoking status: Non-smoker
- Relevant medical history: Obesity, previous hysterectomy
- Social history: Works in an office with no occupational risk factors",55,,,,,,,,,,,,,,,,,,,"- Concurrent lung malignancies: 44% of patients identified with DPM had either active or previous malignancy (Gleason et al.).
- Other systemic associations: Ulcerating skin findings and Raynaud's phenomenon; suspected underlying reactive inflammatory process driving DPM, neurodermatitis with prurigo nodularis, and lymphadenopathy.",,,,,,,,,,,,,,,,,,Not mentioned (the paper does not provide specific values or changes in pulmonary function testing),Not mentioned (the paper does not provide specific bronchoscopy findings),,,,"- Complete blood count (CBC): Normal
- Metabolic panel: Normal
- Autoimmune workup: Normal (including antinuclear antibody, rheumatoid factor, cyclic citrullinated peptide, anti-centromere antibody, myeloperoxidase and proteinase 3 (PR3) antineutrophil cytoplasmic antibody, beta-2 glycoprotein antibody IgG and IgM, anticardiolipin antibody IgG and IgM, cryoglobulin, soluble interleukin-2 receptor (s-IL-2), and myositis panel)
- Infectious workup: Negative (including QuantiFERON gold, histoplasma antigen, and coccidioidomycosis serology and complement fixation)
- Pulmonary function testing: Unremarkable","- Symptoms at presentation: Shortness of breath, exertional dyspnea, Raynaud's phenomenon, skin pruritus
- Lung complications: None mentioned
- Physical examination findings: Perioral rash, blanching maculopapular rash, palpable cervical lymph node
- Circumstances of discovery: Symptomatic workup
- Disease course and natural history: Stable over a year with resolving lymphadenopathy
- Progression over time: Stable disease
- Complications or adverse outcomes: None mentioned
- Pulmonary function testing: Unremarkable","- Imaging modalities used: CT, PET-CT
- Nodule characteristics:
  - Size: Largest nodule was 5mm
  - Number: Innumerable
  - Distribution: Bilateral diffuse
  - Appearance: Ground-glass opacities with cavitations
  - Other unique lung findings: Scattered intra-pulmonary calcified granulomas
- Temporal changes on follow-up imaging: Seemingly stable disease at 1-year follow-up
- Visibility on CT: Visible",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Not mentioned
- Gross anatomic location: Not mentioned
- Microscopic/Histological features and morphology: Meningothelial-like nodules with no evidence of malignancy
- Microscopic location: Not mentioned
- Immunohistochemical markers tested and results: Positive for EMA, vimentin, progesterone; Negative for AE1/AE3, TTF-1, S-100, Langerin, CD1a
- Molecular or genetic findings: Lack of monoclonal cell lineage and mutational damage, suggesting a reactive process
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Presence of meningothelial-like nodules with characteristic immunohistochemical staining",,,,,,,"- Diagnostic criteria used: Middle-aged female patients with diffuse bilateral ground glass opacifications on CT scans and an otherwise non-diagnostic workup.
- Differential diagnoses considered: Inflammatory (connective tissues disease, vasculitis, hypersensitivity pneumonitis, Langerhans cell histiocytosis), infectious (atypical pneumonia, viral pneumonia, tuberculosis, fungal pneumonia), and malignant (atypical adenomatous hyperplasia, adenocarcinoma in situ) causes of diffuse pulmonary nodules.
- Misdiagnosis rates and types: Not explicitly mentioned, but challenges in distinguishing from malignancy or ILD are implied.
- Diagnostic methods employed: CT scans for imaging, surgical robotic-assisted thoracic surgery (RATS) for tissue diagnosis.
- Challenges in distinguishing from malignancy or metastatic meningioma: Implied by the inclusion of malignancy in the differential diagnosis and the need for a tissue diagnosis to confirm DPM.
- Recommendations for diagnosis: Consider DPM in the differential diagnosis for middle-aged females with characteristic imaging findings and obtain a tissue diagnosis through surgical biopsy.",,,,,,,,,,,,Surgical Biopsy: Robotic-assisted thoracic surgery (RATS) with multiple left lung biopsies,"- Positive: Epithelial membrane antigen (EMA), vimentin, progesterone
- Negative: AE1/ AE3, thyroid transcription factor-1 (TTF-1), S-100, Langerin, CD1a",,,,,,,,,,,,,,,,,,"- Management strategies: Surgical robotic-assisted thoracic surgery (RATS) for diagnostic purposes.
- Monitoring intervals: Serial yearly imaging.
- Recommendations for management: Ongoing monitoring with yearly imaging.
- Other: Further research is needed to address long-term management.",,,,,"- Follow-up duration and methods: 1 year after diagnosis, serial yearly imaging.
- Disease progression/stability: Seemingly stable disease.
- Radiological stability or progression: Stable on thoracic CT imaging.
- Symptomatic or asymptomatic: Not explicitly mentioned, but seemingly stable.
- Clinical outcomes and patient status: Stable disease, resolving left groin lymphadenopathy.
- Survival/outcome at last follow up: Stable disease.
- Treatment effectiveness if interventions performed: Not mentioned.
- Long-term prognosis: Uncertain, further research needed.",,,,,,,,,
,Diffuse pulmonary meningotheliomatosis: A case report,"Ji Oh, Jun Hyeok Lim, Lucia Kim, Young Sam Kim",10.1016/j.rmcr.2024.102105,https://doi.org/10.1016/j.rmcr.2024.102105,Respiratory Medicine Case Reports,2024,1-s2.0-S221300712400128X-main.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: 1
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Follow-up at 3 months
- Institution/geographic location: Inha University Hospital
- Method of patient identification: Symptomatic presentation","- Age: 57 years old
- Sex distribution: Female
- Smoking status: Non-smoker
- Relevant medical history: Dyslipidemia
- Social history: No occupational or environmental exposures",57,,,,,,,,,,,,,,,,,,,"- History of turner syndrome or other genetic/inheritable disorder: Not mentioned
- Concurrent lung malignancies: Not mentioned
- Other concurrent malignancies: Not mentioned
- Intracranial meningioma: Excluded in this case
- Other pulmonary disease: Not mentioned
- History of ulcerative colitis: Not mentioned
- History of cardiac disease or infective endocarditis: Not mentioned
- Other systemic associations: Dyslipidemia
- Frequency of associations: Not mentioned
- Temporal relationship between DPM and associated conditions: Not mentioned",,,,,,,,,,,,,,,,,,"- PFTs or spirometry at diagnosis: FVC = 2.8L (88% predicted), FEV1 = 2.28L (93% predicted), DLCO = 101% predicted (18.1 ml/min/mmHg)
- Did these get worse or were stable or improved: Stable
- Comparison of DPM vs MPMN values: Not mentioned","Not mentioned (the paper does not provide specific bronchoscopy findings or results from BAL analysis, cell count, CD4/CD8 ratio, or transbronchial lung biopsy/cryobiopsy)",,,,"- Complete blood count (CBC): Normal
- C-reactive protein (CRP): Normal
- Electrolytes: Normal
- Autoimmune workup: Negative for ANA, ANCA, and RF
- Infectious workup: Negative PPD skin test; low likelihood of acute bacterial infection; negative blood tests for pulmonary toxocariasis
- Pulmonary function tests: Normal spirometry and diffusion capacity","- Symptoms at presentation: Chest discomfort, exertional dyspnea
- Lung complications: None mentioned
- Physical examination findings: Normal vital signs, oxygen saturation 99%
- Circumstances of discovery: Symptomatic workup
- Disease course and natural history: Stable with no progression over 6 months
- Progression over time: No progression
- Complications or adverse outcomes: None reported
- Pulmonary function testing: Normal spirometry (FVC 88% predicted, FEV1 93% predicted), diffusion capacity 101% predicted","- Imaging modalities used: Chest CT
- Nodule characteristics:
  - Size: 1 to 7mm
  - Number/innumerable: Multifocal
  - Distribution: Irregular, predominantly in dependent portion and peripheral areas
  - Centrilobular, panlobar, or paraseptal predominance: Centrilobular
  - Upper or lower predominance: Not specified
  - Left or Right predominance: Not specified
  - Appearance: Ground-glass opacity (GGO)
  - Other unique lung findings on CT: No significant lymph node enlargement
  - Temporal changes on follow-up imaging: No evidence of disease progression at 3 months
  - Visibility on CT: Visible
  - Other radiology studies: Not mentioned",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Not explicitly mentioned
- Gross anatomic location: Diffuse distribution in both lungs
- Microscopic/Histological features and morphology: Interstitial meningothelial-like nodules
- Microscopic location: Interstitial
- Immunohistochemical markers tested and results: Positive for EMA, PR, and Pan-TRK; Negative for CK, CD1a, and HMB45
- Molecular or genetic findings: Not mentioned
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Presence of interstitial meningothelial-like nodules and specific immunohistochemical staining patterns",,,,,,,"- Diagnostic criteria used: Identification of bilateral micronodules on chest CT scans, exclusion of other diseases through differential diagnosis.
- Differential diagnoses considered: Acute bacterial infection, miliary TB, vasculitis, autoimmune diseases, pulmonary toxocariasis, malignancy.
- Diagnostic methods employed: Chest CT scans, blood tests for infection markers and autoantibodies, VATS wedge resection for histological examination, immunohistochemical staining.
- Challenges in distinguishing from malignancy or metastatic meningioma: Careful differential diagnosis required; cerebral MRI to exclude intracranial meningioma.
- Recommendations for diagnosis: Early consideration of surgical diagnostic methods for low-risk patients; use of cerebral MRI to exclude intracranial meningioma.",,,,,,,,,,,,"- Method: Video-assisted thoracoscopic surgery (VATS) wedge resection
- Biopsy site: Right upper lobe (RUL) and right lower lobe (RLL)
- Surgical Biopsy: Yes","- Positive: Epithelial membrane antigen (EMA), Progesterone receptor (PR), Pan-TRK
- Negative: Cytokeratin (CK), CD1a, HMB45",,,,,,,,,,,,,,,,,,"- Management strategies: Thoracoscopic wedge resection for histological examination, observation.
- Monitoring intervals: Follow-up CT scans at 3 months, outpatient observation for 6 months.
- Recommendations for management: Further research is necessary to explore clinical symptom management.
- Other: No specific treatment documented in the literature; patients typically maintain a stable condition.",,,,,"- Follow-up duration and methods: 3 months and 6 months follow-up via chest CT scans.
- Disease progression/stability: No disease progression at 3 months and stability during 6 months.
- Radiological stability or progression: Radiological stability at 3 months.
- Symptomatic or asymptomatic: Asymptomatic during follow-up.
- Clinical outcomes and patient status: Discharged without complications, maintained stability.
- Survival/outcome at last follow-up: Stable condition at 6 months.
- Treatment effectiveness: No specific treatments administered; managed conservatively.
- Long-term prognosis: Favorable prognosis reported for DPM.",,,,,,,,,
,Diffuse pulmonary meningotheliomatosis,Niemierko et al.,10.1148/rg.230221,https://doi.org/10.1148/rg.230221,Radiographics,2024,niemierko-et-al-2024-diffuse-pulmonary-meningotheliomatosis.pdf,Case Report,1,,"- Age: 6th or 7th decade of life
- Sex distribution: Most commonly diagnosed in women
- Smoking status: Not mentioned
- E-cigarette/vape use: Not mentioned
- Relevant medical history: Not mentioned
- History of pulmonary thromboemboli: Not mentioned
- History of pulmonary cryptococcus: Not mentioned
- History of hypersensitivity pneumonitis: Not mentioned
- History of ulcerative colitis: Not mentioned
- History of infective endocarditis: Not mentioned
- Social history: Not mentioned
- Environment exposures: Not mentioned
- Incidence/prevalence data: Not mentioned
- Other demographic characteristics: Not mentioned",52,1,0,,,,,,,,,,,,,,,,,"- Concurrent lung malignancies: primary adenocarcinoma
- Other pulmonary disease: pulmonary embolism
- Not mentioned (no information on other associations)",,,,,,,,,,,,,,,,,,Not mentioned (no information on pulmonary function testing is included in the paper),"- Bronchoscopy findings: Not mentioned
- Bronchoalveolar lavage (BAL) analysis: Not mentioned
- Cell count and predominance: Not mentioned
- CD4/CD8 ratio: Not mentioned
- Was a Transbronchial lung biopsy performed? If yes, describe results: Yes, but results not described
- Was a Transbronchial lung cryobiopsy performed? If yes, describe results: Not mentioned
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? Not mentioned",,,,Not mentioned (no information on laboratory features is included in the paper),"- Symptoms at presentation: Typically asymptomatic; may present with dyspnea or cough.
- Lung complications: Associated with pulmonary embolism and primary adenocarcinoma.
- Physical examination findings: Not mentioned.
- Circumstances of discovery: Not mentioned.
- Disease course and natural history: Not mentioned.
- Progression over time: Not mentioned.
- Complications or adverse outcomes: Not mentioned.
- Pulmonary function testing: Not mentioned.","- Size: <6 mm
- Number/innumerable: Numerous
- Distribution: Random
- Appearance: Ground-glass or solid nodules
- Other unique lung findings: Central lucency (""Cheerio"" sign)",,,,,,,,,,,,,,,,"- Microscopic/Histological features and morphology: Clusters of spindle cells that resemble meningothelial cells.
- Microscopic location: Within the lung interstitium.
- Other features: Not mentioned.",,,,,,,"- Diagnostic criteria: Numerous small (<6 mm) ground-glass or solid nodules throughout the lungs in a random distribution; ""Cheerio"" sign (central lucency within nodules).
- Differential diagnoses: Metastatic mucinous adenocarcinoma, Langerhans cell histiocytosis.
- Diagnostic methods: Imaging (to identify characteristic nodules and ""Cheerio"" sign); histopathologic confirmation via surgical biopsy or transbronchial biopsy if necessary.
- Challenges: Not mentioned.
- Recommendations: Use imaging to identify characteristic features; consider histopathologic confirmation when necessary.",,,,,,,,,,,,"- Method: Surgical biopsy, Transbronchial biopsy
- Frequency: Surgical biopsy (common), Transbronchial biopsy (less common)
- Biopsy site: Not mentioned
- Bronchoscopic biopsy: Not mentioned
- Surgical Biopsy: Mentioned as a common method",Not mentioned (the paper does not provide immunohistochemistry results),,,,,,,,,,,,,,,,,,"Not mentioned (the paper does not provide information on management strategies, monitoring intervals, or recommendations for management beyond diagnostic confirmation)",,,,,"Not mentioned (the paper does not provide information on outcomes at each interval follow-up, including follow-up duration and methods, disease progression/stability, radiological stability or progression, symptomatic or asymptomatic status, clinical outcomes, patient status, survival/outcome at last follow-up, treatment effectiveness, or long-term prognosis)",,,,,,,,,
,Diffuse Pulmonary Meningotheliomatosis - A Case Report,An et al.,10.4132/KoreanJPathol.2011.45.S1.S32,https://doi.org/10.4132/KoreanJPathol.2011.45.S1.S32,The Korean Journal of Pathology,2011,An et al. - 2011 - Diffuse Pulmonary Meningotheliomatosis - A Case Report -.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Korea
- Method of patient identification: Diagnostic procedures following history of hepatocellular carcinoma","- Age: 54 years (individual case), range 12 to 91 years (general demographic)
- Sex distribution: Female (individual case), marked female predilection (general demographic)
- Relevant medical history: Hepatocellular carcinoma (individual case)
- Incidence/prevalence data: 13.8% in surgical lung biopsy specimens (general demographic)",54,1,0,1,0,1,0,0,0,0,0,0,0,0,0,0,,,,"- History of hepatocellular carcinoma
- Endocarditis
- Thymoma
- Ulcerative colitis
- Carcinoid
- Hypersensitivity pneumonia
- Metastatic carcinoma
- Colon carcinoma
- Uterine leiomyosarcoma
- Coronary heart disease
- Thyroid, breast, and lung carcinomas
- Uterine cancer",,1,0,0,0,0,0,0,,,,,,,,,,Not mentioned (the paper does not provide specific pulmonary function testing data or comparisons),Not mentioned (the paper does not provide any information on bronchoscopy findings or related procedures),,,,"Not mentioned (the paper does not include any information on laboratory features such as CBC, metabolic panel, bronchoalveolar lavage, autoimmune workup, or infectious workup)",Asymptomatic,"- Imaging modality: Chest CT
- Nodule characteristics:
  - Size: 1 to 3 mm
  - Number: Multiple
  - Distribution: Diffuse bilateral
  - Appearance: Reticulonodular infiltrates
- Other unique lung findings: Occasional cavitation",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Multiple dispersed small nodules.
- Gross anatomic location: Along the walls of alveolar septa or in a perivascular network within the alveolar interstitium.
- Microscopic/Histological features and morphology: Variably sized nests or whorls of bland epithelioid cells; elongated or spindle-shaped cells with oval nuclei, finely granular chromatin, and inconspicuous nucleoli; abundant, granular, and eosinophilic cytoplasm with indistinct cell borders.
- Microscopic location: Interstitial and perivascular.
- Immunohistochemical markers tested and results: Positive for EMA, vimentin, and PR.
- Molecular or genetic findings: Greater genetic instability and more frequent loss of heterozygosity compared to solitary PMLNs.
- Ultrastructural features: Not mentioned.
- Pathological criteria used for diagnosis: Interstitial location, organization of epithelioid cells in a nesting pattern, lateral capillary displacement, and close association with pulmonary venules.",,,,,,,"- Diagnostic criteria used: Histopathological examination showing nests or whorls of bland epithelioid cells; immunoreactivity for epithelial membrane antigen, vimentin, and progesterone receptor.
- Differential diagnoses considered: Metastatic carcinomas with prominent lymphatic spread.
- Diagnostic methods employed: Chest computed tomography; video-assisted thoracoscopic surgery for biopsy.
- Challenges in distinguishing from malignancy or metastatic meningioma: Distinguishing DPM from metastatic carcinomas with lymphatic spread.
- Recommendations for diagnosis: Include DPM in differential diagnosis for diffuse multiple small nodules or reticular patterns; awareness and understanding of pathogenesis are crucial.",,,,,,,,,,,,"- Method: Video-assisted thoracoscopic surgery
- Biopsy site: Lower edge of the lower lobe of the right lung","- Positive: Epithelial membrane antigen (EMA), Vimentin, Progesterone receptor (PR)
- Negative: Not mentioned",,,,,,,,,,,,,,,,,,"- Management strategies: Video-assisted thoracoscopic surgery for diagnostic purposes.
- Monitoring intervals: Not mentioned.
- Recommendations for management: Not mentioned.
- Other: Awareness and understanding of the pathogenesis are helpful for diagnosis.",,,,,Not mentioned (the paper does not provide specific follow-up data or outcomes for the case reported),,,,,,,,,
,Diffuse Pulmonary Meningotheliomatosis Diagnosed Via Transbronchial Cryobiopsy,Swenson et al.,10.1097/LBR.0000000000000830,https://doi.org/10.1097/LBR.0000000000000830,Journal of Bronchology & Interventional Pulmonology,2022,Swenson et al. - 2022 - Diffuse Pulmonary Meningotheliomatosis Diagnosed Via Transbronchial Cryobiopsy.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: 1
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: 3 years
- Institution/geographic location: Not mentioned
- Method of patient identification: Clinical suspicion and symptomatic presentation","- Age: 61 years (DPM case), 34 years (airway complication case)
- Sex distribution: Female (both cases)
- Smoking status: Extensive cigarette smoking and vaping (DPM case)
- E-cigarette/vape use: Yes (DPM case)
- Relevant medical history: History of intravenous drug use (airway complication case)
- Social history: History of intravenous drug use (airway complication case)",61,,,,,,,,,,,,,,,,,,,"- Associated conditions: Pulmonary thromboembolism, metastatic malignancy
- No mention of other specific conditions such as Turner syndrome, concurrent lung malignancies, intracranial meningioma, or other systemic associations
- No specific frequencies or temporal relationships provided",,,,,,,,,,,,,,,,,,"- DLCO: Decline noted
- Other PFT parameters (FEV1, FVC, FEV/FVC, TLC, RV): Not mentioned
- Comparison of DPM vs MPMN values: Not mentioned","- Bronchoscopy findings: Rigid bronchoscopy with cryobiopsy performed in RUL and RLL.
- Bronchoalveolar lavage (BAL) analysis: Unremarkable from left upper lobe.
- Cell count and predominance: Not mentioned.
- CD4/CD8 ratio: Not mentioned.
- Was a Transbronchial lung biopsy performed? No.
- Was a Transbronchial lung cryobiopsy performed? Yes, with findings of pulmonary meningothelial-like nodules in RUL.
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? No.",,,,- Bronchoalveolar lavage: Unremarkable,"- Symptoms at presentation: Nonproductive cough, nonexertional dyspnea
- Lung complications: Decline in diffusing capacity for carbon monoxide
- Circumstances of discovery: Recent development of symptoms after 3 years of stable imaging
- Disease course and natural history: Stable for 3 years, then progression with decline in pulmonary function
- Progression over time: Decline in diffusing capacity
- Complications or adverse outcomes: None specifically mentioned
- Pulmonary function testing: Decline in diffusing capacity for carbon monoxide","- Imaging modalities used: CT
- Nodule characteristics:
  - Size: 100μm to 5 mm
  - Number/innumerable: Diffuse
  - Distribution: Randomly distributed with peripheral tendency
  - Centrilobular, panlobar, or paraseptal predominance: Centrilobular and perifissural
  - Upper or lower predominance: Upper lobe predominance
  - Appearance: Micronodular
  - Temporal changes on follow-up imaging: Stable over long-term follow-up",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Small (100μm to 5 mm), randomly distributed lesions with a peripheral tendency and upper lobe predominance.
- Gross anatomic location: Upper lobe predominance, not universal.
- Microscopic/Histological features and morphology: Pulmonary meningothelial-like nodules.
- Microscopic location: Not in an airway-or vessel-centric pattern.
- Immunohistochemical markers tested and results: Positive for progesterone receptor and epithelial membrane antigen; negative for pan-cytokeratin, synaptophysin, smooth muscle actin, and HMB-45.
- Molecular or genetic findings: Polyclonal variation suggesting a possible transitional phase to neoplastic proliferation.
- Ultrastructural features: Not mentioned.
- Pathological criteria used for diagnosis: Not specifically mentioned beyond immunohistochemical markers and microscopic morphology.",,,,,,,"- Diagnostic criteria: Presence of pulmonary meningothelial-like nodules positive for progesterone receptor and epithelial membrane antigen, and negative for pan-cytokeratin, synaptophysin, smooth muscle actin, and HMB-45.
- Differential diagnoses: Miliary tuberculosis, diffuse micrometastatic disease, sarcoidosis, amyloidosis, hypersensitivity pneumonitis.
- Diagnostic methods: Transbronchial cryobiopsy recommended due to larger tissue samples compared to traditional forceps biopsy.
- Challenges: Distinguishing from malignancy or metastatic meningioma; presentation may mimic more concerning disease processes.
- Recommendations: Lung biopsy recommended due to potential mimicry of concerning conditions.",,,,,,,,,,,,"Transbronchial cryobiopsy (frequency: twice in RUL and twice in RLL), under fluoroscopic guidance with an in-situ occlusion balloon, using rigid bronchoscopy","- Positive: progesterone receptor, epithelial membrane antigen
- Negative: pan-cytokeratin, synaptophysin, smooth muscle actin, HMB-45",,,,,,,,,,,,,,,,,,"- Management strategies: Counseling on the benign nature of DPM, further workup for abnormal diffusing capacity, evaluation for pulmonary vascular disease.
- Monitoring intervals: Not specified.
- Recommendations for management: Lung biopsy recommended to confirm diagnosis and differentiate from other conditions.
- Other: Transbronchial cryobiopsy may be used for diagnostic confirmation.",,,,,"- Follow-up duration and methods: Not mentioned
- Disease progression/stability: Not mentioned
- Radiological stability or progression: Not mentioned
- Symptomatic or asymptomatic: Symptomatic (nonproductive cough and nonexertional dyspnea)
- Clinical outcomes and patient status: Benign nature of DPM; plans for further workup of abnormal diffusing capacity
- Survival/outcome at last follow up: Not mentioned
- Treatment effectiveness if interventions performed: Not mentioned
- Long-term prognosis: Generally considered benign",,,,,,,,,
,A Rare Case of Pulmonary Nodules: Diffuse Pulmonary Meningotheliomatosis,Saa et al.,10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A2768,https://doi.org/10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A2768,"American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CA",2022,Saa and Assaf - 2022 - A Rare Case of Pulmonary Nodules Diffuse Pulmonary Meningotheliomatosis.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: 1
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Symptomatic presentation","- Age: 51 years old
- Sex: Female
- Smoking status: Former smoker
- Relevant medical history: Transient ischemic attack, hypertension, childhood asthma",51,1,0,,,,,,,,0,0,0,0,0,0,,,,"- History of cardiac disease: Transient ischemic attack, hypertension
- Other pulmonary disease: Childhood asthma
- History of smoking: Former smoker
- Negative associations: Fungal serology, connective tissue disease panels, Quantiferon testing, bacterial/mycobacterial/fungal cultures, malignancy",,,,,,,,,,,,,,,,,,"- PFTs or spirometry at diagnosis: Spirometry consistent with restrictive lung disease
- FEV1, FVC, FEV/FVC, DLCO, TLC, RV: Not mentioned
- Did these get worse or were stable or improved: Not mentioned
- Comparison of DPM vs MPMN values: Not mentioned","- Bronchoscopy findings: Cultures were negative for bacterial, mycobacterial, and fungal growth.
- Bronchoalveolar lavage (BAL) analysis: Cultures were negative for bacterial, mycobacterial, and fungal growth.
- Cell count and predominance: Not mentioned.
- CD4/CD8 ratio: Not mentioned.
- Was a Transbronchial lung biopsy performed? Yes, pathology was negative for malignancy.
- Was a Transbronchial lung cryobiopsy performed? Not mentioned.
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? Yes.",,,,"- Autoimmune workup: Fungal serology and connective tissue disease panels were negative.
- Infectious workup: Quantiferon testing was negative; cultures were negative for bacterial, mycobacterial, and fungal growth.","- Symptoms at presentation: Asymptomatic, shortness of breath, cough
- Lung complications: Restrictive lung disease
- Circumstances of discovery: Incidental, symptomatic workup
- Disease course and natural history: Typically asymptomatic, but can present with respiratory symptoms
- Progression over time: Worsening dyspnea in the case described
- Pulmonary function testing: Spirometry consistent with restrictive lung disease","- Imaging modalities used: CT
- Nodule characteristics:
  - Size: Subcentimetric
  - Number/innumerable: Diffuse
  - Distribution: Random
- Other unique lung findings on CT: Not mentioned
- SUV values if PET performed: Not mentioned
- Temporal changes on follow-up imaging: Not mentioned
- Visibility on CT: Not mentioned
- Other radiology studies: Not mentioned",,,,,,,,,,,,,,,,"- Microscopic/Histological features and morphology: Nested cells
- Immunohistochemical markers tested and results: Positive for EMA, CD56, and progesterone receptor",,,,,,,"- Diagnostic criteria used: Spirometry showing restrictive lung disease, CT scan showing diffuse subcentimetric nodularities, immunostaining positive for EMA, CD56, and progesterone receptor.
- Differential diagnoses considered: Fungal infections, connective tissue diseases, malignancy.
- Diagnostic methods employed: Spirometry, CT scan, bronchoscopy with BAL and TBBX, cultures, pathological examination with immunostaining.
- Challenges in distinguishing from malignancy or metastatic meningioma: Pathological examination was necessary to rule out malignancy.
- Recommendations for diagnosis: Consideration of diffuse pulmonary meningotheliomatosis in differential diagnosis for patients with dyspnea and multiple pulmonary nodules.",,,,,,,,,,,,"- Bronchoscopic biopsy: Bronchoalveolar lavage (BAL) and transbronchial lung biopsies (TBBX)
- Surgical biopsy: Right thoracotomy with multiple lung biopsies","- Positive: Epithelial membrane antigen (EMA), CD56, progesterone receptor
- Negative: Not mentioned",,,,,,,,,,,,,,,,,,"- Management strategies: Surgical intervention (right thoracotomy with multiple lung biopsies), diagnostic procedures (bronchoscopy with BAL and TBBX)
- Monitoring intervals: Not mentioned
- Recommendations for management: Not mentioned
- Other: Limited knowledge about treatment options for multiple lesions",,,,,"Not mentioned (the paper does not provide follow-up data or outcomes at intervals, nor does it mention disease progression, radiological stability, or symptomatic status over time)",,,,,,,,,
,Diffuse Pulmonary Meningotheliomatosis: A Case Report,Forsythe et al.,10.1093/ajcp/aqac126.319,https://doi.org/10.1093/ajcp/aqac126.319,American Journal of Clinical Pathology,2022,,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding","- Age: Individual ages mentioned - 57-year-old woman, 35-year-old male, 64-year-old female
- Sex distribution: Predominantly seen in females
- Relevant medical history: History of chronic cough (57-year-old woman), metastatic melanoma (35-year-old male), breast carcinoma and thyroid papillary microcarcinoma (64-year-old female)",,,,,,,,,,,,,,,,,,,,Not mentioned (the paper does not provide information on associated conditions with DPM),,,,,,,,,,,,,,,,,,Not mentioned (no information on pulmonary function testing is included in the paper),"- Bronchoscopy findings: Cultures grew Mycobacterium avium complex (MAC).
- Bronchoalveolar lavage (BAL) analysis: Not mentioned.
- Cell count and predominance: Not mentioned.
- CD4/CD8 ratio: Not mentioned.
- Was a Transbronchial lung biopsy performed? No.
- Was a Transbronchial lung cryobiopsy performed? No.
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? Yes.",,,,"Not mentioned (the paper does not include specific laboratory tests such as CBC, metabolic panel, bronchoalveolar lavage, autoimmune workup, or infectious workup)","- Symptoms at presentation: Typically asymptomatic; one case report mentions chronic cough.
- Lung complications: Emphysematous change and focal foreign body giant cell reaction.
- Circumstances of discovery: Incidental detection on imaging.
- Disease course and natural history: Not detailed in the paper.
- Progression over time: Not detailed in the paper.
- Complications or adverse outcomes: Not detailed in the paper.
- Pulmonary function testing: Not mentioned.","- Imaging modalities used: CT
- Nodule characteristics:
  - Appearance: Ground-glass opacity
  - Distribution: Bilateral
  - Other unique lung findings on CT: Progressive infiltrates, diffuse bronchiectatic changes, scattered nodularity, tree-in-bud opacities
- Temporal changes on follow-up imaging: Progressive changes observed",,,,,,,,,,,,,,,,"- Microscopic/Histological features and morphology: Discrete areas with variable interstitial expansion of the stroma with ovoid/spindle cells, collagen, elastosis, and mild chronic inflammatory cells, in a somewhat perivascular pattern.
- Microscopic location: Interstitial, somewhat perivascular.
- Immunohistochemical markers tested and results: Vimentin (positive), EMA (positive), PR (positive), CD163 (highlighted increased cells), S100 (negative), CD1a (negative), desmin (negative), SMM (negative), HMB-45 (negative), HHV8 (negative), pan-CK (negative), chromogranin (negative), multiplex SOX10-MART1 (negative).",,,,,,,"- Diagnostic criteria used: Histologic evaluation of wedge resections showing interstitial expansion with ovoid/spindle cells, collagen, elastosis, and mild chronic inflammatory cells; immunohistochemical stains positive for vimentin, EMA, and PR, and negative for S100 and CD1a.
- Differential diagnoses considered: Diffuse interstitial pulmonary infiltrates.
- Diagnostic methods employed: Imaging (incidental detection), biopsy (wedge resections), histologic evaluation, immunohistochemical stains.
- Challenges in distinguishing from malignancy or metastatic meningioma: Requires sufficient histological evaluation to accurately diagnose DPM.
- Recommendations for diagnosis: Consider DPM in the differential diagnosis for diffuse interstitial pulmonary infiltrates; thorough histological evaluation is necessary.",,,,,,,,,,,,"- Method (frequency) of tissue acquisition/biopsy type: EBUS-TBNA, TBB, wedge resection, lobectomy
- Biopsy site: Right upper and right lower lobes (DPM), right middle lobe and lingula (Lady Windermere syndrome)
- Bronchoscopic biopsy: EBUS-TBNA
- Surgical Biopsy: Wedge resection, lobectomy","- Positive: vimentin, EMA, PR, CD163
- Negative: S100, CD1a, desmin, SMM, HMB-45, HHV8, pan-CK, chromogranin, multiplex SOX10-MART1",,,,,,,,,,,,,,,,,,Not mentioned (the paper does not provide specific management strategies or follow-up information for diffuse pulmonary meningotheliomatosis),,,,,Not mentioned (the paper does not provide specific outcomes or follow-up data for diffuse pulmonary meningotheliomatosis),,,,,,,,,
,Diffuse Pulmonary Meningotheliomatosis Diagnosed Concurrently With Pulmonary Adenocarcinoma,Prater et al.,-,-,American Journal of Respiratory and Critical Care Medicine,2025,Prater et al. - Diffuse Pulmonary Meningotheliomatosis Diagnosed Concurrently With Pulmonary Adenocarcinoma.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding","- Age: 77 years old
- Sex distribution: Female
- Smoking status: Smoker with >45 pack-year history
- Relevant medical history: Previous pulmonary embolism, renal cell carcinoma, polycythemia, obstructive sleep apnea, pulmonary hypertension, essential hypertension, pulmonary nodule",,,,,,,,,,,,,,,,,,,,"- Concurrent lung malignancies: T1b adenocarcinoma
- Other concurrent malignancies: Renal cell carcinoma
- Other pulmonary disease: Previous pulmonary embolism
- Other systemic associations: Tobacco use, polycythemia, obstructive sleep apnea, pulmonary hypertension, essential hypertension
- Temporal relationship: Concurrent diagnosis of DPM and T1b adenocarcinoma",,,,,,,,,,,,,,,,,,Not mentioned (no information on pulmonary function testing is included in the paper),Not mentioned (the paper does not provide any information on bronchoscopy findings or related procedures),,,,Not mentioned (no specific laboratory tests are mentioned in the paper),"- Symptoms at presentation: Dyspnea and significant hypoxemia
- Circumstances of discovery: Incidental
- Disease course and natural history: Typically benign, asymptomatic
- Progression over time: Not mentioned
- Complications or adverse outcomes: Not mentioned
- Pulmonary function testing: Not mentioned","- Imaging modality: CT
- Nodule characteristics:
  - Distribution: Bilateral
  - Appearance: Micronodular, ground glass attenuation, discrete micronodules with near solid appearance due to alveolar compression
  - Other unique findings: Cranio-caudal gradient",,,,,,,,,,,,,,,,"- Microscopic/Histological features and morphology: Uniform oval or spindle-shaped cells with abundant pale pink cytoplasm.
- Microscopic location: Perivascular.
- Immunohistochemical markers tested and results: Positive for vimentin and EMA.
- Ultrastructural features: Features reminiscent of meningioma cells with absence of mitosis.",,,,,,,"- Diagnostic criteria used: Pathologic examination of resected tissue showing multifocal perivascular aggregates of spindle cells; immunohistochemistry positive for vimentin and EMA.
- Diagnostic methods employed: CT imaging, video-assisted thorascopic surgery with left lower lobe resection, pathologic examination, immunohistochemistry.
- Challenges in distinguishing from malignancy or metastatic meningioma: Not mentioned.
- Recommendations for diagnosis: Not mentioned.",,,,,,,,,,,,Surgical Biopsy: Video-assisted thorascopic surgery with left lower lobe resection,"- Positive: vimentin, EMA, progesterone receptor
- Negative: Not mentioned",,,,,,,,,,,,,,,,,,"- Management strategies: Video-assisted thorascopic surgery with left lower lobe resection for adenocarcinoma.
- Monitoring intervals: Not mentioned.
- Recommendations for management: Not mentioned.
- Other: Not mentioned.",,,,,Not mentioned (the paper does not provide follow-up data or outcomes for the patient),,,,,,,,,
,Diffuse Pulmonary Meningotheliomatosis: A Case Report,Forsythe et al.,10.1093/ajcp/aqac126.319,https://doi.org/10.1093/ajcp/aqac126.319,American Journal of Clinical Pathology,2022,,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: 1
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding","- Age: 57 years old
- Sex distribution: Predominantly seen in females
- Smoking status: Not mentioned
- E-cigarette/vape use: Not mentioned
- Relevant medical history: Chronic cough
- Social history: Not mentioned
- Environment exposures: Not mentioned
- Incidence/prevalence data: Not mentioned",,,,,,,,,,,,,,,,,,,,"Not mentioned (the paper does not provide information on associated conditions such as genetic disorders, concurrent malignancies, or other systemic associations)",,,,,,,,,,,,,,,,,,Not mentioned (no information on pulmonary function testing or spirometry results is included in the paper),Not mentioned (the paper does not provide information on bronchoscopy findings or related procedures),,,,"Not mentioned (the paper does not include specific laboratory tests such as CBC, metabolic panel, bronchoalveolar lavage, autoimmune workup, or infectious workup)","- Symptoms at presentation: Typically asymptomatic; case presented with chronic cough.
- Lung complications: Not mentioned.
- Physical examination findings: Not mentioned.
- Circumstances of discovery: Typically incidental on imaging.
- Disease course and natural history: Not detailed.
- Progression over time: Not detailed.
- Complications or adverse outcomes: Not mentioned.
- Pulmonary function testing, spirometry, or walking tests: Not mentioned.","- Imaging modality: CT
- Nodule characteristics:
  - Appearance: Ground-glass opacity
  - Distribution: Bilateral
- Other unique lung findings: Emphysematous change and focal foreign body giant cell reaction to non-polarizable material",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Gross changes suggestive of interstitial lung disease from wedge resections of the right upper and right lower lobes.
- Gross anatomic location: Deep or interstitial.
- Microscopic/Histological features and morphology: Discrete areas with variable interstitial expansion of the stroma with ovoid/spindle cells, collagen, elastosis, and mild chronic inflammatory cells in a somewhat perivascular pattern; some areas are cystic; background of emphysematous change and focal foreign body giant cell reaction.
- Microscopic location: Somewhat perivascular.
- Immunohistochemical markers tested and results: Vimentin, EMA, PR (positive); CD163 (highlighted increased cells); S100, CD1a (negative); desmin, SMM, HMB-45, HHV8, pan-CK, chromogranin, multiplex SOX10-MART1 (negative).
- Molecular or genetic findings: Not mentioned.
- Ultrastructural features: Not mentioned.
- Pathological criteria used for diagnosis: Not mentioned beyond histological and immunohistochemical characteristics.",,,,,,,"- Diagnostic criteria used: Histological evaluation of wedge resections showing ovoid/spindle cells, collagen, elastosis, and mild chronic inflammatory cells.
- Differential diagnoses considered: Cases of diffuse interstitial pulmonary infiltrates.
- Diagnostic methods employed: Imaging for initial detection, histological evaluation of wedge resections, immunohistochemical stains.
- Challenges in distinguishing from malignancy or metastatic meningioma: Not mentioned.
- Recommendations for diagnosis: Sufficient histological evaluation to identify characteristic cell components.",,,,,,,,,,,,Surgical Biopsy: Wedge resections from the right upper and right lower lobes,"- Positive: vimentin, EMA, PR, CD163
- Negative: S100, CD1a, desmin, SMM, HMB-45, HHV8, pan-CK, chromogranin, multiplex SOX10-MART1",,,,,,,,,,,,,,,,,,"- Management strategies: Surgical intervention (wedge resections)
- Monitoring intervals: Not mentioned
- Recommendations for management: Not mentioned
- Other: Not mentioned",,,,,Not mentioned (the paper does not provide specific follow-up data or outcomes for the patient),,,,,,,,,
,Diffuse Pulmonary Meningotheliomatosis: An Exceedingly Rare Disease for a Not-So-Rare Pattern,Monteiro De Castro et al.,10.7759/cureus.87023,https://doi.org/10.7759/cureus.87023,,2025,cureus-0017-00000087023.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding during breast cancer staging","- Age: 72 years (individual age)
- Sex distribution: Female
- Smoking status: Nonsmoker
- E-cigarette/vape use: Not mentioned
- Relevant medical history: Breast cancer, hypertension, dyslipidemia, hypothyroidism
- History of pulmonary thromboemboli: Not mentioned
- History of pulmonary cryptococcus: Not mentioned
- History of hypersensitivity pneumonitis: Not mentioned
- History of ulcerative colitis: Not mentioned
- History of infective endocarditis: Not mentioned
- Social history: Not mentioned
- Environment exposures: Not mentioned
- Incidence/prevalence data: Not mentioned
- Other demographic characteristics: Caucasian",,,,,,,,,,,,,,,,,,,,"- Concurrent malignancies: Recent diagnosis of carcinoma of the left breast
- Systemic associations: Arterial hypertension, dyslipidemia, supplemented hypothyroidism
- Excluded conditions: Metastatic disease, granulomatous conditions, intracranial meningioma",,,,,,,,,,,,,,,,,,"- PFTs or spirometry at diagnosis: Mild diffusion defect (TLCO 62% of predicted)
- FEV1, FVC, FEV/FVC, DLCO, TLC, RV: Not mentioned
- Did these get worse or were stable or improved: Not mentioned
- Comparison of DPM vs MPMN values: Not mentioned","- Bronchoscopy findings: Microbiological and mycobacterial tests from bronchial lavage were negative.
- Bronchoalveolar lavage (BAL) analysis: Negative for microbiological and mycobacterial tests.
- Cell count and predominance: Not mentioned.
- CD4/CD8 ratio: Not mentioned.
- Was a Transbronchial lung biopsy performed? Yes, results showed morphological and immunohistochemical aspects compatible with MMNs (EMA, CD56, and PR positive).
- Was a Transbronchial lung cryobiopsy performed? No.
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? No.",,,,"- Bronchoalveolar lavage: Microbiological and mycobacterial tests were negative.
- Lung function tests: Mild diffusion defect (TLCO 62% of predicted).","- Symptoms at presentation: Often asymptomatic; mild respiratory symptoms like dyspnea and dry cough.
- Lung complications: Mild diffusion defect (TLCO 62% of predicted).
- Physical examination findings: Unremarkable.
- Circumstances of discovery: Incidental during breast cancer staging.
- Disease course and natural history: Generally favorable; no specific treatment required.
- Progression over time: Stable without therapy over a year.
- Complications or adverse outcomes: None reported.
- Pulmonary function testing: Mild diffusion defect (TLCO 62% of predicted).","- Imaging modality: Chest CT
- Nodule characteristics:
  - Size: <6 mm in diameter
  - Number: Multiple and bilateral
  - Distribution: Random distribution with upper lobe predominance
  - Appearance: Ground-glass or solid micronodules
  - Other unique findings: Central lucency (""cheerio sign"") may be present",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Not mentioned
- Gross anatomic location: Not mentioned
- Microscopic/Histological features and morphology: Minute meningothelial-like nodules (MMNs) composed of small nests of epithelioid cells
- Microscopic location: Pulmonary interstitium
- Immunohistochemical markers tested and results: EMA, CD56, and PR positive
- Molecular or genetic findings: Not mentioned
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Correlation between histological findings (MMNs) and imaging findings (micronodular pattern on chest CT), with exclusion of other causes",,,,,,,"- Diagnostic criteria: Diffuse and bilateral micronodules on chest CT; histological confirmation of meningothelial-like nodules expressing EMA, CD56, and progesterone receptor.
- Differential diagnoses: Granulomatous processes (sarcoidosis or infectious diseases), metastatic disease.
- Misdiagnosis rates and types: Often misdiagnosed due to similarity with other conditions.
- Diagnostic methods: Chest CT, conventional transbronchial biopsy, brain MRI to rule out meningioma.
- Challenges: Distinguishing from malignancy or metastatic meningioma; correlation between imaging and histology is essential.
- Recommendations: Consider DPM as a differential diagnosis in patients with nonspecific, diffuse micronodular pattern; exclude meningioma through imaging and histology.",,,,,,,,,,,,"- Method: Conventional transbronchial biopsy
- Biopsy site: Not specified
- Bronchoscopic biopsy: Yes
- Surgical Biopsy: Not used","- Positive: EMA, CD56, progesterone receptor
- Negative: Not mentioned",,,,,,,,,,,,,,,,,,"- Management strategies: Conservative approach; no specific treatment required.
- Monitoring intervals: Ongoing surveillance with clinical, imaging, and functional stability.
- Recommendations for management: Consider DPM as a differential diagnosis; exclude meningioma.
- Other: Further research is needed to refine management strategies.",,,,,"- Follow-up duration and methods: One year, under surveillance with clinical, imaging, and functional stability.
- Disease progression/stability: Stable without treatment.
- Radiological stability or progression: Stable.
- Symptomatic or asymptomatic: Symptomatic with dyspnea (mMRC 1).
- Clinical outcomes and patient status: Stable without specific therapy.
- Survival/outcome at last follow-up: Stable.
- Treatment effectiveness: Not applicable (no specific treatment).
- Long-term prognosis: Generally favorable and good with prolonged stable disease.",,,,,,,,,
,Minute Pulmonary Meningothelial-like Nodules Showing Multiple Ring-shaped Opacities,Harada et al.,10.2169/internalmedicine.2108-18,https://doi.org/10.2169/internalmedicine.2108-18,Internal Medicine,2019,1349-7235-58-3149 (1).pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: Not mentioned
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding during routine medical checkup","- Age: 56 years (individual age)
- Sex distribution: Predominantly women (general statement)
- Smoking status: Non-smoker (case report)
- Relevant medical history: Turner's syndrome (case report)
- Social history: Not mentioned
- Environment exposures: Not mentioned
- Incidence/prevalence data: Not mentioned
- Other demographic characteristics: Turner's syndrome (case report)",,,,,,,,,,,,,,,,,,,,"- History of Turner syndrome: The patient had Turner syndrome, diagnosed concurrently with MPMNs.
- Concurrent lung malignancies: Not mentioned in the case report, but MPMNs are more common in patients with malignant pulmonary tumors.
- Other concurrent malignancies: Not mentioned.
- Intracranial meningioma: Not mentioned.
- Other pulmonary disease: Chronic lung diseases are associated with MPMNs, but not present in this case.
- History of ulcerative colitis: Not mentioned.
- History of cardiac disease or infective endocarditis: Not mentioned.
- Other systemic associations: Chronic thyroiditis.
- Frequency of associations: Not specified.
- Temporal relationship: Turner syndrome diagnosed concurrently with MPMNs.",,,,,,,,,,,,,,,,,,Not mentioned (no information on pulmonary function testing is included in the paper),Not mentioned (the paper does not provide any information on bronchoscopy findings or related procedures),,,,"- Carcinoembryonic antigen: Normal
- Cytokeratin19: Normal
- Pro-gastrin-releasing peptide: Normal
- Serum progesterone: 0.21 ng/mL (normal range <0.44 ng/mL)
- Serum estradiol: Below detected range
- Thyroid-stimulating hormone (TSH): Normal
- Free T3: Normal
- Free T4: Normal
- Antibodies against thyroglobulin: 388 IU/mL
- Antibodies against thyroid peroxidase: Higher than 600 IU/mL","- Symptoms at presentation: Asymptomatic
- Lung complications: None reported
- Physical examination findings: Normal except for slightly short stature
- Circumstances of discovery: Incidental during routine medical checkup
- Disease course and natural history: Benign course with conservative treatment
- Progression over time: No change in morphologic characteristics over 8 months
- Complications or adverse outcomes: None reported
- Pulmonary function testing: Not mentioned","- Imaging modalities used: Chest CT, PET-CT
- Nodule characteristics:
  - Size: 2-5 mm in diameter
  - Number: Multiple, randomly distributed
  - Distribution: Bilateral
  - Appearance: Ground-glass opacity, some with central lucency and ring-like appearance
- Other unique lung findings on CT: Diffuse, thin-walled cystic lesions
- SUV values if PET performed: No abnormal uptake of FDG
- Temporal changes on follow-up imaging: No change in morphologic characteristics
- Visibility on CT: Visible
- Other radiology studies: MRI of the head and contrast-enhanced CT of the abdomen showed no evidence of malignancy",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Not specifically mentioned
- Gross anatomic location: Not specifically mentioned
- Microscopic/Histological features and morphology: Nodular lesions with interstitial proliferation of uniform, round to oval cells; variable widening of alveolar septa; central airspace lesions
- Microscopic location: Interstitial
- Immunohistochemical markers tested and results: Positive for epithelial membrane antigen, vimentin, progesterone receptor, and CD56
- Molecular or genetic findings: Speculation of transition between reactive and neoplastic process; loss of heterogeneity-based genotyping analysis
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Presence of meningothelial-like nodules in the interstitium; positive immunohistochemical markers",,,,,,,"- Diagnostic criteria used: Chest CT findings of tiny nodules (2-5 mm in diameter) of ground-glass attenuation or diffuse, thin-walled cystic lesions.
- Differential diagnoses considered: Metastatic lung neoplasia, primary adenocarcinoma of the lungs, military tuberculosis.
- Diagnostic methods employed: Chest CT, MRI, PET-CT, video-assisted thoracic surgery, immunohistochemistry.
- Challenges in distinguishing from malignancy: Nonspecific CT findings; recommendation for workup for undiagnosed malignancy.
- Recommendations for diagnosis: Use of imaging techniques and histological confirmation; consider differential diagnoses and potential for malignancy.",,,,,,,,,,,,Video-assisted thoracic surgery (VATS) was used for tissue acquisition. The specific lung lobe is not mentioned.,"- Positive: Epithelial membrane antigen, vimentin, progesterone receptor, CD56
- Negative: Not mentioned",,,,,,,,,,,,,,,,,,"- Management strategies: Conservative treatment is favored; surgical intervention may be considered in certain cases.
- Monitoring intervals: Follow-up chest CT scans were performed eight months after diagnosis.
- Recommendations for management: Clinicians should be aware of imaging characteristics to guide appropriate management; a workup for undiagnosed malignancy is warranted.",,,,,"- Follow-up duration and methods: Eight months after diagnosis, follow-up chest CT showed no change in morphologic characteristics.
- Disease progression/stability: Stable, no progression.
- Radiological stability or progression: No change in radiological findings.
- Symptomatic or asymptomatic: Asymptomatic.
- Clinical outcomes and patient status: Patient remained free of symptoms.
- Survival/outcome at last follow-up: Not explicitly mentioned.
- Treatment effectiveness if interventions performed: Conservative treatment favored, no specific interventions mentioned.
- Long-term prognosis: Typically benign course, but potential association with malignancy.",,,,,,,,,
,DIFFUSE PULMONARY MENINGOTHELIOMATOSIS DIAGNOSED BY TRANSBRONCHIAL CRYOBIOPSY,Trieu et al.,10.1016/j.chest.2020.08.1471,https://doi.org/10.1016/j.chest.2020.08.1471,Chest,2020,PIIS0012369220336576.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding","- Age: 67 years (individual age)
- Sex distribution: Predominantly affects females (2.2:1 male-to-female ratio)
- Smoking status: Non-smoking (individual case)
- Relevant medical history: History of scleroderma
- History of pulmonary thromboemboli: Not mentioned for the individual case, but noted as a general association
- History of malignancy: Not mentioned for the individual case, but noted as a general association",,,,,,,,,,,,,,,,,,,,"- History of scleroderma (autoimmune condition)
- Higher incidence among patients with underlying lung disease, particularly thromboembolism and malignancy",,,,,,,,,,,,,,,,,,"- PFTs or spirometry at diagnosis: Isolated reduction in diffusing capacity at 58%
- FEV1, FVC, FEV/FVC, DLCO, TLC, RV: Only DLCO mentioned (58%)
- Did these get worse or were stable or improved: Stability noted at 1-year follow-up
- Comparison of DPM vs MPMN values: Not mentioned","- Bronchoscopy findings: Not mentioned
- Bronchoalveolar lavage (BAL) analysis: Not mentioned
- Cell count and predominance: Not mentioned
- CD4/CD8 ratio: Not mentioned
- Was a Transbronchial lung biopsy performed? If yes, describe results: Not mentioned
- Was a Transbronchial lung cryobiopsy performed? If yes, describe results: Yes, pathology revealed a meningothelial nodule. Immunohistochemistry was positive for EMA and PR, negative for synaptophysin and chromogranin.
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? No",,,,"- Pulmonary function testing: isolated reduction in diffusing capacity at 58%
- Echocardiogram: normal","- Symptoms at presentation: Asymptomatic
- Lung complications: Isolated reduction in diffusing capacity at 58%
- Circumstances of discovery: Incidental discovery during CT scan
- Disease course and natural history: Stability over 1 year
- Associations: Higher incidence among patients with underlying lung disease (thromboembolism, malignancy)","- Imaging modality: CT
- Nodule characteristics: Diffuse bilateral
- Distribution: Diffuse
- Temporal changes: Stability at 1-year follow-up",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Meningothelial nodules
- Gross anatomic location: Not explicitly mentioned
- Microscopic/Histological features and morphology: Epithelioid cells arranged in small nests
- Microscopic location: Pulmonary interstitium
- Immunohistochemical markers tested and results: Positive for EMA and PR; negative for synaptophysin and chromogranin
- Molecular or genetic findings: Not mentioned
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Not explicitly mentioned beyond histological and immunohistochemical characteristics",,,,,,,"- Diagnostic criteria used: Transbronchial cryobiopsy, immunohistochemistry (positive for EMA and PR, negative for synaptophysin and chromogranin).
- Differential diagnoses considered: DIPNECH.
- Diagnostic methods employed: CT scan, pulmonary function testing, transbronchial cryobiopsy.
- Challenges in distinguishing from malignancy or metastatic meningioma: DPM can be mistaken for metastatic or interstitial disease due to its diffuse nature and lack of specific lobe predilection.
- Recommendations for diagnosis: Consider DPM in the differential diagnosis of bilateral micronodular lung disease.",,,,,,,,,,,,Transbronchial cryobiopsy (2 samples) from the right lower lobe,"- Positive: Epithelial membrane antigen (EMA), Progesterone receptor (PR)
- Negative: Synaptophysin, Chromogranin",,,,,,,,,,,,,,,,,,"- Management strategies: Observation
- Monitoring intervals: Follow-up imaging at 1 year
- Recommendations for management: Not mentioned
- Other: Not mentioned",,,,,"- Follow-up duration and methods: 1-year follow-up with imaging
- Disease progression/stability: Stable
- Radiological stability or progression: Stable
- Symptomatic or asymptomatic: Not mentioned
- Clinical outcomes and patient status: Stable condition
- Survival/outcome at last follow-up: Not mentioned
- Treatment effectiveness: Not mentioned
- Long-term prognosis: Not mentioned",,,,,,,,,
,A rarely seen diffuse parenchymal lung disease: diffuse pulmonary meningotheliomatosis,Şen et al.,10.5578/tt.8468,https://doi.org/10.5578/tt.8468,Turkish Journal of Tuberculosis & Thorax,2015,Şen et al. - 2015 - A rarely seen diffuse parenchymal lung disease diffuse pulmonary meningotheliomatosis.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: 1
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: One and a half years
- Institution/geographic location: Not specified
- Method of patient identification: Symptomatic presentation","- Age: 66 years old
- Sex distribution: Female
- Smoking status: Smoker with 13 pack/year history
- Relevant medical history: Diabetes mellitus, hypertension, chronic renal disease
- Male-female ratio: 2.3:1
- Age range for MLNs: 6th and 7th decades of life",66,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,,,,"- Concurrent lung malignancies: Association with smoking-induced interstitial lung disease and neoplasia, particularly lung adenocarcinoma.
- Other pulmonary disease: Pulmonary thromboembolism (42% incidence).
- Frequency of associations: Higher incidence in patients with adenocarcinoma (9.4% vs. 4.5%).
- Temporal relationship: No specific temporal relationship mentioned.
- Other systemic associations: None mentioned.",,,,,,,,,,,,,,,,,,"- PFTs or spirometry at diagnosis: Normal spirometry, slightly decreased total lung capacity (71%).
- FEV1, FVC, FEV/FVC, DLCO, TLC, RV: Not explicitly mentioned.
- Did these get worse or were stable or improved: Not mentioned.
- Comparison of DPM vs MPMN values: Not mentioned.",Not mentioned (the paper does not provide specific findings from bronchoscopy or related procedures),,,,"- Metabolic panel: BUN was 38 mg/dL, creatinine was 2.45 mg/dL, blood glucose was 167 mg/dL; other blood and urine analyses were within normal ranges.","- Symptoms at presentation: Nonproductive cough
- Lung complications: None mentioned
- Physical examination findings: Normal
- Circumstances of discovery: Referred for definitive diagnosis after being followed for a year and a half
- Disease course and natural history: Stable over a year and a half
- Progression over time: No radiological changes over a year and a half
- Complications or adverse outcomes: None reported
- Pulmonary function testing: Normal spirometry and carbon monoxide diffusion capacity; slightly decreased total lung capacity (71%)","- Imaging modality: CT
- Nodule size: 1-4 mm
- Number: Multiple
- Distribution: Diffuse, randomly distributed in both lungs
- Appearance: Micronodules
- Temporal changes: No radiological difference over 1.5 years
- Visibility on CT: Visible",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Small, 1 to 4 mm nodules in the lung parenchyma.
- Gross anatomic location: Visceral pleural surface and lung parenchyma.
- Microscopic/Histological features and morphology: Clusters of cells with round-to-oval nuclei and large cytoplasm.
- Microscopic location: Lung parenchyma.
- Immunohistochemical markers tested and results: Positive for EMA, vimentin, PR, CD56; negative for keratin, smooth muscle actin, chromogranine, CD34, sinaptophysin.
- Molecular or genetic findings: MLNs are a reactive event unrelated to intracranial meningiomas.
- Ultrastructural features: Similar to meningiomas.
- Pathological criteria used for diagnosis: Histopathological findings consistent with ""meningothe-gotelyomatozis.""",,,,,,,"- Diagnostic criteria used: Histopathological examination revealing small nodular lesions with specific immunohistochemical markers (EMA, vimentin, PR, CD56).
- Differential diagnoses considered: Inflammatory conditions and benign neoplasms.
- Misdiagnosis rates and types: Can mimic metastatic disease, leading to misstaging.
- Diagnostic methods employed: Video-assisted thoracoscopic surgery (VATS) for its high diagnostic yield.
- Challenges in distinguishing from malignancy or metastatic meningioma: Difficulty in distinguishing from metastatic disease, particularly in patients with malignancy.
- Recommendations for diagnosis: Consider DPM in differential diagnosis of diffuse bilateral lung nodules; use VATS for definitive diagnosis.",,,,,,,,,,,,Surgical Biopsy: Video-assisted thoracoscopic surgery (VATS),"- Positive: EMA, vimentin, progesterone receptor (PR), CD56
- Negative: keratin, smooth muscle actin, chromogranine, CD34, sinaptophysin",,,,,,,,,,,,,,,,,,"The management strategy for the patient involved video-assisted thoracoscopic surgery (VATS) for diagnostic purposes due to its high diagnostic yield. No other management strategies, monitoring intervals, or recommendations for management are mentioned in the paper.",,,,,"- Follow-up duration and methods: 1.5 years, thoracic CT scan
- Disease progression/stability: Stable
- Radiological stability or progression: Stable
- Symptomatic or asymptomatic: Asymptomatic except for nonproductive cough
- Clinical outcomes and patient status: Normal spirometry and carbon monoxide diffusion capacity, slightly decreased total lung capacity
- Survival/outcome at last follow up: Not mentioned
- Treatment effectiveness if interventions performed: Not mentioned
- Long-term prognosis: Not mentioned",,,,,,,,,
,Diffuse pulmonary meningothelial like nodules simulating metastatic thymoma,Tamburini et al.,10.21037/jtd.2018.05.178,https://doi.org/10.21037/jtd.2018.05.178,Journal of Thoracic Disease,2018,jtd-10-06-E442.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: 1
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: February 2016 with 12-month follow-up
- Institution/geographic location: Not specified
- Method of patient identification: Symptomatic presentation","- Age: 78 years (individual age)
- Sex distribution: Female
- Relevant medical history: Previous hysterectomy for fibromatosis, arterial hypertension, chronic atrial fibrillation, chronic pericardial effusion
- Median age for DPM: 59.5 years
- Female prevalence for DPM: 92%",78,1,0,1,0,0,0,0,0,1,0,0,0,0,0,0,,,,"- History of cardiac disease: Arterial hypertension, chronic atrial fibrillation, chronic pericardial effusion
- Other pulmonary disease: Congestive heart failure
- Frequency of associations: Not specified
- Temporal relationship: Not explicitly detailed",,,,,,,,,,,,,,,,,,Not mentioned (the paper does not provide specific pulmonary function testing values or comparisons),Not mentioned (the paper does not provide any information on bronchoscopy findings or related procedures),,,,"- Blood tests: No abnormalities, including tumor markers (a-fetoprotein, b-human chorionic gonadotropin, neuron-specific enolase, lactic acid dehydrogenase)
- Other laboratory findings: Not mentioned","- Symptoms at presentation: Malaise, dyspnea, inferior limbs pitting edema
- Lung complications: Bilateral pleural effusion, pericardial effusion
- Physical examination findings: Glasgow Coma Scale Score 15, blood pressure 140/80 mmHg, SPO2 96%, heart rate 120 bpm
- Circumstances of discovery: Symptomatic workup
- Disease course and natural history: Surgical intervention with postoperative acute respiratory failure
- Progression over time: No evidence of local recurrence or metastasis at 12-month follow-up
- Complications: Acute respiratory failure requiring intubation
- Pulmonary function testing: Not mentioned","- Imaging modalities used: CT, FDG-PET
- Nodule characteristics:
  - Size: Largest nodule 7 mm in diameter
  - Number/innumerable: Bilateral micronodules
  - Distribution: Bilateral, largest in right upper lobe
  - Appearance: Micronodular
  - Other unique lung findings: Bilateral pleural effusion, more pronounced on the left
- SUV values: SUVmax of 8.4 for mediastinal mass
- Temporal changes: No evidence of local recurrence or metastasis at 12-month follow-up",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Not explicitly mentioned
- Gross anatomic location: Lung parenchyma
- Microscopic/Histological features and morphology: Minute, nodular well-circumscribed lesions consisting of solid sheets of polygonal to oval cells with distinct cellular borders; cytoplasm clear to pale eosinophilic; nuclei round to oval, centrally located, with fine chromatin and inconspicuous nucleolus; no mitotic figures
- Microscopic location: Not explicitly mentioned
- Immunohistochemical markers tested and results: Strong expression of EMA, vimentin, CD56, and progesterone; negative for cytokeratin-cocktail and neuroendocrine markers (synaptophysin and chromogranin)
- Molecular or genetic findings: Not mentioned
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Histopathological confirmation requires nodule sampling, often through surgical lung resection or VATS technique",,,,,,,"- Diagnostic criteria used: Histopathological examination, immunohistochemical analysis (EMA, vimentin, CD56, progesterone)
- Differential diagnoses considered: Type A thymoma with multiple pulmonary metastases, Type A thymoma with associated occult metastatic second primary tumor, Type A thymoma with associated pulmonary nodules of inflammatory nature
- Diagnostic methods employed: Echographic-guided biopsy, FDG-PET, surgical lung resection, VATS, bronchoscopic biopsies
- Challenges in distinguishing from malignancy or metastatic meningioma: Accurate definition of uncertain metastatic lesions is crucial to avoid misdiagnosis
- Recommendations for diagnosis: Accurate histopathological and immunohistochemical analysis, consideration of differential diagnoses, use of advanced imaging techniques like FDG-PET",,,,,,,,,,,,"- Method: Echographic-guided biopsy of the mediastinal mass; Surgical resection (open resection of the mediastinal mass and atypical pulmonary resection)
- Biopsy site: Right lower lobe
- Surgical Biopsy: Yes","- Positive: Epithelial membrane antigen (EMA), vimentin, CD56, progesterone
- Negative: Cytokeratin-cocktail, neuroendocrine markers (synaptophysin and chromogranin)",,,,,,,,,,,,,,,,,,"- Management strategies: Surgery (open resection of mediastinal mass, atypical pulmonary resection)
- Monitoring intervals: Follow-up at 12 months post-surgery
- Recommendations for management: Surgery with curative intent for localized disease; importance of accurate definition of metastatic lesions
- Other: No clear consensus on management or follow-up for MPMNs; potential roles for adjuvant radiotherapy and chemotherapy in thymic neoplasms",,,,,"- Follow-up duration and methods: 12 months, CT chest imaging
- Disease progression/stability: No local recurrence or metastasis
- Radiological stability or progression: Stable, no recurrence or metastasis
- Symptomatic or asymptomatic: Initially symptomatic with acute respiratory failure, recovered by postoperative day 12
- Clinical outcomes and patient status: Recovered from acute respiratory failure, discharged from hospital
- Survival/outcome at last follow-up: No evidence of recurrence or metastasis
- Treatment effectiveness: Successful surgical intervention
- Long-term prognosis: Not explicitly mentioned, but favorable short-term prognosis",,,,,,,,,
,Diffuse pulmonary meningotheliomatosis: a rare cause of multiple pulmonary nodules,Healy et al.,10.1136/bcr-2022-254039,https://doi.org/10.1136/bcr-2022-254039,BMJ Case Reports,2023,bcr-2022-254039.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Symptomatic presentation","- Age: The patient is a woman in her 50s.
- Sex distribution: The patient is female.
- Smoking status: Ex-smoker with a 50 pack-year smoking history.
- E-cigarette/vape use: Uses e-cigarettes daily.
- Relevant medical history: Juvenile arthritis, hypothyroidism, hyperlipidaemia, depression.
- Social history: Worked on a livestock farm with exposure to poultry and goats.",,,,,,,,,,,,,,,,,,,,"- History of turner syndrome or other genetic/inheritable disorder: Not mentioned
- Concurrent lung malignancies: Not mentioned
- Other concurrent malignancies: Not mentioned
- Intracranial meningioma: Not mentioned
- Other pulmonary disease: Background fibrotic ILD likely smoking related; possible link with thromboembolic disease
- History of ulcerative colitis: Not mentioned
- History of cardiac disease or infective endocarditis: Not mentioned
- Other systemic associations: Juvenile arthritis, hypothyroidism, hyperlipidaemia, depression; positive antinuclear antibody titre; elevated IgE to cat dander
- Frequency of associations: Not specified
- Temporal relationship between DPM and associated conditions: Not specified",,,,,,,,,,,,,,,,,,"- PFTs or spirometry at diagnosis:
  - FEV1: 1.96 L (85% of predicted)
  - FVC: 2.65 L (98% of predicted)
  - FEV1/FVC ratio: 74%
  - DLCO: 76% of predicted
- Did these get worse or were stable or improved:
  - Spirometry remained stable over 4 years
  - DLCO dropped from 76% to 67.6% of predicted
- Comparison of DPM vs MPMN values:
  - Not mentioned","- Bronchoscopy findings: Bronchoalveolar lavage (BAL) and transbronchial biopsy did not confirm a unifying diagnosis.
- Bronchoalveolar lavage (BAL) analysis: Negative for bacteria and fungi; cell count and predominance: 75% macrophages, 18% lymphocytes, 2% neutrophils, 5% eosinophils.
- CD4/CD8 ratio: Not mentioned.
- Was a Transbronchial lung biopsy performed? Yes, results suggested respiratory bronchiolitis.
- Was a Transbronchial lung cryobiopsy performed? No.
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? Yes.",,,,"- Normal inflammatory markers
- Antinuclear antibody titre positive at 400 IU/mL
- Remainder of connective tissue disease screen normal
- Peak eosinophil count: 0.4 (range: 0.02-0.5×10 9 /L)
- Total IgE: 100 kU/L (range: 0-100 kU/L)
- IgE house dust mite, dog dander, and grass mix: negative
- IgE to cat dander: mildly elevated at 0.42 kU/L
- Microbiological testing on BAL: negative for bacteria and fungi
- BAL cell differential: 75% macrophages, 18% lymphocytes, 2% neutrophils, 5% eosinophils","- Symptoms at presentation: Recurrent lower respiratory tract infections, chronic cough, dyspnea on exertion, generalized malaise.
- Lung complications: Not mentioned.
- Physical examination findings: Normal oxygen saturation, no respiratory distress, no finger clubbing, normal vesicular breath sounds.
- Circumstances of discovery: Symptomatic workup.
- Disease course and natural history: Stable with ongoing cough; prognosis and natural history not well understood.
- Progression over time: Stable spirometry, decrease in DLCO.
- Complications or adverse outcomes: Not mentioned.
- Pulmonary function testing: FEV1 85% of predicted, FVC 98% of predicted, FEV1/FVC ratio 74%, DLCO 76% of predicted (later decreased to 67.6%).","- Imaging modalities used: Chest radiograph, CT of the chest
- Nodule characteristics:
  - Size: One 6 mm nodule in the left upper lobe, two 5 mm nodules in the right upper lobe
  - Number: Multiple bilateral nodules
  - Distribution: Mainly in the upper lobes bilaterally
  - Upper or lower predominance: Upper lobe predominance
  - Appearance: Not specifically described as ground-glass opacity, solid, mixed, micronodular, or miliary pattern
  - Other unique lung findings on CT: Background fibrotic ILD with predominantly subpleural changes, small calcified granulomata
- Temporal changes on follow-up imaging: Stable appearances at 2-year follow-up",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Intraparenchymal minute nodules
- Gross anatomic location: Intraparenchymal
- Microscopic/Histological features and morphology: Bland epithelioid cells without evidence of malignancy
- Microscopic location: Intraparenchymal
- Immunohistochemical markers tested and results: Positive for CD56 and progesterone receptor; weakly positive for EMA and SMA; negative for TTF-1, napsin A, chromogranin, HMB45, S100, and desmin
- Molecular or genetic findings: Not mentioned
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Presence of intraparenchymal minute nodules of bland epithelioid cells and specific immunohistochemical staining patterns",,,,,,,"- Diagnostic criteria used: Characteristic staining patterns (CD56 and progesterone receptor positivity), intraparenchymal minute nodules.
- Differential diagnoses considered: Infections, sarcoidosis, hypersensitivity pneumonitis, small airways disease, malignancy, other rare lung diseases.
- Diagnostic methods employed: Chest radiographs, CT scans, bronchoalveolar lavage, transbronchial biopsy, surgical biopsy.
- Challenges in distinguishing from malignancy or metastatic meningioma: Ruling out primary lung malignancy and metastatic disease through specific staining patterns.
- Recommendations for diagnosis: Detailed history and clinical examination, high-resolution CT scans, surgical lung biopsy for definitive diagnosis.",,,,,,,,,,,,"- Method: Video-assisted thoracoscopic surgical (VATS) guided biopsy
- Frequency: Single procedure
- Biopsy type: Surgical resection (VATS guided wedge resection)
- Biopsy site: Right upper, middle, and lower lobes","- Positive: CD56, progesterone receptor, epithelial membrane antigen (weakly positive), smooth muscle actin (weakly positive)
- Negative: TTF-1, napsin A, chromogranin, HMB45, S100, desmin",,,,,,,,,,,,,,,,,,"- Management strategies: Close follow-up in a specialist respiratory outpatient clinic.
- Monitoring intervals: Spirometry stable over 4 years; repeat CT thorax at 2-year intervals.
- Recommendations for management: No specific treatments or recommendations due to rarity and benign nature.
- Other: Uncertainty in treatment and prognosis; need for further research to clarify clinical significance.",,,,,"- Follow-up duration and methods: Followed up closely in the specialist respiratory outpatient clinic; spirometry and repeat CT scans at 2-year intervals.
- Disease progression/stability: Stable symptoms with ongoing productive cough; spirometry stable over 4 years; DLCO dropped from 76% to 67.6%.
- Radiological stability or progression: Stable appearances of pulmonary nodules on repeat CT scans.
- Symptomatic or asymptomatic: Asymptomatic in terms of severe symptoms; occasional cough and wheezing.
- Clinical outcomes and patient status: Patient feels better with less frequent coughing; able to carry on normal activities.
- Survival/outcome at last follow up: Not explicitly mentioned.
- Treatment effectiveness if interventions performed: Not mentioned.
- Long-term prognosis: Suggests a benign course with stable symptoms and radiological findings.",,,,,,,,,
,Meningotheliomatosis Presenting as Miliary Nodules in a Patient with Polyarteritis Nodosa,Neilan et al.,10.1164/ajrccm-conference.2020.201.1_MeetingAbstracts.A6648,https://doi.org/10.1164/ajrccm-conference.2020.201.1_MeetingAbstracts.A6648,"American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA",2020,Neilan and Reddy - 2020 - Meningotheliomatosis Presenting as Miliary Nodules in a Patient with Polyarteritis Nodosa.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: 1
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned (follow-up nearly 2 years)
- Institution/geographic location: Not mentioned
- Method of patient identification: Symptomatic presentation","- Age: 54 years old
- Sex distribution: Female
- Relevant medical history: Hypothyroidism, polyarteritis nodosa",,,,,,,,,,,,,,,,,,,,"- Concurrent autoimmune condition: Polyarteritis nodosa
- Gender association: Predominantly affects females
- Association with malignancy: May confer a higher risk of malignant pulmonary tumors, most commonly lung adenocarcinomas",,,,,,,,,,,,,,,,,,Not mentioned (no information on pulmonary function testing is included in the paper),"- Bronchoscopy findings: Transbronchial biopsy revealed meningothelial-like micronodules.
- Bronchoalveolar lavage (BAL) analysis: Not specified.
- Cell count and predominance: Not mentioned.
- CD4/CD8 ratio: Not mentioned.
- Was a Transbronchial lung biopsy performed? Yes, revealed meningothelial-like micronodules.
- Was a Transbronchial lung cryobiopsy performed? No.
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? Not specified.",,,,"- Infectious workup: Respiratory viral panel, serologies for fungal infections, RAST allergy panel, HIV, sputum culture with AFB x3, bronchoalveolar lavage, hypersensitivity pneumonitis panel, RPR, Hepatitis C and B (all negative)
- Autoimmune workup: ANCA (negative)
- CRP: 144
- ESR: 53","- Symptoms at presentation: Rapidly progressing lower extremity weakness due to nontraumatic epidural hematoma.
- Lung complications: Miliary pulmonary nodules.
- Circumstances of discovery: Incidental during imaging for other conditions.
- Disease course and natural history: Improved with treatment; normalized inflammatory markers; able to walk without a walker.
- Progression over time: Improved clinically.
- Complications or adverse outcomes: Not mentioned.
- Pulmonary function testing, spirometry, or walking tests: Not mentioned.","- Imaging modalities used: CT Chest, MRA of the abdomen
- Nodule characteristics:
  - Size: Not specified
  - Number/innumerable: Miliary pattern
  - Distribution: Not specified
  - Centrilobular, panlobar, or paraseptal predominance: Not specified
  - Upper or lower predominance: Not specified
  - Left or Right predominance: Not specified
  - Appearance: Miliary pattern
- Other unique lung findings on CT: Luminal contour irregularities suspicious for aneurysms in the kidney and hepatic arteries
- Temporal changes on follow-up imaging: Not specified
- Visibility on CT: Not specified
- Other radiology studies: Not mentioned",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Miliary nodules
- Gross anatomic location: Not explicitly mentioned
- Microscopic/Histological features and morphology: Meningothelial like micronodules; multiple, patchy scattered foci of EMA+, PR+ whorled epithelioid cells
- Microscopic location: Not explicitly mentioned
- Immunohistochemical markers tested and results: EMA+, PR+, negative for chromogranin and synaptophysin; often positive for progesterone and vimentin, negative for myosin, actin, S-100, keratin, chromogranin A, and synaptophysin
- Molecular or genetic findings: Lack of consistent monoclonal expansion
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Histological appearance of whorled epithelioid cells; specific immunohistochemical marker profile",,,,,,,"- Diagnostic criteria used: Imaging (CT Chest, MRA), extensive infectious workup, autoimmune workup (ANCA), transbronchial biopsy, wedge resection.
- Differential diagnoses considered: Tuberculosis, sarcoidosis, pneumoconiosis, metastatic cancer, histoplasmosis, varicella infection, Langerhans cell histiocytosis.
- Diagnostic methods employed: Imaging (CT Chest, MRA), transbronchial biopsy, wedge resection.
- Challenges in distinguishing from malignancy or metastatic meningioma: Lack of consistent monoclonal expansion in meningothelial-like nodules.
- Recommendations for diagnosis: Consider meningotheliomatosis in the differential diagnosis of miliary nodules; use histological characteristics (EMA+, PR+, negative for chromogranin and synaptophysin) to confirm diagnosis.",,,,,,,,,,,,"- Method: Transbronchial biopsy, Wedge resection
- Biopsy site: Not specified
- Bronchoscopic biopsy: Transbronchial biopsy
- Surgical Biopsy: Wedge resection","- Positive: EMA, PR, progesterone, vimentin
- Negative: chromogranin, synaptophysin, myosin, actin, S-100, keratin",,,,,,,,,,,,,,,,,,"- Management strategies: Corticosteroids, cyclophosphamide (following the French Vasculitis Study Protocol), methotrexate.
- Monitoring intervals: Not mentioned.
- Recommendations for management: Not explicitly mentioned.
- Other: The patient showed significant clinical improvement with normalized inflammatory markers and no pulmonary symptoms nearly two years post-discharge.",,,,,"- Follow-up duration and methods: Nearly 2 years post-discharge.
- Disease progression/stability: Improved clinically with normalized inflammatory markers.
- Radiological stability or progression: Not mentioned.
- Symptomatic or asymptomatic: Asymptomatic; no pulmonary symptoms.
- Clinical outcomes and patient status: Walking without a walker; inflammatory markers normalized.
- Survival/outcome at last follow-up: Improved clinically.
- Treatment effectiveness: Corticosteroids and cyclophosphamide followed by methotrexate were effective in improving clinical status.
- Long-term prognosis: Not explicitly mentioned.",,,,,,,,,
,Diffuse Pulmonary Meningotheliomatosis Diagnosed by Transbronchial Lung Biopsy,Bernabeu Mora et al.,10.1159/000350430,https://doi.org/10.1159/000350430,Respiration,2013,bernabeumora2013.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: 1
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding during CT scan for chronic diarrhoea","- Age: 59 years old
- Sex: Female
- Smoking status: Smoker, 20 pack-years
- Relevant medical history: Uterine cancer treated with hysterectomy, double adnexectomy, and radiation therapy; multiple surgical interventions for anal abscesses
- Social history: Not mentioned
- Environment exposures: Not mentioned
- Incidence/prevalence data: Not mentioned",,,,,,,,,,,,,,,,,,,,"- History of other concurrent malignancies: Uterine cancer
- Concurrent lung malignancies: Lung adenocarcinoma
- Other pulmonary diseases: Pulmonary thromboembolism, respiratory bronchiolitis-associated interstitial lung disease/desquamative pneumonia, vasculitis, atypical adenomatous hyperplasia of the lung
- Frequency of associations: Higher prevalence in patients with malignant pulmonary tumors (7.3% vs. 2.5%)
- Temporal relationship: Not specified",,,,,,,,,,,,,,,,,,"- PFTs or spirometry at diagnosis: Normal spirometry results
- FEV1, FVC, FEV/FVC, DLCO, TLC, RV: Not mentioned
- Did these get worse or were stable or improved: Stable or improved (patient is free of symptoms)
- Comparison of DPM vs MPMN values: Not mentioned","- Bronchoscopy findings: Normal mucosa
- Bronchoalveolar lavage (BAL) analysis: No tumor cells or microorganisms
- Cell count and predominance: Not mentioned
- CD4/CD8 ratio: Not mentioned
- Was a Transbronchial lung biopsy performed? Yes, results described in detail
- Was a Transbronchial lung cryobiopsy performed? No
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? No",,,,"- Laboratory test values: Normal
- Autoimmune workup: Negative for ANA, anti-DNA, ANCA, rheumatoid factor, RNP, Sm, Ro, La, Scl-70, and Jo-1
- Tumor marker levels: Normal
- Infectious workup: Negative HIV serology, negative tuberculin skin test
- Bronchoalveolar lavage (BAL): No tumor cells or microorganisms","- Symptoms at presentation: Asymptomatic
- Lung complications: Cavitating nodules
- Physical examination findings: Normal
- Circumstances of discovery: Incidental during investigation for chronic diarrhea
- Disease course and natural history: Favorable progression, currently free of symptoms
- Progression over time: Not detailed beyond being symptom-free
- Complications or adverse outcomes: Not mentioned
- Pulmonary function testing: Spirometry results were normal","- Imaging modality: Chest CT scan
- Nodule characteristics:
  - Size: Minute
  - Number: Multiple
  - Distribution: Randomly distributed throughout both lungs
  - Appearance: Poorly defined, cotton wool appearance, some cavitated
  - Other unique findings: Cavitating nodules",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Not mentioned
- Gross anatomic location: Randomly distributed throughout the subpleural interstitium of the lungs
- Microscopic/Histological features and morphology: Interstitial proliferation of epithelioid cells with oval monomorphic nuclei, without atypia or mitosis, arranged in irregular clusters with poorly defined borders
- Microscopic location: Interstitial tissue of the lung
- Immunohistochemical markers tested and results: Negative for cytokeratin AE1/AE3, chromogranin A, synaptophysin, actin, desmin, and HMB-45; positive for vimentin, EMA, progesterone receptors, and CD56
- Molecular or genetic findings: Not mentioned
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Not explicitly mentioned",,,,,,,"- Diagnostic criteria used: CT scan findings of multiple disseminated minute nodules with a cotton wool appearance, some cavitated; transbronchial lung biopsy showing interstitial proliferation of epithelioid cells with specific immunohistochemical staining patterns.
- Differential diagnoses considered: Other conditions presenting with bilateral lung nodules.
- Diagnostic methods employed: CT scan, transbronchial lung biopsy.
- Challenges in distinguishing from malignancy or metastatic meningioma: Not explicitly discussed, but immunohistochemical staining helps in differentiation.
- Recommendations for diagnosis: Use of CT scans for initial identification and transbronchial lung biopsy for definitive diagnosis with specific immunohistochemical staining patterns.",,,,,,,,,,,,Transbronchial lung biopsy (frequency not specified); Biopsy site not mentioned,"- Positive: vimentin, EMA, progesterone receptors, CD56
- Negative: cytokeratin AE1/AE3, chromogranin A, synaptophysin, actin, desmin, HMB-45",,,,,,,,,,,,,,,,,,"Not mentioned (the paper does not provide specific information on management strategies, monitoring intervals, or recommendations for management)",,,,,"- Follow-up duration and methods: Not mentioned
- Disease progression/stability: Favourable progression, patient is asymptomatic
- Radiological stability or progression: Not mentioned
- Symptomatic or asymptomatic: Asymptomatic
- Clinical outcomes and patient status: Favourable, patient is free of symptoms
- Survival/outcome at last follow-up: Not mentioned
- Treatment effectiveness if interventions performed: Not mentioned
- Long-term prognosis: Not mentioned",,,,,,,,,
,A Rare Benign Etiology Mimicking Metastatic Pulmonary Malignancies: A Case Report and Literature Review,Katta et al.,10.1164/ajrccm-conference.2020.201.1_MeetingAbstracts.A1461,https://doi.org/10.1164/ajrccm-conference.2020.201.1_MeetingAbstracts.A1461,"American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA",2020,Katta and Kopas - 2020 - A Rare Benign Etiology Mimicking Metastatic Pulmonary Malignancies A Case Report and Literature Rev.pdf,Case Report,35,"- Study type: Case report and literature review
- Total number of DPM patients: 35
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: January 2000 to September 2019
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding, symptomatic presentation","- Age: mean 64±8 years, range 51 to 75 years
- Sex distribution: 33 females, 2 males
- Smoking status: 5 (14%) patients had significant smoking history
- Relevant medical history: hypertension, GERD, obstructive sleep apnea, history of malignancy (breast, uterine, lung adenocarcinoma)
- Other demographic characteristics: Caucasian female in the case report","Mean 64±8 years, range 51 to 75 years",33,2,30 of 35,,,0,1,,1,0,0,0,0,0,0,,,,"- History of malignancy: 13 (39%) patients had active history of malignancy, including breast, uterine, and lung adenocarcinoma.
- Smoking history: 5 (14%) patients had significant smoking history.
- Pulmonary function tests: 8 (22%) patients had mild restrictive defect.
- No information on Turner syndrome, intracranial meningioma, other pulmonary diseases, ulcerative colitis, cardiac disease, or autoimmune diseases.
- Temporal relationship between DPM and associated conditions not explicitly mentioned.",,,,,,,,,,,,,,,,,,"- PFTs or spirometry at diagnosis: Mild restrictive defect in 22% of patients
- FEV1, FVC, FEV/FVC, DLCO, TLC, RV: Not mentioned
- Did these get worse or were stable or improved: Not mentioned
- Comparison of DPM vs MPMN values: Not mentioned",Not mentioned (the paper does not provide specific bronchoscopy findings or detailed results from transbronchial biopsies or cryobiopsies),,,,Not mentioned (no specific laboratory features are included in the paper),"- Symptoms at presentation: Chronic dry cough, dyspnea on exertion
- Lung complications: Not mentioned
- Physical examination findings: Not mentioned
- Circumstances of discovery: Incidental in 62% of cases
- Disease course and natural history: Stabilization of lung nodules over time
- Progression over time: Stabilization of lesions
- Complications or adverse outcomes: Not mentioned
- Pulmonary function testing: Mild restrictive defect in 22% of patients","- Imaging modalities used: CT
- Nodule characteristics:
  - Size: <5mm
  - Number/innumerable: Diffuse
  - Distribution: Randomly distributed
  - Centrilobular, panlobar, or paraseptal predominance: Centrilobular
  - Upper or lower predominance: Not specified
  - Left or Right predominance: Not specified
  - Appearance: Ground glass to solid
  - Other unique lung findings on CT: Cavitation in 2% of cases
  - SUV values if PET performed: Not mentioned
  - Temporal changes on follow-up imaging: Stabilization after 2 years
  - Visibility on CT: Visible
  - Other radiology studies: Not mentioned",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Not mentioned
- Gross anatomic location: Not mentioned
- Microscopic/Histological features and morphology: MPMN by histopathology
- Microscopic location: Not mentioned
- Immunohistochemical markers tested and results: Not mentioned
- Molecular or genetic findings: Not mentioned
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Not mentioned",,,,,,,"- Diagnostic criteria used: Consideration of DPM in patients with diffuse bilateral pulmonary nodules on HRCT.
- Diagnostic methods employed: CT imaging, video-assisted thoracoscopic biopsy, histopathology, immunochemistry, transbronchial biopsy, transbronchial cryobiopsy, surgical lung biopsy.
- Recommendations for diagnosis: Use CT imaging and surgical lung biopsy as modalities of choice; consider DPM in patients with diffuse bilateral pulmonary nodules on HRCT.",,,,,,,,,,,,"- Method (frequency) of tissue acquisition/biopsy type: Surgical lung biopsy (most common), transbronchial biopsy (3 cases), transbronchial cryobiopsy (2 cases)
- Include biopsy site: Not specified
- Bronchoscopic biopsy: Transbronchial biopsy (3 cases), transbronchial cryobiopsy (2 cases)
- Surgical Biopsy: Video-assisted thoracoscopic biopsy (specific case), surgical lung biopsy (remainder of cases)",Not mentioned (the paper does not specify immunohistochemistry results),,,,,,,,,,,,,,,,,,"- Management strategies: Video-assisted thoracoscopic biopsy, serial imaging for follow-up.
- Monitoring intervals: Follow-up for 2 years after diagnosis.
- Recommendations for management: CT imaging and surgical lung biopsy are recommended for diagnosis; transbronchial cryobiopsies are also used.
- Other: Stabilization of lung nodules observed in all patients after 2 years.",,,,,"- Follow-up duration and methods: Serial imaging for two years.
- Disease progression/stability: Stabilization of lung nodules observed in all patients after two years.
- Radiological stability or progression: Stabilization of lesions on pulmonary CT after two years.
- Symptomatic or asymptomatic: Initially presented with chronic dry cough and dyspnea on exertion.
- Clinical outcomes and patient status: Stabilization of lung nodules.
- Survival/outcome at last follow up: Not mentioned.
- Treatment effectiveness if interventions performed: Not mentioned.
- Long-term prognosis: Not mentioned.",,,,,,,,,
,Minute Pulmonary Meningothelial-Like Nodules: An Incidental Benign Entity in Association With Lung Adenocarcinoma,Siala et al.,10.1155/crra/3311702,https://doi.org/10.1155/crra/3311702,Case Reports in Radiology,2025,Case Reports in Radiology - 2025 - Siala - Minute Pulmonary Meningothelial‐Like Nodules  An Incidental Benign Entity in.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: Not mentioned
- Total number of multiple MPMN patients: At least one
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: At least 6 months
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding during imaging for aortoiliac occlusive disease","- Age: 69 years
- Sex distribution: Female
- Smoking status: Current smoker with a 30 pack-year smoking history
- Relevant medical history: Hypertension, coronary artery disease, remote myocardial infarction, coronary artery bypass grafting
- Social history: Not mentioned
- Environment exposures: Not mentioned
- Incidence/prevalence data: MPMNs are most common in the sixth decade; female-to-male ratio is 12:1",,,,,,,,,,,,,,,,,,,,"- Concurrent lung malignancies: Adenocarcinoma
- Other concurrent malignancies: Not mentioned
- Intracranial meningioma: Not mentioned
- Other pulmonary disease: Not mentioned
- History of ulcerative colitis: Not mentioned
- History of cardiac disease or infective endocarditis: Not mentioned
- Other systemic associations: Not mentioned
- Frequency of associations: Not quantified
- Temporal relationship between DPM and associated conditions: Not specified",,,,,,,,,,,,,,,,,,Not mentioned (the paper does not provide specific pulmonary function test values or comparisons between DPM and MPMN),Not mentioned (the paper does not include any information on bronchoscopy findings),,,,"Not mentioned (the paper does not specify any laboratory features such as CBC, metabolic panel, etc.)","- Symptoms at presentation: Asymptomatic
- Lung complications: Not mentioned
- Physical examination findings: Not mentioned
- Circumstances of discovery: Incidental findings during imaging or surgical procedures
- Disease course and natural history: Stable, benign
- Progression over time: No growth over time
- Complications or adverse outcomes: Not mentioned
- Pulmonary function testing, spirometry, or walking tests: Not mentioned","- Imaging modalities used: Chest CT
- Nodule characteristics:
  - Size: Typically around 5 mm in diameter
  - Number/innumerable: Numerous or innumerable
  - Distribution: Peripheral, along interlobular septa; random distribution but often clustering near pleural surfaces
  - Appearance: Ground glass attenuation with smooth margins; may exhibit central lucency or cystic-like features
  - Other unique lung findings: Heterogeneity of density and shape; small solid, ground glass, and cystic nodules
  - Temporal changes on follow-up imaging: Lack of growth over at least 6 months",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Innumerable unrelated pulmonary micronodules measuring 2-4 mm.
- Gross anatomic location: Peripherally located along the interlobular septa.
- Microscopic/Histological features and morphology: Nests of bland spindled cells arranged in a whorled pattern; clusters of epithelioid cells.
- Microscopic location: Around small veins in the interlobular pulmonary septa.
- Immunohistochemical markers tested and results: Positive for CD56, PR, EMA; negative for synaptophysin and cytokeratin.
- Molecular or genetic findings: Benign, reactive proliferation process.
- Ultrastructural features: Lack endocrine granules; not associated with nerve structures; resemble meningothelial cells.
- Pathological criteria used for diagnosis: Histological appearance; immunohistochemical markers.",,,,,,,"- Diagnostic criteria: Peripheral location along interlobular septa, small size (around 5 mm), smooth margins, ground glass attenuation on CT scans.
- Differential diagnoses: Pulmonary carcinoid tumorlets, primary pulmonary meningioma (PPM), metastatic pulmonary meningioma.
- Misdiagnosis rates and types: Similarity with metastatic nodules, especially in patients with existing malignancies.
- Diagnostic methods: Chest CT scans, histological examination with immunohistochemistry.
- Challenges: Nonspecific radiological features, need for careful pathological evaluation.
- Recommendations: Cautious evaluation in patients with coexisting malignancies, surveillance imaging, histological confirmation.",,,,,,,,,,,,Surgical resection (right lower lobectomy),"- Positive: CD56, progesterone receptor (PR), epithelial membrane antigen (EMA), Somatostatin Receptor 2a (SSTR2A)
- Negative: synaptophysin, cytokeratin",,,,,,,,,,,,,,,,,,"- Management strategies: Conservative management with surveillance imaging.
- Monitoring intervals: Not specified.
- Recommendations for management: Recognize imaging characteristics to distinguish from malignancies; primarily observational approach.
- Other: No specific treatment required due to benign nature.",,,,,"- Follow-up duration and methods: Long-term stability confirmed with comparisons to chest CTs from 2 to 5 years earlier.
- Disease progression/stability: Stable over time.
- Radiological stability or progression: Stable, no significant changes over follow-up periods.
- Symptomatic or asymptomatic: Typically asymptomatic.
- Clinical outcomes and patient status: Managed conservatively with surveillance imaging.
- Survival/outcome at last follow up: Not specifically mentioned.
- Treatment effectiveness if interventions performed: Not applicable; conservative management.
- Long-term prognosis: Benign, reactive nature; observational management approach.",,,,,,,,,
,Minute Pulmonary Meningothelial-like Nodules,Fadl et al.,10.1148/ryct.2021210219,https://doi.org/10.1148/ryct.2021210219,Radiology: Cardiothoracic Imaging,2021,ryct.2021210219.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding during abdominal CT scan for diarrhea","- Age: 63 years old
- Sex: Female
- Smoking status: Not mentioned
- E-cigarette/vape use: Not mentioned
- Relevant medical history: Not mentioned
- Social history: Not mentioned
- Environment exposures: Not mentioned
- Incidence/prevalence data: Not mentioned",,,,,,,,,,,,,,,,,,,,"- Concurrent lung malignancies: primary lung neoplasia
- Other pulmonary disease: pulmonary embolism, chronic lung diseases
- History of cardiac disease: chronic cardiac diseases",,,,,,,,,,,,,,,,,,Not mentioned (no information on pulmonary function testing is included in the paper),"- Bronchoscopy findings: Not mentioned
- Bronchoalveolar lavage (BAL) analysis: Not mentioned
- Cell count and predominance: Not mentioned
- CD4/CD8 ratio: Not mentioned
- Was a Transbronchial lung biopsy performed? If yes, describe results: Not mentioned
- Was a Transbronchial lung cryobiopsy performed? If yes, describe results: Yes, showed nodular cellular proliferation expanding the interstitium with whorllike appearance
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? Not mentioned",,,,"Not mentioned (no information on laboratory features such as CBC, metabolic panel, etc., is included in the paper)","- Symptoms at presentation: Asymptomatic (discovered incidentally during abdominal CT for diarrhea)
- Lung complications: Not mentioned
- Physical examination findings: Not mentioned
- Circumstances of discovery: Incidental discovery during abdominal CT for diarrhea
- Disease course and natural history: Benign, indolent course
- Progression over time: Not mentioned
- Complications or adverse outcomes: Not mentioned
- Pulmonary function testing, spirometry, or walking tests: Not mentioned","- Imaging modalities used: CT
- Nodule characteristics:
  - Size: Small (<6 mm)
  - Number/innumerable: Numerous
  - Distribution: Randomly distributed, no lobe spared
  - Appearance: Ground-glass opacity, rounded
  - Other unique lung findings on CT: Central lucencies with a ringlike appearance",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Numerous small (,6 mm), rounded, ground-glass, randomly distributed nodules with no lobe spared.
- Gross anatomic location: Randomly distributed with no lobe spared.
- Microscopic/Histological features and morphology: Nodular cellular proliferation expanding the interstitium with whorllike appearance.
- Microscopic location: Within the lung interstitium.
- Immunohistochemical markers tested and results: Positive for epithelial membrane antigen and progesterone receptor; negative for neuroendocrine markers such as synaptophysin.
- Molecular or genetic findings: Not mentioned.
- Ultrastructural features: Not mentioned.
- Pathological criteria used for diagnosis: Tissue sampling required for definitive diagnosis.",,,,,,,"- Diagnostic criteria used: Histopathological findings of nodular cellular proliferation with whorllike appearance; positive staining for epithelial membrane antigen and progesterone receptor; negative staining for neuroendocrine markers.
- Differential diagnoses considered: Adenocarcinoma in situ, carcinoid tumor, tumorlets, nonfibrotic hypersensitivity pneumonitis, vasculitis, atypical infection.
- Diagnostic methods employed: Chest CT imaging; transbronchial cryobiopsy; immunohistochemistry.
- Recommendations for diagnosis: Tissue sampling is required for definitive diagnosis.",,,,,,,,,,,,Transbronchial cryobiopsy (Right lower lobe),"- Positive: Epithelial membrane antigen, Progesterone receptor
- Negative: Neuroendocrine markers such as synaptophysin",,,,,,,,,,,,,,,,,,"Not mentioned (no information on management strategies, monitoring intervals, or recommendations for management is included in the paper)",,,,,"Not mentioned (the paper does not provide follow-up data or outcomes related to disease progression, radiological stability, symptomatic status, or treatment effectiveness)",,,,,,,,,
,Diffuse pulmonary meningotheliomatosis,Maasdorp et al.,10.7196/AJTCCM.2020.v26i1.012,https://doi.org/10.7196/AJTCCM.2020.v26i1.012,African Journal of Thoracic and Critical Care Medicine,2020,AJTCCM-26-1-012.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Follow-up after 6 months
- Institution/geographic location: University of the Free State
- Method of patient identification: Symptomatic presentation","- Age: 58 years old
- Sex: Female
- Smoking status: Nonsmoker
- Relevant medical history: Frontal lobe syndrome due to traumatic brain injury; on treatment with lamotrigine and donepezil; previous Nissen fundoplication
- Incidence/prevalence data: Up to 13.8% incidence in surgical lung specimen biopsy series; more common in females (female:male ratio of 2.2:1); mainly in patients >40 years old",58,1,0,N,,,,,,,,,,,,,,,,"- Other pulmonary disease: Pulmonary emboli, vasculitis, respiratory bronchiolitis-associated interstitial lung disease, lung cancer
- Frequency of associations: Not mentioned
- Temporal relationship: Not mentioned",,,,,,,,,,,,,,,,,,"- PFTs or spirometry at diagnosis: FVC of 3.03 L (117% of predicted), FEV1 of 2.56 L (117% of predicted), FEV1/FVC of 0.84
- Did these get worse or were stable or improved: Stable
- Comparison of DPM vs MPMN values: Not mentioned",Not mentioned (the paper does not include any information on bronchoscopy findings or procedures),,,,"- Lung function evaluation: Normal spirometry with FVC of 3.03 L (117% of predicted), FEV 1 of 2.56 L (117% of predicted), and FEV 1 /FVC of 0.84, with no reversibility post bronchodilator.
- Autoimmune workup: Negative","- Symptoms at presentation: Dyspnea on exertion, persistent non-productive coughing, dyspepsia, nausea
- Lung complications: None reported
- Physical examination findings: Normal chest examination, normal vesicular breath sounds
- Circumstances of discovery: Symptomatic workup
- Disease course and natural history: Benign course
- Progression over time: No change in clinical condition or lung function over 6 months
- Complications or adverse outcomes: Potential associations with pulmonary emboli, vasculitis, respiratory bronchiolitis-associated interstitial lung disease, and lung cancer
- Pulmonary function testing: Normal spirometry (FVC 117% of predicted, FEV1 117% of predicted, FEV1/FVC 0.84)","- Imaging modalities used: Chest X-ray, CT
- Nodule characteristics:
  - Size: 0.1 - 3.0 mm
  - Number/innumerable: Multiple small random nodules
  - Distribution: Diffusely present in both lungs
  - Appearance: Micronodular, miliary pattern
- Temporal changes on follow-up imaging: Unchanged after 6 months",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Numerous small stellate-shaped nodular lesions distributed throughout the lung tissue.
- Microscopic/Histological features and morphology: Islands of epithelioid cells with arachnoidal appearance, eosinophilic cytoplasm, uniform and ovoid nuclei, some with pseudoinclusions.
- Immunohistochemical markers tested and results: Positive for EMA and PR.
- Pathological criteria used for diagnosis: Histological appearance and immunohistochemical profile.",,,,,,,"- Diagnostic criteria used: Miliary pattern on chest-imaging studies.
- Differential diagnoses considered: Should be considered in the differential diagnosis of an undefined 'miliary-type' pattern of pulmonary nodules on chest imaging.
- Diagnostic methods employed: Chest X-ray, CT scans, thoracoscopic lung biopsy, immunohistochemical staining for EMA and PR.
- Recommendations for diagnosis: Consider diffuse pulmonary meningotheliomatosis in the differential diagnosis of a miliary pattern on chest imaging.",,,,,,,,,,,,Thoracoscopic lung biopsy (surgical biopsy) - distributed throughout the lung tissue,"- Positive: EMA, PR, CD56, vimentin
- Negative: Not mentioned",,,,,,,,,,,,,,,,,,"- Management strategies: Observation
- Monitoring intervals: 6 months
- Recommendations for management: No specific treatment indicated
- Other: Conservative management with observation",,,,,"- Follow-up duration and methods: 6 months after initial presentation
- Disease progression/stability: Stable
- Radiological stability or progression: Stable
- Symptomatic or asymptomatic: Asymptomatic
- Clinical outcomes and patient status: Unchanged
- Survival/outcome at last follow-up: Not mentioned beyond 6 months
- Treatment effectiveness: Not applicable (no specific treatment indicated)
- Long-term prognosis: Generally benign, but potential associations with other conditions",,,,,,,,,
,Diffuse Pulmonary Meningotheliomatosis Presenting with the Cheerios Sign Diagnosed by a Transbronchial Lung Cryobiopsy: A Case Report,"Tetsu Hirakawa, Kiyofumi Shimoji, Sachiko Shioya, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Taku Nakashima, Hiroshi Iwamoto, Hironobu Hamada, Noboru Hattori",10.2169/internalmedicine.6181-25,https://doi.org/10.2169/internalmedicine.6181-25,Internal Medicine,2025,advpub_6181-25.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: 1
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding during routine health screening","- Age: 48 years old
- Sex: Female
- Smoking status: Non-smoker
- Relevant medical history: Turner syndrome, hormone supplementation with estrogen and progesterone",,,,,,,,,,,,,,,,,,,,"- History of Turner syndrome: Yes
- Concurrent lung malignancies: Not mentioned
- Other concurrent malignancies: Uterine polyp
- Intracranial meningioma: No evidence
- Other pulmonary disease: Not mentioned
- History of ulcerative colitis: Not mentioned
- History of cardiac disease: Not mentioned
- Other systemic associations: Potential hormonal influence
- Frequency of associations: Not applicable
- Temporal relationship: Concurrent diagnosis of uterine polyp",,,,,,,,,,,,,,,,,,Not mentioned (the paper does not provide specific pulmonary function test values or comparisons),"- Bronchoscopy findings: Mildly elevated lymphocyte fraction of 21% in BALF.
- Bronchoalveolar lavage (BAL) analysis: Cultures for bacteria, mycobacteria, and fungi were all negative.
- Cell count and predominance: Mild increase in lymphocytes.
- CD4/CD8 ratio: Not mentioned.
- Was a Transbronchial lung biopsy performed? Yes, but it was non-diagnostic.
- Was a Transbronchial lung cryobiopsy performed? Yes, it provided a definitive diagnosis.
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? No.",,,,"- Complete blood count (CBC): Not mentioned as significant.
- Metabolic panel: Not mentioned as significant.
- Bronchoalveolar lavage (BAL): Mildly elevated lymphocyte fraction (21%), cultures for bacteria, mycobacteria, and fungi were negative.
- Autoimmune workup: Not mentioned as significant.
- Infectious workup: Negative cultures for bacteria, mycobacteria, and fungi.","- Symptoms at presentation: Asymptomatic
- Lung complications: None reported
- Physical examination findings: Normal vital signs, unremarkable auscultation
- Circumstances of discovery: Incidental during routine health screening
- Disease course and natural history: Stable over seven-month follow-up without treatment
- Progression over time: No decline in pulmonary function
- Complications or adverse outcomes: None reported
- Pulmonary function testing: Not mentioned","- Imaging modalities used: Chest computed tomography (CT)
- Nodule characteristics:
  - Size: Small
  - Number: Diffuse
  - Distribution: Bilateral, centrilobular
  - Appearance: Ring-shaped with central lucency (Cheerios sign), ground-glass opacities, solid components
- Other unique lung findings on CT: Central cavities
- Temporal changes on follow-up imaging: Stable over seven months without treatment
- Visibility on CT: Visible",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Multiple small nodules measuring approximately 2 mm in diameter in the interstitium.
- Gross anatomic location: Interstitium.
- Microscopic/Histological features and morphology: Low-grade, round to short spindle-shaped cells resembling meningeal epithelial cells, with uniform round nuclei and eosinophilic cytoplasm.
- Microscopic location: Interstitium.
- Immunohistochemical markers tested and results: Positive for EMA, PgR, and CD56.
- Molecular or genetic findings: Not mentioned.
- Ultrastructural features: Not mentioned.
- Pathological criteria used for diagnosis: Histological and immunohistochemical findings characteristic of MPMN.",,,,,,,"- Diagnostic criteria used: Presence of ring-shaped nodules with central lucency (Cheerios sign) on chest CT; histological confirmation of meningothelial-like cells positive for epithelial membrane antigen, progesterone receptor, and CD56.
- Differential diagnoses considered: Pulmonary Langerhans cell histiocytosis, granulomatosis with polyangiitis, metastatic lung tumors, infectious diseases.
- Misdiagnosis rates and types: TBLB has a diagnostic yield of approximately half; failure to capture target lesions may lead to misdiagnosis.
- Diagnostic methods employed: Transbronchial lung cryobiopsy (TBLC) recommended as initial approach; TBLB and SLB also used.
- Challenges in distinguishing from malignancy or metastatic meningioma: Establishing a definitive diagnosis based solely on imaging findings is challenging; histopathological confirmation is necessary.
- Recommendations for diagnosis: TBLC should be considered the initial diagnostic approach for patients presenting with the Cheerios sign and suspected DPM.",,,,,,,,,,,,"- Method: Transbronchial lung cryobiopsy (TBLC)
- Biopsy site: Right B 8b and B 9 segments
- Bronchoscopic biopsy: TBLC
- Surgical Biopsy: Not mentioned","- Positive: Epithelial membrane antigen (EMA), Progesterone receptor (PgR), CD56
- Negative: Neuroendocrine markers",,,,,,,,,,,,,,,,,,"- Management strategies: Discontinuation of estrogen and progesterone hormone therapy.
- Monitoring intervals: Seven-month follow-up period.
- Recommendations for management: Discontinuation of hormone therapy due to potential hormonal influence on the disease.
- Other: No additional treatments or interventions were mentioned.",,,,,"- Follow-up duration and methods: Seven-month follow-up period.
- Disease progression/stability: Stable disease progression.
- Radiological stability or progression: Radiological findings remained stable.
- Symptomatic or asymptomatic: Asymptomatic.
- Clinical outcomes and patient status: Stable clinical outcomes with no decline in pulmonary function.
- Survival/outcome at last follow up: Stable disease at last follow-up.
- Treatment effectiveness: Discontinuation of hormone therapy led to stable disease.
- Long-term prognosis: Not explicitly mentioned, but short-term prognosis appears favorable.",,,,,,,,,
,"Diffuse Pulmonary Meningotheliomatosis: A Scary, Yet Benign Picture",Jayaschandran et al.,,,American Thoracic Society 2017 International Conference,2017,"Jayaschandran et al. - Diffuse Pulmonary Meningotheliomatosis A Scary, Yet Benign Picture.pdf",Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Follow-up at 3 months and 1 year
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding on CT scan","- Age: 74 years
- Sex distribution: Female
- Smoking status: Non-smoker
- E-cigarette/vape use: Not mentioned
- Relevant medical history: Not mentioned
- History of pulmonary thromboemboli: Not mentioned
- History of pulmonary cryptococcus: Not mentioned
- History of hypersensitivity pneumonitis: Not mentioned
- History of ulcerative colitis: Not mentioned
- History of infective endocarditis: Not mentioned
- Social history: Not mentioned
- Environment exposures: Not mentioned
- Incidence/prevalence data: Not mentioned
- Other demographic characteristics: Not mentioned",,,,,,,,,,,,,,,,,,,,"Not mentioned (the paper does not provide information on associated conditions such as genetic disorders, concurrent malignancies, or other systemic diseases)",,,,,,,,,,,,,,,,,,"- PFTs at diagnosis: Normal
- FEV1, FVC, FEV/FVC, DLCO, TLC, RV: Not mentioned
- Changes over time: Not mentioned
- Comparison of DPM vs MPMN values: Not mentioned","- Bronchoscopy findings: Not mentioned
- Bronchoalveolar lavage (BAL) analysis: Not mentioned
- Cell count and predominance: Not mentioned
- CD4/CD8 ratio: Not mentioned
- Was a Transbronchial lung biopsy performed? Yes, results: Biopsy demonstrated collection of cytologically bland epithelioid cells with occasional cytoplasmic intranuclear pseudoinclusions, situated within the interstitium and arranged in a distinctly nested, whorled pattern typical of meningothelial-like nodules.
- Was a Transbronchial lung cryobiopsy performed? No
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? No",,,,Not mentioned (the paper does not specify any laboratory features beyond stating that basic labs were normal),"- Symptoms at presentation: Asymptomatic
- Lung complications: None mentioned
- Physical examination findings: Normal
- Circumstances of discovery: Incidental detection on CT scan
- Disease course and natural history: Stable nodules with some mild progression in size over six weeks
- Progression over time: Stable at follow-up
- Complications or adverse outcomes: None reported
- Pulmonary function testing: Normal PFT","- Imaging modality: CT
- Nodule characteristics:
  - Size: 5mm or less in diameter
  - Number: Innumerable
  - Distribution: Throughout the lungs, centri-lobular predominance
  - Appearance: Solid and ground glass nodular opacities
  - Other unique findings: Central cavitation in some nodules
- Temporal changes: Mild progression in size of some ground glass nodules over six weeks
- Visibility on CT: Visible
- Follow-up imaging: Annual CT scans planned for 2 years",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Multiple, asymptomatic nodules
- Gross anatomic location: Around small veins
- Microscopic/Histological features and morphology: Epitheloid cell nests with cytologically bland cells and occasional cytoplasmic intranuclear pseudoinclusions; nested, whorled pattern
- Microscopic location: Interstitium
- Immunohistochemical markers tested and results: Supported diagnosis of meningoendothelioma (specific markers not detailed)
- Molecular or genetic findings: Not mentioned
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Not detailed beyond histological and immunohistochemical characteristics",,,,,,,"- Diagnostic criteria used: Comprehensive review of systems, physical exam, basic labs, PFTs, chest CT scans showing small solid and ground glass nodular opacities, trans-bronchial lung biopsy demonstrating characteristic histological features of meningothelial-like nodules, immunohistochemical staining supporting meningoendothelioma diagnosis.
- Differential diagnoses considered: Metastatic malignancy, miliary tuberculosis, idiopathic interstitial pneumonia.
- Diagnostic methods employed: Chest CT scans, trans-bronchial lung biopsy, immunohistochemical staining.
- Challenges in distinguishing from malignancy or metastatic meningioma: Requires tissue diagnosis to distinguish from other conditions.
- Recommendations for diagnosis: Tissue diagnosis is important to obtain to avoid misdiagnosis.",,,,,,,,,,,,Transbronchial lung biopsy,Not mentioned (the paper does not specify the immunohistochemistry results),,,,,,,,,,,,,,,,,,"- Management strategies: Conservative management with observation and follow-up imaging.
- Monitoring intervals: 3-month follow-up CT scan, annual imaging for 2 years.
- Recommendations for management: Continue annual imaging for 2 years and discontinue if lesions remain stable.
- Other: No other treatments or interventions mentioned.",,,,,"- Follow-up duration and methods: Follow-up CT scans at 3 months and 1 year.
- Disease progression/stability: Stable nodules at both follow-up intervals.
- Radiological stability or progression: Stable nodules at both follow-up intervals.
- Symptomatic or asymptomatic: Asymptomatic throughout the follow-up period.
- Clinical outcomes and patient status: Stable clinical status.
- Survival/outcome at last follow up: Stable at 1 year follow-up.
- Treatment effectiveness if interventions performed: Conservative management with observation and follow-up imaging.
- Long-term prognosis: Planned annual imaging for 2 years, with discontinuation if lesions remain stable.",,,,,,,,,
,A 58-Year-Old Woman With Lung Nodules and Chronic Cough,Tzilas et al.,10.1016/j.chest.2021.04.051,https://doi.org/10.1016/j.chest.2021.04.051,Chest,2021,Tzilas and Bouros - 2021 - A 58-Year-Old Woman With Lung Nodules and Chronic Cough.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned (follow-up period: 14 months)
- Institution/geographic location: Not mentioned
- Method of patient identification: Symptomatic presentation","- Age: Individual age - 58 years; General age range - 22 to 84 years; Median age - 62 years
- Sex distribution: Female predominance; Female-to-male ratio - 2.2:1
- Smoking status: Never-smoker
- Relevant medical history: Negative medical history; No history of cancer, gastroesophageal reflux disease, asthma, allergic rhinitis, or other allergies
- Social history: No occupational or domestic exposures",58,1,0,1,,,0,,,,0,0,0,0,0,0,,,,"- Concurrent lung malignancies: Pulmonary minute meningothelial-like nodules are found significantly more often in patients with malignant pulmonary tumors.
- Other concurrent malignancies: Not mentioned.
- Intracranial meningioma: Not mentioned.
- Other pulmonary disease: Mentioned in the context of various diseases including infections and pulmonary embolism.
- History of ulcerative colitis: Not mentioned.
- History of cardiac disease or infective endocarditis: Not mentioned.
- Other systemic associations: Not mentioned.
- Frequency of associations: Not mentioned.
- Temporal relationship: Not mentioned.",,,,,,,,,,,,,,,,,,"- PFTs or spirometry at diagnosis:
  - FEV1: 2.47 L, 100% predicted
  - FVC: 3.22 L, 111% predicted
  - FEV1/FVC: 0.77
  - FEV1 after bronchodilation: -6%
  - TLC: 90% predicted
  - DLCO: 89% predicted
- Did these get worse or were stable or improved: Not mentioned
- Comparison of DPM vs MPMN values: Not mentioned","- Bronchoscopy findings: No visible airway abnormalities.
- Bronchoalveolar lavage (BAL) analysis: Negative for bacterial, mycobacterial, and fungal organisms; no malignant cells.
- Cell count and predominance: Not mentioned.
- CD4/CD8 ratio: Not mentioned.
- Was a Transbronchial lung biopsy performed? No.
- Was a Transbronchial lung cryobiopsy performed? No.
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? Yes.",,,,"- Pulmonary function tests: FEV 1 , 2.47 L, 100% predicted; FVC, 3.22 L, 111% predicted; FEV 1 / FVC, 0.77; FEV 1 after bronchodilation, -6%; TLC, 90% predicted; DLCO, 89% predicted.
- Infectious workup: Gram and Ziehl-Neelsen staining of bronchial washings were negative for bacterial, mycobacterial, and fungal organisms.
- Cytologic examination: No malignant cells found.","- Symptoms at presentation: Chronic cough
- Lung complications: None mentioned
- Physical examination findings: Unremarkable
- Circumstances of discovery: Symptomatic workup
- Disease course and natural history: Benign
- Progression over time: Spontaneous improvement of cough
- Complications or adverse outcomes: None reported
- Pulmonary function testing: Normal limits (FEV1, FVC, FEV1/FVC, TLC, DLCO)","- Imaging modalities used: HRCT, Chest X-ray
- Nodule characteristics:
  - Size: Approximately 5 mm; smaller than 10 mm
  - Number/innumerable: Numerous
  - Distribution: Centrilobular, peripheral involving the outer third of the lung parenchyma
  - Appearance: Solid with central hyperlucent area (""cheerio sign"")
  - Other unique lung findings on CT: Miliary pattern in some cases
- Temporal changes on follow-up imaging: Unchanged after 14 months",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Not mentioned
- Gross anatomic location: Not mentioned
- Microscopic/Histological features and morphology: Interstitial nests of epithelioid cells; rounded polyhedral or spindle-shaped cells arranged in nests (zellballen)
- Microscopic location: Interstitial; centered on pulmonary venules
- Immunohistochemical markers tested and results: Positive for epithelial membrane antigen (EMA) and vimentin; low Ki-67 positivity of 1% to 2%
- Molecular or genetic findings: Not mentioned
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Not explicitly mentioned",,,,,,,"- Diagnostic criteria used: Presence of multiple minute meningothelial nodules on HRCT with a central hyperlucent area (""cheerio sign"").
- Differential diagnoses considered: Infectious diseases (mycobacterial, fungal), neoplastic diseases (adenocarcinoma), granulomatosis with polyangiitis, rheumatoid arthritis, pulmonary Langerhans cell histiocytosis.
- Diagnostic methods employed: HRCT, surgical lung biopsy, transbronchial biopsy.
- Challenges in distinguishing from malignancy or metastatic meningioma: Similar imaging findings; importance of tissue confirmation to avoid misdiagnosis.
- Recommendations for diagnosis: Tissue confirmation through surgical lung biopsy or transbronchial biopsy; workup for unidentified malignancy on an individualized basis.",,,,,,,,,,,,"- Method: Surgical lung biopsy
- Frequency: Not specified
- Biopsy site: Not specified
- Bronchoscopic biopsy: Transbronchial biopsy (mentioned as an alternative method)
- Surgical Biopsy: Surgical lung biopsy","- Positive: Epithelial membrane antigen, Vimentin
- Negative: Not mentioned",,,,,,,,,,,,,,,,,,"- Management strategies: No therapeutic intervention is required due to the benign nature of the disease.
- Monitoring intervals: Follow-up HRCT was performed 14 months after diagnosis.
- Recommendations for management: No specific treatment is needed; a workup for underlying malignancy may be considered on an individual basis.
- Other: The patient reported spontaneous improvement of symptoms.",,,,,"- Follow-up duration and methods: 14 months, HRCT
- Disease progression/stability: Unchanged
- Radiological stability or progression: Unchanged
- Symptomatic or asymptomatic: Symptomatic improvement; cough improved
- Clinical outcomes and patient status: Excellent clinical status
- Survival/outcome at last follow-up: Not explicitly mentioned
- Treatment effectiveness: No treatment given
- Long-term prognosis: Benign course",,,,,,,,,
,An uncommon cause of miliary pattern of pulmonary nodules-diffuse pulmonary meningotheliomatosis,Jayaschandran et al.,10.1002/rcr2.238,https://doi.org/10.1002/rcr2.238,Respirology Case Reports,2017,RCR2-5-na.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: More than 2 years
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding","- Age: 74 years old
- Sex distribution: Female
- Smoking status: Non-smoker
- Relevant medical history: Hypertension, dyslipidaemia, prediabetes, well-controlled asthma",74,1,0,1,0,0,0,0,0,1,,,0,0,0,0,,,,"- History of hypertension
- History of dyslipidaemia
- History of prediabetes
- History of well-controlled asthma
- No association with smoking history
- Fatigue and dyspnea reported in some cases, possibly due to comorbidities like ischemic heart disease or lung cancer",,,,,,,,,,,,,,,,,,"- PFTs or spirometry at diagnosis: Normal spirometry, lung volumes, and diffusion capacity.
- FEV1, FVC, FEV/FVC, DLCO, TLC, RV: Not mentioned.
- Did these get worse or were stable or improved: Not mentioned.
- Comparison of DPM vs MPMN values: Not mentioned.","- Bronchoscopy findings: No airway abnormalities.
- Bronchoalveolar lavage (BAL) analysis: No tumor cells or microorganisms.
- Cell count and predominance: Not mentioned.
- CD4/CD8 ratio: Not mentioned.
- Was a Transbronchial lung biopsy performed? Yes, results showed collections of cytologically bland epithelioid cells with specific immunohistochemical stains.
- Was a Transbronchial lung cryobiopsy performed? No.
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? No.",,,,"- Complete blood count (CBC): Within normal limits
- Kidney function: Within normal limits
- Electrolytes: Within normal limits
- Bronchoalveolar lavage (BAL): No tumor cells or microorganisms","- Symptoms at presentation: Asymptomatic; anxiety and weight loss
- Lung complications: None mentioned
- Physical examination findings: Not explicitly mentioned
- Circumstances of discovery: Incidental on abdominal CT scan
- Disease course and natural history: Stable over more than two years
- Progression over time: No progression
- Complications or adverse outcomes: None reported
- Pulmonary function testing: Normal spirometry, lung volumes, and diffusion capacity","- Imaging modalities used: CT
- Nodule characteristics:
  - Size: 5 mm or less in diameter
  - Number/innumerable: Innumerable
  - Distribution: Throughout the lungs in a predominantly centrilobular distribution
  - Appearance: Solid and ground glass nodular opacities
  - Other unique lung findings on CT: Central cavitation in some nodules
- Temporal changes on follow-up imaging: Stable bilateral lung nodules over more than 2 years",,,,,,,,,,,,,,,,"- Microscopic/Histological features and morphology: Collections of cytologically bland epithelioid cells with occasional cytoplasmic intranuclear pseudoinclusions within the interstitium arranged in a distinctly nested, whorled pattern. Nests of moderately sized elongated cells with oval nuclei, finely granular chromatin, inconspicuous nucleoli, and abundant granular and eosinophilic cytoplasm with indistinct cell borders.
- Microscopic location: Within the interstitium.
- Immunohistochemical markers tested and results: Positive for epithelial membrane antigen and vimentin; negative for pancytokeratins, TTF-1, synaptophysin, chromogranin, S100 protein, and smooth muscle actin.",,,,,,,"- Diagnostic criteria used: Transbronchial biopsy showing cytologically bland epithelioid cells with specific immunohistochemical staining patterns.
- Differential diagnoses considered: Metastatic malignancy and miliary tuberculosis.
- Diagnostic methods employed: Chest CT and transbronchial biopsy.
- Challenges in distinguishing from malignancy or metastatic meningioma: Not explicitly detailed, but tissue sampling is crucial.
- Recommendations for diagnosis: Tissue sampling via transbronchial biopsy; conservative management with observation and follow-up imaging.",,,,,,,,,,,,Transbronchial biopsy (frequency not specified); Bronchoscopic biopsy; No specific lung lobe mentioned,"- Positive: Epithelial membrane antigen, Vimentin
- Negative: Pancytokeratins, Thyroid Transcription Factor 1 (TTF-1), Synaptophysin, Chromogranin, S100 protein, Smooth muscle actin",,,,,,,,,,,,,,,,,,"- Management strategies: Conservative management with observation and follow-up imaging.
- Monitoring intervals: CT scans repeated at 2, 17, and 25 months.
- Recommendations for management: Conservative approach with regular imaging follow-up.
- Other: No surgical interventions or other treatments mentioned.",,,,,"- Follow-up duration and methods: More than 2 years; CT scans repeated at 2, 17, and 25 months.
- Disease progression/stability: Stable disease throughout the follow-up period.
- Radiological stability or progression: Stable bilateral lung nodules on repeated CT scans.
- Symptomatic or asymptomatic: Asymptomatic throughout the follow-up period.
- Clinical outcomes and patient status: Stable and asymptomatic.
- Survival/outcome at last follow-up: Stable and asymptomatic.
- Treatment effectiveness: Conservative management with observation and follow-up imaging was effective.
- Long-term prognosis: Stable disease with no progression.",,,,,,,,,
,Diffuse Pulmonary Meningotheliomatosis: A Rare Lung Disease Presenting with Diffuse Ground Glass Opacities and Cavitation,Almodallal et al.,-,-,American Thoracic Society 2020 International Conference,2020,Almodallal et al. - Diffuse Pulmonary Meningotheliomatosis A Rare Lung Disease Presenting with Diffuse Ground Glass Opa.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not explicitly mentioned; follow-up period of 1 year
- Institution/geographic location: Mayo Clinic, Rochester, MN, United States
- Method of patient identification: Symptomatic presentation (non-exertional chest pressure and dry cough)","- Age: 55 years old
- Sex distribution: Female
- Smoking status: Lifelong nonsmoker
- Relevant medical history: Hypertension, hypercholesterolemia, hypothyroidism, gastroesophageal reflux disease, impaired fasting blood glucose",,,,,,,,,,,,,,,,,,,,"- History of malignancy: More common in patients with a history of malignancy.
- Concurrent systemic conditions: Hypertension, hypercholesterolemia, hypothyroidism, gastroesophageal reflux disease, impaired fasting blood glucose.
- Negative for autoimmune and infectious etiologies.
- No mention of Turner syndrome, concurrent lung malignancies, intracranial meningioma, or other specific systemic associations.",,,,,,,,,,,,,,,,,,"Pulmonary function tests did not reveal any abnormalities at diagnosis. No specific values for FEV1, FVC, FEV/FVC, DLCO, TLC, or RV are provided. No comparison with MPMN values is mentioned. Follow-up indicates stable symptoms and imaging findings, but no specific PFT changes are noted.",Not mentioned (no information on bronchoscopy findings or related procedures is included in the paper),,,,"- Complete blood count (CBC): Negative
- Autoimmune workup: Negative (ANA, anti-dsDNA, anti scl-70, RNA polymerase III antibodies, rheumatoid factor, anti CCP antibody, ANCA, extractable nuclear antibody panels)
- Infectious workup: Negative (hypersensitivity pneumonitis panel, cystic fibrosis genetic mutation testing, fungal serologies)
- Pulmonary function tests: No abnormalities","- Symptoms at presentation: Chest discomfort, dry cough
- Lung complications: None mentioned
- Physical examination findings: Unremarkable
- Circumstances of discovery: Symptomatic workup
- Disease course and natural history: Stable with continued non-exertional chest pressure
- Progression over time: Stable findings on repeat imaging
- Complications or adverse outcomes: None reported
- Pulmonary function testing: Normal pulmonary function tests","- Imaging modalities used: High-resolution chest computed tomography (CT)
- Nodule characteristics:
  - Size: Small
  - Number/innumerable: Innumerable
  - Distribution: Diffuse
  - Appearance: Ground-glass opacity, some cavitary
- Temporal changes on follow-up imaging: Stable findings",,,,,,,,,,,,,,,,"- Microscopic/Histological features and morphology: Multiple well-circumscribed interstitial meningothelial-like nodules with occasional whorling of cells.
- Microscopic location: Interstitial, perivenular.",,,,,,,"- Diagnostic criteria used: High-resolution chest CT showing diffuse small ground-glass nodules; surgical lung biopsy showing meningothelial-like nodules.
- Differential diagnoses considered: Autoimmune and infectious etiologies.
- Diagnostic methods employed: High-resolution chest CT; surgical lung biopsy.
- Recommendations for diagnosis: Consider DPM in differential diagnosis for diffuse bilateral pulmonary nodules; use surgical lung biopsy for confirmation.",,,,,,,,,,,,Surgical Biopsy: Video-assisted thoracoscopic surgery (VATS) with multiple lung biopsies,Not mentioned (the paper does not provide specific immunohistochemistry results),,,,,,,,,,,,,,,,,,"- Management strategies: Surgery (video-assisted thoracoscopic surgery), monitoring (repeat chest CT at least one year after diagnosis)
- Monitoring intervals: At least one year
- Recommendations for management: Consider DPM in differential diagnosis for patients with diffuse bilateral pulmonary nodules
- Other: Further research is needed to better understand the disease and its clinical significance",,,,,"- Follow-up duration and methods: 1 year, repeat chest CT scan
- Disease progression/stability: Stable
- Radiological stability or progression: Stable findings on repeat chest CT
- Symptomatic or asymptomatic: Symptomatic with non-exertional chest pressure
- Clinical outcomes and patient status: Stable with persistent symptoms
- Survival/outcome at last follow up: Not mentioned
- Treatment effectiveness if interventions performed: Not mentioned
- Long-term prognosis: Not mentioned",,,,,,,,,
,Diffuse Pulmonary Meningotheliomatosis Mimicking Multiple Lung Metastases of Prostate Cancer: A Case Report,Sakano et al.,10.1002/rcr2.70176,https://doi.org/10.1002/rcr2.70176,Respirology Case Reports,2025,,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding during cancer staging and routine medical examination","- Age: 64 years (individual age)
- Sex distribution: Male (individual case)
- Smoking status: Smoker
- Relevant medical history: Carotid artery disease with stroke, arterial hypertension, nephrolithiasis, urolithiasis
- Incidence/prevalence data: DPM is more prevalent in females and more common in the 6th decade",,,,,,,,,,,,,,,,,,,,"- Concurrent lung malignancies: Lung adenocarcinoma
- Other concurrent malignancies: Not mentioned
- Intracranial meningioma: Not mentioned
- Other pulmonary disease: Pulmonary thromboembolism
- History of ulcerative colitis: Not mentioned
- History of cardiac disease: Chronic ischemic heart disease
- Other systemic associations: Hormonal imbalance with progesterone stimulation, chronic lung diseases with inducing hypoxia and ischemia
- Frequency of associations: Not specified
- Temporal relationship: DPM tends to coexist with these conditions",,,,,,,,,,,,,,,,,,"- PFTs or spirometry at diagnosis: Normal spirometry, lung volumes, and diffusion capacity.
- FEV1, FVC, FEV/FVC, DLCO, TLC, RV: Not mentioned.
- Did these get worse or were stable or improved: Not mentioned.
- Comparison of DPM vs MPMN values: Not mentioned.","- Bronchoscopy findings: Normal endobronchial finding
- Bronchoalveolar lavage (BAL) analysis: No tumor cells; CD4/CD8 ratio = 7.5
- Cell count and predominance: Not mentioned
- CD4/CD8 ratio: 7.5
- Was a Transbronchial lung biopsy performed? Yes; results showed normal peribronchial lung parenchyma with a micronodule of benign neuroendocrine hyperplasia
- Was a Transbronchial lung cryobiopsy performed? Not mentioned
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? Yes",,,,"- Laboratory test values and tumor marker levels: Normal
- Tuberculin skin test: Negative
- Bronchoalveolar lavage (BAL) fluid analysis: No tumor cells; CD4/CD8 ratio = 7.5","- Symptoms at presentation: Asymptomatic
- Lung complications: None mentioned
- Physical examination findings: Normal
- Circumstances of discovery: Incidental during cancer staging
- Disease course and natural history: Stable, with conservative management
- Progression over time: Not mentioned
- Complications or adverse outcomes: Not mentioned
- Pulmonary function testing: Normal spirometry, lung volumes, and diffusion capacity","- Imaging modalities used: HRCT
- Nodule characteristics:
  - Size: 1-5 mm
  - Number/innumerable: Multiple
  - Distribution: Diffuse, bilateral
  - Upper or lower predominance: Slight predominance in upper lobes
  - Appearance: Ground-glass opacity
- Other unique lung findings on CT: Not mentioned
- SUV values if PET performed: Not mentioned
- Temporal changes on follow-up imaging: Not mentioned
- Visibility on CT: Visible
- Other radiology studies: Not mentioned",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Small nodules ranging from 1 to 5 mm in size.
- Gross anatomic location: Perivascular.
- Microscopic/Histological features and morphology: Epithelioid cell nests or whorls in a zellballen-like arrangement centered on small veins; small clusters of epithelioid cells with round to oval nuclei devoid of atypia and surrounded by abundant eosinophilic cytoplasm.
- Microscopic location: Perivascular.
- Immunohistochemical markers tested and results: Positive for vimentin, CD56, and progesterone receptor; negative for CK7, TTF-1, p40, CK5/6, HMB45, AE1/AE3, S100, and des-min.
- Molecular or genetic findings: Not mentioned.
- Ultrastructural features: Not mentioned.
- Pathological criteria used for diagnosis: Histopathological examination and immunohistochemical studies.",,,,,,,"- Diagnostic criteria used: Histopathology, typically obtained through videothoracoscopic lung biopsy.
- Differential diagnoses considered: Hematogenous lung metastasis, primary adenocarcinoma of the lungs, lymphangitis carcinomatosa, and other conditions that mimic DPM on CT scans.
- Misdiagnosis rates and types: Not explicitly mentioned in the paper.
- Diagnostic methods employed: Videothoracoscopic lung biopsy, transbronchial biopsy, high-resolution computed tomography (HRCT), and positron emission tomography (PET) for larger nodules.
- Challenges in distinguishing from malignancy or metastatic meningioma: DPM can mimic various malignancies and conditions, requiring careful differential diagnosis.
- Recommendations for diagnosis: Consider DPM in patients with nonspecific diffuse bilateral pulmonary nodules on HRCT; use videothoracoscopic lung biopsy for definitive diagnosis; employ a multidisciplinary team approach for differential diagnosis.",,,,,,,,,,,,"- Method: Videothoracoscopic lung biopsy
- Frequency: Most common method
- Biopsy site: Upper lobe
- Surgical Biopsy: Videoassisted thoracoscopic surgery (VATS)","- Positive: vimentin, CD56, progesterone receptor, epithelial membrane antigen
- Negative: synaptophysin, chromogranin A, InsM1, CK7, TTF-1, p40, CK5/6, HMB45, AE1/AE3, S100, des-min, cytokeratin, actin, CD34",,,,,,,,,,,,,,,,,,"- Management strategies: Conservative treatment with observation and follow-up chest computed tomography imaging.
- Monitoring intervals: Not specified.
- Recommendations for management: Conservative approach with observation and follow-up CT imaging.
- Other: Videothoracoscopic lung biopsy is used for diagnosis.",,,,,Not mentioned (the paper does not provide specific follow-up data or outcomes beyond initial diagnosis and management),,,,,,,,,
,Pulmonary Meningotheliomatosis,Kumar et al.,10.1016/j.arbres.2017.06.026,https://doi.org/10.1016/j.arbres.2017.06.026,Archivos de Bronconeumología,2018,Kumar et al. - 2018 - Pulmonary Meningotheliomatosis.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: 1
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding during abdominal CT scan","- Age: 58 years (individual age)
- Sex distribution: Female
- Smoking status: Non-smoker
- Age range: 20 to 80 years
- Female predilection: Yes",,,,,,,,,,,,,,,,,,,,"- Concurrent lung malignancies: Higher incidence in patients with malignant pulmonary tumors, particularly lung adenocarcinoma.
- Other pulmonary disease: Pulmonary thromboembolic disease; smoking-related interstitial lung disease (respiratory bronchiolitis-associated interstitial lung disease/desquamative interstitial pneumonia).
- Frequency of associations: 26% of patients had smoking-related interstitial lung disease; higher incidence in patients with malignant pulmonary tumors compared to benign disease (7.3% vs. 2.5%).
- Temporal relationship: PM likely occurs as a reaction to chronic lung disease or underlying malignancy.",,,,,,,,,,,,,,,,,,Pulmonary function tests were unremarkable at diagnosis. No specific values or changes over time are provided. No comparison with MPMN values is mentioned.,"- Bronchoscopy findings: Unremarkable
- Bronchoalveolar lavage (BAL) analysis: Normal macrophage predominance
- Cell count and predominance: Normal macrophage predominance
- CD4/CD8 ratio: Not mentioned
- Was a Transbronchial lung biopsy performed? Yes, non-diagnostic
- Was a Transbronchial lung cryobiopsy performed? No
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? Yes",,,,"- Complete blood count (CBC): Not mentioned
- Metabolic panel: Not mentioned
- Bronchoalveolar lavage (BAL): Unremarkable with normal macrophage predominance
- Autoimmune workup: Not mentioned
- Infectious workup: Not mentioned","- Symptoms at presentation: Intermittent dry cough for 3 months
- Lung complications: None mentioned
- Physical examination findings: Unremarkable
- Circumstances of discovery: Incidental discovery during CT scan for abdominal pain
- Disease course and natural history: Typically presents in the sixth decade of life with a strong female predilection; associated with chronic lung insults
- Progression over time: Not mentioned
- Complications or adverse outcomes: Not mentioned
- Pulmonary function testing: Unremarkable","- Imaging modalities used: CT
- Nodule characteristics:
  - Size: Sub-centimeter
  - Number/innumerable: Multiple
  - Distribution: Bilateral
  - Centrilobular, panlobar, or paraseptal predominance: Not specified
  - Upper or lower predominance: Basal predominance
  - Left or Right predominance: Not specified
  - Appearance: Ground glass and well-defined
  - Other unique lung findings on CT: Not specified
- SUV values if PET performed: Not mentioned
- Temporal changes on follow-up imaging: Not mentioned
- Visibility on CT: Not specified
- Other radiology studies: Not mentioned",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Not mentioned
- Gross anatomic location: Not mentioned
- Microscopic/Histological features and morphology: Interstitial proliferation of epithelioid cells with oval, bland nuclei and stippled chromatin; cells are arranged in nests within the alveolar septa, often around pulmonary veins
- Microscopic location: Interstitial, around pulmonary veins
- Immunohistochemical markers tested and results: Positive for vimentin, EMA, PR, and CD56
- Molecular or genetic findings: Not mentioned
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Histological pattern and immunohistochemical characteristics",,,,,,,"- Diagnostic criteria used: Histopathological features, radiological findings
- Differential diagnoses considered: Infections, inflammatory disorders, malignancy
- Diagnostic methods employed: CT scan, VATS biopsy, transbronchial biopsy
- Challenges in distinguishing from malignancy or metastatic meningioma: Resembles granulomatous infections or metastatic malignancy
- Recommendations for diagnosis: Histopathology is required for diagnosis; VATS biopsy has a higher yield",,,,,,,,,,,,"- Method: Video-assisted thoracoscopic (VATS) biopsy
- Frequency: Used in the reported case
- Biopsy site: Not specified (general lung tissue)
- Bronchoscopic biopsy: Transbronchial biopsy was attempted but non-diagnostic
- Surgical Biopsy: VATS biopsy was diagnostic","- Positive: Vimentin, Epithelial membrane antigen (EMA), Progesterone receptors (PR), CD 56
- Negative: Not mentioned",,,,,,,,,,,,,,,,,,"Not mentioned (the paper does not provide information on management strategies, treatment, or follow-up recommendations for pulmonary meningotheliomatosis)",,,,,Not mentioned (the paper does not provide specific follow-up data or outcomes for the patient),,,,,,,,,
,Puzzling Pulmonary Patterns: Unraveling the Mystery of Minute Pulmonary Meningothelial-like Nodules (MPMN),"H Decarvalho, N Shah, T Uchel, R W Shepherd, D Khemasuwan",10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A4822,https://doi.org/10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A4822,"American Thoracic Society 2024 International Conference, May 17-22, 2024 - San Diego, CA",2024,Decarvalho et al. - 2024 - Puzzling Pulmonary Patterns Unraveling the Mystery of Minute Pulmonary Meningothelial-like Nodules.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned (follow-up period: 3 months)
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding during coronary calcium CT","- Age: 83 years old
- Sex distribution: Female
- Smoking status: Non-smoker
- Relevant medical history: Chronic baseline dyspnea",,,,,,,,,,,,,,,,,,,,"- Other pulmonary disease: Pulmonary embolism
- Concurrent lung malignancies: Primary lung cancer
- History of cardiac disease: Chronic cardiac conditions
- Other pulmonary disease: Chronic lung conditions",,,,,,,,,,,,,,,,,,Not mentioned (no information on pulmonary function testing is included in the paper),"- Bronchoscopy findings: Normal cell differentials and negative cultures for bacteria, mycobacteria, and fungi.
- Bronchoalveolar lavage (BAL) analysis: Normal cell differentials and negative cultures for bacteria, mycobacteria, and fungi.
- Cell count and predominance: Not mentioned.
- CD4/CD8 ratio: Not mentioned.
- Was a Transbronchial lung biopsy performed? Yes, via transbronchial cryobiopsy (TBCB).
- Was a Transbronchial lung cryobiopsy performed? Yes, using a 1.7 mm cryoprobe with positive EMA and negative chromogranin and synaptophysin.
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? No.",,,,"- Bronchoalveolar lavage (BAL): Normal cell differentials and negative cultures for bacteria, mycobacteria, and fungi.","- Symptoms at presentation: Chronic baseline dyspnea
- Circumstances of discovery: Incidental discovery during coronary calcium CT
- Disease course and natural history: Generally considered benign
- Progression over time: Clinically and radiographically stable during three-month follow-up
- Management: Conservative management
- Associations: Pulmonary embolism, primary lung cancer, chronic lung or cardiac conditions","- Imaging modality: Coronary calcium CT
- Nodule characteristics:
  - Appearance: Diffuse, small, groundglass nodules
  - Distribution: Diffuse
- Other radiology studies: Not mentioned",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Diffuse, small, groundglass nodules
- Gross anatomic location: Right lower lobe
- Microscopic/Histological features and morphology: Not specifically detailed
- Microscopic location: Not specifically detailed
- Immunohistochemical markers tested and results: Positive for EMA, negative for chromogranin and synaptophysin
- Molecular or genetic findings: Not mentioned
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Histological diagnosis essential to exclude other conditions; positivity for EMA and negativity for chromogranin and synaptophysin",,,,,,,"- Diagnostic criteria used: Histological diagnosis, immunohistochemical testing (positive for EMA, negative for chromogranin and synaptophysin).
- Differential diagnoses considered: Infectious, inflammatory, or malignant processes.
- Diagnostic methods employed: Bronchoscopy with BAL, TBCB.
- Challenges in distinguishing from malignancy or metastatic meningioma: Not mentioned.
- Recommendations for diagnosis: Tissue acquisition is imperative for a definitive diagnosis; TBCB is recommended as a less invasive and cost-effective method.",,,,,,,,,,,,Transbronchial cryobiopsy (TBCB) - Right lower lobe,"- Positive: Epithelial membrane antigen (EMA)
- Negative: Chromogranin, Synaptophysin",,,,,,,,,,,,,,,,,,"- Management strategies: Conservative management
- Monitoring intervals: Three-month follow-up
- Recommendations for management: Conservative approach due to benign nature of the condition
- Other: Tissue acquisition via TBCB is emphasized for definitive diagnosis",,,,,"- Follow-up duration and methods: Three months, clinical and radiographic follow-up.
- Disease progression/stability: Stable.
- Radiological stability or progression: Stable.
- Symptomatic or asymptomatic: Asymptomatic for infection or other conditions; chronic baseline dyspnea.
- Clinical outcomes and patient status: Clinically stable.
- Survival/outcome at last follow up: Stable at three months.
- Treatment effectiveness if interventions performed: Conservative management; stable condition.
- Long-term prognosis: Generally considered benign.",,,,,,,,,
,Minute Pulmonary Meningothelial-like Nodules: High-Resolution Computed Tomography and Pathologic Correlations:,Kuroki et al.,10.1097/00005382-200207000-00008,https://doi.org/10.1097/00005382-200207000-00008,Journal of Thoracic Imaging,2002,,Case Report,1,"- Study type: Case report
- Total number of DPM patients: Not mentioned
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Not mentioned",Not mentioned (no demographic information is provided in the abstract),,,,,,,,,,,,,,,,,,,,"- Concurrent lung malignancies: Adenocarcinoma of the lung
- Other pulmonary disease: Thromboembolism
- History of cardiac disease: Cardiac disease
- Other systemic associations: Malignancy",,,,,,,,,,,,,,,,,,Not mentioned (no information on pulmonary function testing is included in the abstract),Not mentioned (no information on bronchoscopy findings or related procedures is included in the abstract),,,,Not mentioned (no information on laboratory features is included in the abstract),Not mentioned (the abstract does not provide specific clinical features or presentation details for MPMNs),"- Imaging modalities used: HRCT
- Nodule characteristics:
  - Size: 1–3 mm
  - Number/innumerable: Multiple
  - Appearance: Ground-glass attenuation",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Small (1–3 mm), often multiple
- Gross anatomic location: Not explicitly mentioned, but implied to be interstitial
- Microscopic/Histological features and morphology: Interstitial nodular proliferation of small oval or spindle-shape cells arranged in a 'zellenballen' nesting pattern
- Microscopic location: Interstitial
- Immunohistochemical markers tested and results: Not mentioned
- Molecular or genetic findings: Not mentioned
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Not mentioned",,,,,,,"- Diagnostic methods employed: HRCT
- Pathological characteristics: Interstitial nodular proliferation of small oval or spindle-shape cells in a “zellenballen” nesting pattern
- Associations: Thromboembolism, cardiac disease, malignancy
- Not mentioned: Diagnostic criteria, differential diagnoses, misdiagnosis rates, challenges in distinguishing from malignancy or metastatic meningioma, recommendations for diagnosis",,,,,,,,,,,,Not mentioned (the abstract does not specify the method of diagnosis or tissue acquisition),Not mentioned (no information on immunohistochemistry is included in the abstract),,,,,,,,,,,,,,,,,,Not mentioned (the abstract does not provide information on management strategies or treatment options),,,,,"Not mentioned (the abstract does not provide any information on outcomes such as follow-up duration, disease progression, or treatment effectiveness)",,,,,,,,,
,Rethinking Chronic Multinodular Interstitial Disease in a 70-year-old Woman: A Case of Diffuse Pulmonary Meningotheliomatosis,Walton et al.,-,-,American Thoracic Society 2025 International Conference,2025,Walton et al. - Rethinking Chronic Multinodular Interstitial Disease in a 70-year-old Woman A Case of Diffuse Pulmo.pdf,Case Report,1,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Symptomatic presentation","- Age: 70 years old
- Sex distribution: Female
- Smoking status: Never smoker
- Relevant medical history: Suspected hypersensitivity pneumonitis, intracranial meningioma",,,,,,,,,,,,,,,,,,,,"- Other pulmonary disease: Hypersensitivity pneumonitis (HP)
- Other concurrent malignancies: Intracranial meningioma (treated with external beam radiation)
- Other systemic associations: Possible shared pathogenesis or genetic predisposition with intracranial meningioma",,,,,,,,,,,,,,,,,,"Pulmonary function testing at diagnosis was unremarkable. No specific values for FEV1, FVC, FEV/FVC, DLCO, TLC, or RV are provided. No comparison with MPMN values or changes over time are mentioned.","- Bronchoscopy findings: Rigid bronchoscopy with transbronchial lung cryobiopsy was performed.
- Bronchoalveolar lavage (BAL) analysis: Not mentioned.
- Cell count and predominance: Not mentioned.
- CD4/CD8 ratio: Not mentioned.
- Was a Transbronchial lung biopsy performed? Yes, with results showing multiple meningothelial-like nodules.
- Was a Transbronchial lung cryobiopsy performed? Yes, with results showing multiple meningothelial-like nodules.
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? No.",,,,- Autoimmune workup: Weakly positive SSA antibody,"- Symptoms at presentation: Dyspnea and dry cough
- Lung complications: Not mentioned
- Physical examination findings: Not mentioned
- Circumstances of discovery: Symptomatic workup
- Disease course and natural history: Generally indolent
- Progression over time: No significant change in appearance or distribution
- Complications or adverse outcomes: Not mentioned
- Pulmonary function testing: Unremarkable at initial evaluation","- Imaging modalities used: CT, HRCT
- Nodule characteristics:
  - Size: Small
  - Number/innumerable: Innumerable
  - Distribution: Centrilobular and peri-lymphatic
  - Appearance: Ground-glass opacity, micronodular
- Temporal changes on follow-up imaging: No significant change",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Small nodules partially involving the pleura.
- Gross anatomic location: Subpleural.
- Microscopic/Histological features and morphology: Multiple meningothelial-like nodules.
- Microscopic location: Not explicitly mentioned.
- Immunohistochemical markers tested and results: Not mentioned.
- Molecular or genetic findings: Not mentioned.
- Ultrastructural features: Not mentioned.
- Pathological criteria used for diagnosis: Identification of meningothelial-like nodules.",,,,,,,"- Diagnostic criteria used: Clinical history, CT imaging showing ground glass nodules, pulmonary function testing, laboratory studies (weakly positive SSA antibody), surgical biopsy, and transbronchial lung cryobiopsy.
- Differential diagnoses considered: Sarcoidosis, miliary infectious and malignant etiologies, DIPNECH, and follicular bronchiolitis.
- Diagnostic methods employed: CT imaging, pulmonary function testing, laboratory studies, surgical biopsy, and transbronchial lung cryobiopsy.
- Challenges in distinguishing from malignancy or metastatic meningioma: Overlapping imaging characteristics with more aggressive pulmonary pathologies.
- Recommendations for diagnosis: Systematic approach with clinical re-evaluation and biopsy for unclear etiology.",,,,,,,,,,,,"- Surgical Biopsy: Right mini-thoracotomy wedge resection
- Bronchoscopic Biopsy: Rigid bronchoscopy with transbronchial lung cryobiopsy",Not mentioned (the paper does not provide specific immunohistochemistry results),,,,,,,,,,,,,,,,,,"- Management strategies: Right mini-thoracotomy wedge resection, inhaled therapies, antibiotics, two-year course of steroids, rigid bronchoscopy with transbronchial lung cryobiopsy.
- Monitoring intervals: Not mentioned.
- Recommendations for management: Biopsy for diagnosis of pulmonary nodules of unclear etiology.
- Other: Emphasis on systematic approach to diagnosis due to ineffective empiric treatment.",,,,,"- Follow-up duration and methods: Not mentioned
- Disease progression/stability: Radiological stability; no significant change in appearance or distribution of nodules
- Radiological stability or progression: Stable; no significant change
- Symptomatic or asymptomatic: Symptomatic; dyspnea and dry cough
- Clinical outcomes and patient status: Generally indolent clinical course
- Survival/outcome at last follow up: Not mentioned
- Treatment effectiveness if interventions performed: Ineffective for suspected hypersensitivity pneumonitis; no specific treatment outcomes for DPM
- Long-term prognosis: Not mentioned",,,,,,,,,
,RIDDLE ME THIS: A RARE CASE OF DIFFUSE PULMONARY MENINGIOTHELIOMAS,Virk et al.,10.1016/j.chest.2023.07.3118,https://doi.org/10.1016/j.chest.2023.07.3118,CHEST,2023,,Case Report,,"- Study type: Case report
- Total number of DPM patients: 1
- Total number of multiple MPMN patients: 1
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental finding during CT angiogram for COVID-19 infection","- Age: 61 years old
- Sex distribution: Female
- Relevant medical history: Ductal hyperplasia of the breast, common variable immunodeficiency syndrome (CVID), asthma, obstructive sleep apnea, thyroid follicular cancer",,,,,,,,,,,,,,,,,,,,"- Concurrent lung malignancies: Lung adenocarcinoma
- Other concurrent malignancies: Ductal hyperplasia of the breast, thyroid follicular cancer
- Other pulmonary disease: Pulmonary thromboembolism, interstitial lung disease
- Other systemic associations: Common variable immunodeficiency syndrome (CVID)",,,,,,,,,,,,,,,,,,Not mentioned (the paper does not provide information on pulmonary function testing),"- Bronchoscopy findings: The patient underwent bronchoscopy with bronchioalveolar lavage (BAL) and transbronchial cryo biopsy.
- Bronchoalveolar lavage (BAL) analysis: Not specified.
- Cell count and predominance: Not specified.
- CD4/CD8 ratio: Not specified.
- Was a Transbronchial lung biopsy performed? Yes, transbronchial cryo biopsy was performed.
- Was a Transbronchial lung cryobiopsy performed? Yes, results showed MPMNs with immunostaining negative for malignancy.
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? No.",,,,"- Complete blood count (CBC): Chronic neutropenia with lymphocytosis
- Autoimmune workup: Positive for PANCA & CANCA, negative for ANA, MPO, and PR3
- Bronchoalveolar lavage (BAL): Part of diagnostic process, no specific findings mentioned","- Symptoms at presentation: Asymptomatic
- Lung complications: Not mentioned
- Physical examination findings: Not mentioned
- Circumstances of discovery: Incidental during CT angiogram for COVID-19
- Disease course and natural history: Indolent course
- Progression over time: Stable with no significant progression
- Complications or adverse outcomes: Not mentioned
- Pulmonary function testing: Not mentioned","- Imaging modalities used: CT angiogram, follow-up CT scans
- Nodule characteristics:
  - Size: sub 6 mm
  - Number/innumerable: numerous
  - Distribution: bilateral centrilobular
  - Centrilobular, panlobar, or paraseptal predominance: centrilobular
  - Upper or lower predominance: mild upper lobe predominance
  - Appearance: ground-glass opacity (GGNs), solid
- Other radiology studies: thyroid radioactive iodine uptake scan (no abnormal uptake in lungs)",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Not mentioned
- Gross anatomic location: Not mentioned
- Microscopic/Histological features and morphology: Small, benign lesions due to meningothelial cellular proliferation in the lung interstitium
- Microscopic location: Interstitium
- Immunohistochemical markers tested and results: Negative for malignancy (specific markers not listed)
- Molecular or genetic findings: Not mentioned
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Not mentioned",,,,,,,"- Diagnostic criteria used: Initial CT angiogram, follow-up CT scan, laboratory tests for antibodies, thyroid radioactive iodine uptake scan.
- Differential diagnoses considered: Malignant nodules, atypical infection, autoimmune interstitial lung disease (ILD), granulomatous lymphocytic interstitial lung disease (GLI-ILD).
- Misdiagnosis rates and types: Potential misdiagnosis due to similarity with adenocarcinoma in situ, metastasis, or atypical infection.
- Diagnostic methods employed: CT angiogram, CT scan, laboratory tests, thyroid radioactive iodine uptake scan, bronchoscopy with BAL and transbronchial cryo biopsy.
- Challenges in distinguishing from malignancy or metastatic meningioma: Similar radiological appearances.
- Recommendations for diagnosis: Use of lung biopsy for unclear etiology, close follow-up with serial CT scans.",,,,,,,,,,,,Transbronchial cryo biopsy during bronchoscopy with bronchioalveolar lavage (BAL),"- Positive: Not mentioned
- Negative: Negative for malignancy",,,,,,,,,,,,,,,,,,"- Management strategies: Close follow-up with serial CT scans.
- Monitoring intervals: Not specified.
- Recommendations for management: Conservative approach with close follow-up.
- Other: Diagnostic procedures included bronchoscopy with BAL and transbronchial cryo biopsy.",,,,,"- Follow-up duration and methods: 1-year follow-up with serial CT scans.
- Disease progression/stability: Radiological stability with no progression.
- Radiological stability or progression: Stable with numerous sub 6 mm bilateral centrilobular GGNs and solid pulmonary nodules.
- Symptomatic or asymptomatic: Asymptomatic.
- Clinical outcomes and patient status: Improved symptoms post-COVID, stable at follow-up.
- Survival/outcome at last follow up: Not mentioned.
- Treatment effectiveness if interventions performed: Not mentioned.
- Long-term prognosis: Indolent course, but no specific long-term prognosis mentioned.",,,,,,,,,
Case-control Study,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,"Clinical, radiological, and pathological features of minute pulmonary meningothelial-like nodules and diffuse pulmonary meningotheliomatosis",Li et al.,10.3389/fmed.2023.1209491,https://doi.org/10.3389/fmed.2023.1209491,Frontiers in Medicine,2023,"Li et al. - 2023 - Clinical, radiological, and pathological features of minute pulmonary meningothelial-like nodules an 1.pdf",Case-control Study,13,"- Study type: Retrospective case-control study
- Total number of DPM patients: 13
- Total number of multiple MPMN patients: 167
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: January 2018 to December 2022
- Institution/geographic location: Department of Thoracic Surgery, National Center for Respiratory Medicine, Guangzhou, P.R., China
- Method of patient identification: Incidental finding during pulmonary resections for other reasons","- Age: MPMNs mean age 57.9 years; DPM mean age 51.4 years
- Sex distribution: MPMNs - 132 women (79.4%), 35 men (20.6%); DPM - all women
- Smoking status: MPMNs - 7.8% smokers, 92.2% non-smokers; DPM - no smoking history mentioned
- E-cigarette/vape use: Not mentioned
- Relevant medical history: Not mentioned
- Social history: Not mentioned
- Incidence/prevalence data: DPM - 0.15%",,,,,,,,,,,,,,,,,,,,"- Concurrent lung malignancies: Lung adenocarcinoma is significantly associated with MPMNs (83.2% of MPMN patients) and also found in DPM patients (76.9%).
- Frequency of associations: 83.2% of MPMN patients and 76.9% of DPM patients have lung adenocarcinoma.
- Temporal relationship: The primary reason for surgery in MPMN patients was often the detection of other malignant nodules, suggesting these conditions are often discovered concurrently.",,,,,,,,,,,,,,,,,,"- FEV1: MPMNs = 2.0 ± 0.5 L, DPM = 2.6 ± 0.6 L (P < 0.01)
- FVC: MPMNs = 2.8 ± 0.6 L, DPM = 3.3 ± 0.8 L (P = 0.031)
- FEV1/FVC: MPMNs = 76.3 ± 6.6%, DPM = 77.5 ± 6.0% (P = 0.751)
- FEV1%: MPMNs = 87.1 ± 15.8%, DPM = 102.2 ± 9.2% (P < 0.01)
- FVC%: MPMNs = 103.0 ± 18.0%, DPM = 111.8 ± 10.8% (P = 0.053)
- DLCO, TLC, RV: Not mentioned
- Changes over time: Not mentioned",Not mentioned (the paper does not provide specific bronchoscopy findings or detailed results from bronchoscopic procedures),,,,"Not mentioned (no information on specific laboratory tests such as CBC, metabolic panel, bronchoalveolar lavage, autoimmune workup, or infectious workup is included in the paper)","- Symptoms at presentation: MPMNs are typically asymptomatic; DPM patients often present with respiratory symptoms like cough and shortness of breath, but many are asymptomatic.
- Lung complications: Not specifically mentioned.
- Physical examination findings: Not detailed.
- Circumstances of discovery: Both conditions are often discovered incidentally during imaging or surgery for other reasons.
- Disease course and natural history: Limited information; follow-up showed no significant changes in lesions over a year.
- Progression over time: Not detailed.
- Complications or adverse outcomes: Not mentioned.
- Pulmonary function testing: DPM patients had higher FEV1 and FVC values compared to MPMN patients.","- Imaging modality: Unenhanced chest CT scans with a 256-row multidetector system
- Nodule characteristics:
  - Size: 2.0-8.0 mm
  - Number: 40 to >600 per lung
  - Distribution: More abundant in the subpleural region, present in both deep and subpleural locations
  - Left or Right predominance: More widespread in the right lung
  - Appearance: Diffuse ground-glass opacity nodules
- Temporal changes: No significant changes on 1-year follow-up CT scans
- Visibility: Visible on CT",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: MPMNs are solitary or multiple reactive hyperplasia pulmonary nodules.
- Gross anatomic location: DPM nodules are widespread.
- Microscopic/Histological features and morphology: Elliptical cell nuclei without obvious nuclear atypia, small nucleoli, no apparent mitotic figures; focal whorling of cells in DPM.
- Microscopic location: Interstitial.
- Immunohistochemical markers tested and results: EMA, PR, vimentin, TTF-1, CK, CD56 with specific positivity rates.
- Molecular or genetic findings: Not mentioned.
- Ultrastructural features: Not mentioned.
- Pathological criteria used for diagnosis: Not explicitly mentioned.",,,,,,,"- Diagnostic criteria used: Chest CT scans for radiological features; VATS lung wedge biopsy for histological confirmation.
- Differential diagnoses considered: Not explicitly mentioned, but implies distinction from other lung diseases.
- Misdiagnosis rates and types: Acknowledges potential for misdiagnosis due to rarity and need for high expertise in pathology.
- Diagnostic methods employed: Chest CT scans, VATS lung wedge biopsy, histological analysis with hematoxylin and eosin staining, immunohistochemical staining.
- Challenges in distinguishing from malignancy or metastatic meningioma: Not explicitly addressed, but implies difficulty due to rarity and need for expert pathology.
- Recommendations for diagnosis: Use of chest CT scans and VATS lung wedge biopsy for definitive diagnosis; high expertise in pathology is necessary.",,,,,,,,,,,,"- Method: Surgical resection (mainly incidental findings during resections for other lung nodules)
- Biopsy type: VATS lung wedge biopsy
- Biopsy site: Not specifically mentioned, but resected lobes were analyzed","- Positive: EMA (100%), PR (100%), vimentin (100%), CD56 (76.9%), TTF-1 (53.9%), CK (23.1%)
- Negative: CK (76.9%), TTF-1 (46.1%), CD56 (23.1%)",,,,,,,,,,,,,,,,,,"- Management strategies: MPMNs do not require specific treatment as they are considered reactive changes. DPM diagnosis involves VATS lung wedge biopsy, but no specific treatment strategies are mentioned.
- Monitoring intervals: A 1-year postoperative follow-up was conducted for DPM patients.
- Recommendations for management: Not mentioned in the paper.
- Other: MPMNs are often incidentally removed during surgery for other conditions.",,,,,"- Follow-up duration and methods: 1-year postoperative follow-up on 13 patients with chest CT scans.
- Disease progression/stability: No significant changes in lesions observed on chest CT scans.
- Radiological stability or progression: Radiological stability observed.
- Symptomatic or asymptomatic: Not mentioned.
- Clinical outcomes and patient status: Not mentioned.
- Survival/outcome at last follow-up: Not mentioned.
- Treatment effectiveness if interventions performed: Not mentioned.
- Long-term prognosis: Not mentioned.",,,,,,,,,
Case Series,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,LONG-TERM FOLLOW-UP OF PATIENTS WITH BIOPSY CONFIRMED DIFFUSE PULMONARY MENINGOTHELIOMATOSIS,"Nadrous et al,",10.1016/j.chest.2023.07.2732,https://doi.org/10.1016/j.chest.2023.07.2732,CHEST,2023,Nadrous et al. - 2023 - LONG-TERM FOLLOW-UP OF PATIENTS WITH BIOPSY CONFIRMED DIFFUSE PULMONARY MENINGOTHELIOMATOSIS.pdf,Case Series,,"- Study type: Retrospective case series
- Total number of DPM patients: 11
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Median follow-up of 3.5 years
- Institution/geographic location: Mayo Clinic sites
- Method of patient identification: Biopsy confirmed, likely through symptomatic presentation or incidental findings","- Age: Median age of 58 years (IQR 52.3, 63.8)
- Sex distribution: 100% female, 0% male
- Smoking status: 36% former smokers
- Relevant medical history: 46% prior history of cancer, 9% concurrent lung adenocarcinoma, 27% on HRT",,,,,,,,,,,,,,,,,,,,"- History of cancer: 5 patients (46%) had a prior history of cancer.
- Concurrent lung malignancies: 1 patient was diagnosed with lung adenocarcinoma concurrently with DPM.
- Other systemic associations: Possible pathophysiologic link to estrogens/progestins suggested by improvement in symptoms after discontinuing HRT.",,,,,,,,,,,,,,,,,,Not mentioned (the paper does not provide any information on pulmonary function testing or spirometry),Not mentioned (the paper does not provide information on bronchoscopy findings or related procedures),,,,"Not mentioned (no specific laboratory features such as CBC, metabolic panel, bronchoalveolar lavage, autoimmune workup, or infectious workup are included in the paper)","- Symptoms at presentation: Most patients reported cough, dyspnea, or chest discomfort; two patients were asymptomatic with incidental findings.
- Lung complications: Not mentioned.
- Physical examination findings: Not mentioned.
- Circumstances of discovery: Most patients were symptomatic; two were incidental findings.
- Disease course and natural history: 80% showed no progression over a median follow-up of 3.5 years.
- Progression over time: One patient showed slight growth in nodules; another developed a new nodule.
- Complications or adverse outcomes: Not explicitly mentioned; one patient improved symptomatically after discontinuing HRT.
- Pulmonary function testing, spirometry, or walking tests: Not mentioned.","- Imaging modality: Chest computed tomography (CT)
- Nodule characteristics:
  - Size: Small (<5mm)
  - Number: Innumerable
  - Distribution: Bilateral
  - Appearance: Ground glass nodules
  - Other unique findings: Central cavitation (""cheerio""-sign) in 27%
- Temporal changes: 80% showed no progression; one patient showed slight growth; another developed a new nodule",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Innumerable small (<5mm) bilateral ground glass nodules with central cavitation (""cheerio""-sign).
- Gross anatomic location: Widespread distribution in the lungs.
- Microscopic/Histological features and morphology: Meningothelial nodules with oval to spindle cells, indistinct cellular borders, and some whorling.
- Immunohistochemical markers tested and results: Positive for vimentin, EMA, CD56, and ER.
- Molecular or genetic findings: Not mentioned.
- Ultrastructural features: Not mentioned.
- Pathological criteria used for diagnosis: Not mentioned.",,,,,,,"- Diagnostic criteria used: Biopsy confirmation, histological examination showing meningothelial nodules with oval to spindle cells and whorling, immunochemical staining positive for vimentin, EMA, CD56, and ER.
- Diagnostic methods employed: Chest CT scans to identify innumerable small bilateral ground glass nodules and the ""cheerio""-sign, biopsy.
- Challenges in distinguishing from malignancy or metastatic meningioma: Not explicitly mentioned, but implied due to rarity and similar radiological findings.
- Recommendations for diagnosis: Use of the ""cheerio""-sign in CT scans to facilitate recognition and management.",,,,,,,,,,,,Biopsy confirmed DPM; specific biopsy type and site not mentioned,"- Positive: vimentin, EMA, CD56, ER
- Negative: Not mentioned",,,,,,,,,,,,,,,,,,"- Management strategies: Observation
- Monitoring intervals: Median follow-up of 3.5 years
- Recommendations for management: Discontinuation of HRT in symptomatic patients
- Other: Increased lung cancer CT screening efforts may aid in recognition and management",,,,,"- Follow-up duration and methods: Median follow-up of 3.5 years (IQR 1, 5.75)
- Disease progression/stability: 80% showed no progression; one patient showed slight growth in size and number of MPMN's after 7 years; another developed a new nodule after 6 years
- Radiological stability or progression: Most patients showed no progression; some showed slow progression
- Symptomatic or asymptomatic: Most patients were symptomatic; one patient improved after discontinuing HRT
- Clinical outcomes and patient status: Most patients remained stable; some showed slow progression
- Survival/outcome at last follow-up: Not explicitly mentioned
- Treatment effectiveness if interventions performed: One patient improved after discontinuing HRT
- Long-term prognosis: Reassuring, with most patients not showing disease progression",,,,,,,,,
,Diffuse Pulmonary Meningotheliomatosis: Clinic-Pathologic Entity or Indolent Metastasis from Meningioma (or Both)?,Melocchi et al.,doi.org/10.3390/diagnostics13040802,https://doi.org/10.3390/diagnostics13040802,Diagnostics,2023,diagnostics-13-00802.pdf,Case Series,4,"- Study type: Case series
- Total number of DPM patients: 4
- Total number of multiple MPMN patients: Not explicitly mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: January 2008 to December 2021
- Institution/geographic location: Infermi Hospital of Rimini, Santa Maria delle Croci Hospital of Ravenna, Santa Maria Nuova Hospital of Reggio Emilia, Italy
- Method of patient identification: Incidental finding during routine practice or consultations","- Age: Mean age at diagnosis for the case series is 57.5 years (range 51-68 years). Literature review shows a mean age of 60 years (range 30-80 years).
- Sex distribution: Case series includes three women and one man. Literature review shows a female-to-male ratio of 10:1 (40 women, 4 men).
- Smoking status: Case series includes three never-smokers. Literature review mentions 9 former or current smokers and 12 never-smokers.
- Relevant medical history: Three patients in the case series had a history of intracranial meningioma. Literature review notes 12 patients with a history of malignancy and vascular hypertension as a common co-morbidity.
- Other demographic characteristics: Two patients with Turner's syndrome.",,,,,,,,,,,,,,,,,,,,"- History of Turner syndrome: 2 cases reported in the literature.
- Concurrent lung malignancies: Pulmonary malignancies (mainly adenocarcinoma) are associated with MMNs.
- Other concurrent malignancies: 12 patients had a history of malignancy.
- Intracranial meningioma: Present in 3 out of 4 cases studied, ranging from 4 to 10 mm in size, located in the frontal and temporal regions.
- Other pulmonary diseases: Sarcoidosis and DIPNECH were considered in differential diagnosis based on radiologic findings.
- History of cardiac disease: Cardiac diseases are associated with MMNs.
- Other systemic associations: Vascular hypertension was a common comorbidity in 12 cases (27%).
- Frequency of associations: Intracranial meningioma was present in 75% of the cases studied in this paper.
- Temporal relationship: Intracranial meningioma was discovered before or concomitant with DPM diagnosis in the cases studied.",,,,,,,,,,,,,,,,,,Not mentioned (the paper does not provide information on pulmonary function testing or spirometry results for DPM patients),"- Bronchoscopy findings: Not specifically detailed
- Bronchoalveolar lavage (BAL) analysis: Not mentioned
- Cell count and predominance: Not mentioned
- CD4/CD8 ratio: Not mentioned
- Was a Transbronchial lung biopsy performed? If yes, describe results: Yes, performed in two cases, demonstrating pulmonary meningothelial-like nodules
- Was a Transbronchial lung cryobiopsy performed? If yes, describe results: Not specifically mentioned for the four cases, but used in some literature cases
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? Yes, required in two cases",,,,"Not mentioned (no information on specific laboratory tests such as CBC, metabolic panel, bronchoalveolar lavage, autoimmune workup, or infectious workup is included in the paper)","- Symptoms at presentation: Asymptomatic in the study cases; literature reports 43% with respiratory symptoms (dry cough, dyspnea)
- Lung complications: Not mentioned
- Physical examination findings: Not mentioned
- Circumstances of discovery: Incidental during imaging for other reasons
- Disease course and natural history: Indolent and stable; no therapy required
- Progression over time: Not mentioned
- Reported complications or adverse outcomes: None reported
- Pulmonary function testing, spirometry, or walking tests: Not mentioned","- Imaging modality: CT
- Nodule characteristics:
  - Size: Up to 6 mm in maximum diameter
  - Number: Innumerable
  - Distribution: Diffuse and bilateral, randomly distributed
  - Appearance: Solid or ground glass density, some with central lucency (""cheerio sign"")
- Other unique lung findings: Central lucency or ""cheerio sign"" in some nodules",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Tiny proliferation (up to 5-6 mm) of bland-looking meningothelial cells.
- Gross anatomic location: Perivenular and interstitial distribution.
- Microscopic/Histological features and morphology: Bland-looking proliferation of oval-to-spindle-shaped or epithelioid cells around venules, with variable amounts of collagenized fibrous tissue.
- Microscopic location: Interstitial and perivenular.
- Immunohistochemical markers tested and results: EMA, progesterone receptor, and CD56 are positive; neuroendocrine, smooth muscle, melanocytic, vascular markers, CD10, cytokeratins, TTF1, and estrogen receptors are negative.
- Molecular or genetic findings: Sharing of neurofibromatosis (NF)-2 gene deletion with intracranial meningiomas.
- Ultrastructural features: Not mentioned.
- Pathological criteria used for diagnosis: Close correlation with clinic-radiologic data, exclusion of other lesions as a cause of micronodules.",,,,,,,"- Diagnostic criteria: Multiple bilateral MMNs leading to interstitial lung disease with diffuse and micronodular/miliariform patterns on radiology.
- Differential diagnoses: Metastatic disease, granulomatous processes (sarcoidosis, infections), metastatic sarcoma, DIPNECH, LAM.
- Diagnostic methods: CT imaging, transbronchial biopsy, surgical lung biopsy.
- Challenges: Distinguishing from metastatic meningioma due to overlapping findings.
- Recommendations: Exclude past history of meningioma and concomitant meningioma by imaging studies.",,,,,,,,,,,,"- Method: Transbronchial biopsy (2 cases), Surgical lung biopsy (2 cases)
- Biopsy site: Not specified
- Bronchoscopic biopsy: Transbronchial biopsy
- Surgical Biopsy: Surgical lung biopsy","- Positive: Epithelial membrane antigen (EMA), progesterone receptor, CD56
- Negative: Neuroendocrine, smooth muscle, melanocytic, vascular markers, CD10, cytokeratins, TTF1, estrogen receptors",,,,,,,,,,,,,,,,,,"- Management strategies: Observation
- Monitoring intervals: Follow-up ranged from 38 to 99 months
- Recommendations for management: Conservative management with observation; no specific therapy administered
- Other: Prognosis is good with stable disease without significant morbidity",,,,,"- Follow-up duration and methods: Follow-up ranged from 38 to 99 months; no specific methods mentioned.
- Disease progression/stability: All patients were asymptomatic at follow-up, indicating stable disease.
- Radiological stability or progression: Not specifically mentioned.
- Symptomatic or asymptomatic: All patients were asymptomatic at follow-up.
- Clinical outcomes and patient status: All patients were alive and well at follow-up.
- Survival/outcome at last follow-up: All patients were alive at last follow-up.
- Treatment effectiveness if interventions performed: No therapy was administered for DPM.
- Long-term prognosis: Generally good with a stable disease course and no significant morbidity.",,,,,,,,,
,Diffuse Pulmonary Meningotheliomatosis,Suster et al.,-,-,American Journal of Surgical Pathology,2007,suster2007.pdf,Case Series,,"- Study type: Case series
- Total number of DPM patients: 5
- Total number of multiple MPMN patients: 5
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Not mentioned
- Institution/geographic location: Not mentioned
- Method of patient identification: Symptomatic presentation and radiological findings","- Age: Range 54 to 75 years
- Sex distribution: 4 women, 1 man
- Smoking status: None of the patients had a history of smoking
- Relevant medical history: Previous malignancies (colon carcinoma, uterine leiomyosarcoma, papillary thyroid carcinoma, invasive ductal breast carcinoma, lung adenocarcinoma)
- Environmental exposures: None mentioned",,,,,,,,,,,,,,,,,,,,"- History of malignancy: 3 patients (colon adenocarcinoma, uterine leiomyosarcoma, papillary thyroid carcinoma, invasive ductal breast carcinoma, lung adenocarcinoma)
- Concurrent lung malignancies: 1 patient (lung adenocarcinoma)
- Other concurrent malignancies: uterine leiomyosarcoma, invasive ductal breast carcinoma
- Other pulmonary disease: mild restrictive lung disease, subpleural fibrosis
- Frequency of associations: 3 out of 5 patients had a history of malignancy
- Temporal relationship: varies, with some malignancies occurring years before DPM diagnosis",,,,,,,,,,,,,,,,,,"- PFTs or spirometry at diagnosis: Results showed a pattern of mild restrictive lung disease.
- FEV1, FVC, FEV/FVC, DLCO, TLC, RV: Not mentioned.
- Did these get worse or were stable or improved: Not mentioned.
- Comparison of DPM vs MPMN values: Not mentioned.",Not mentioned (the paper does not provide any information on bronchoscopy findings or related procedures),,,,"- Pulmonary function tests: mild restrictive lung disease
- Microscopic examination: no asbestos bodies identified","- Symptoms at presentation: Dyspnea, shortness of breath, fatigue
- Lung complications: Spontaneous pneumothorax
- Circumstances of discovery: Incidental or during symptomatic workup for suspected interstitial lung disease or metastatic disease
- Disease course and natural history: Progression over time, stabilization in one case, increasing symptoms in another
- Complications: Additional metastases, respiratory symptoms
- Pulmonary function testing: Mild restrictive lung disease","- Imaging modalities used: Chest x-rays, computed tomography (CT) scans
- Nodule characteristics:
  - Size: 2 to 3 mm, with some larger ones up to 8 mm
  - Number: Ranged from 30 to >100 per lung
  - Distribution: Bilateral and diffuse
  - Appearance: Reticulonodular infiltrates or ground-glass opacities
- Other unique lung findings: Absence of hilar adenopathy
- Temporal changes on follow-up imaging: Stabilization of lesions in one case",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Small gray-white nodules, 1 to 5 mm in diameter, scattered throughout the lung parenchyma, both subpleurally and deep.
- Gross anatomic location: Subpleural and deep within the lung tissue.
- Microscopic/Histological features and morphology: Small clusters of epithelioid cells with round to oval nuclei and abundant eosinophilic cytoplasm.
- Microscopic location: Interstitial, primarily in perivenular and perivascular areas.
- Immunohistochemical markers tested and results: Positive for EMA and vimentin; negative for cytokeratin, actin, S-100 protein, CD34, chromogranin, and synaptophysin.
- Ultrastructural features: Complex cytoplasmic interdigitations joined by well-developed desmosomes and abundant intracytoplasmic intermediate filaments.
- Pathological criteria used for diagnosis: Absence of marked nuclear atypia, mitotic activity, and negative cytokeratin stains.",,,,,,,"- Diagnostic criteria: Small clusters of epithelioid cells with EMA and vimentin positivity, negative for cytokeratin, actin, S-100 protein, CD34, chromogranin, and synaptophysin.
- Differential diagnoses: Idiopathic interstitial pneumonia, lymphangitis carcinomatosa, pulmonary tumorlets, metastatic tumors.
- Diagnostic methods: Clinical presentation, imaging (chest x-rays and CT scans), open lung biopsies for histological examination.
- Challenges: Distinguishing from malignancy or metastatic meningioma requires careful histological and immunohistochemical analysis.
- Recommendations: Use of open lung biopsies and specific immunohistochemical markers for diagnosis.",,,,,,,,,,,,"- Method: Open lung biopsy (surgical resection)
- Biopsy site: Right middle lobe (mentioned for one case)
- Surgical Biopsy: Wedge resections of lung","- Positive: Epithelial membrane antigen (EMA), Vimentin
- Negative: Cytokeratin, Actin, S-100 protein, CD34, Chromogranin, Synaptophysin",,,,,,,,,,,,,,,,,,"- Management strategies: Open lung biopsies for diagnosis and evaluation.
- Monitoring intervals: Surveillance CT scans over a period of 92 months for one patient.
- Recommendations for management: Consideration in differential diagnosis of diffuse interstitial pulmonary infiltrates.
- Other: No specific treatment strategies mentioned; three patients lost to follow-up.",,,,,"- Follow-up duration and methods: Case 2 had a follow-up of 92 months with surveillance CT scans. Case 5 was on surveillance with periodic CT scans.
- Disease progression/stability: Case 2 showed stabilization of lung lesions. Case 5 had an increase in lung lesions.
- Radiological stability or progression: Case 2 showed no additional growth or metastatic disease. Case 5 had an increase in lung lesions.
- Symptomatic or asymptomatic: Case 5 developed respiratory symptoms.
- Clinical outcomes and patient status: Case 2 had additional metastases from uterine leiomyosarcoma. Case 5 was a recent case with no additional follow-up.
- Survival/outcome at last follow up: Case 2 had stabilization of lung lesions. Case 5 had no additional follow-up.
- Treatment effectiveness if interventions performed: Not mentioned.
- Long-term prognosis: Not mentioned.",,,,,,,,,
,Diffuse Pulmonary Meningothelial-Like Nodules: A Case Series,Mirza et al.,10.1016/j.chest.2017.08.476,https://doi.org/10.1016/j.chest.2017.08.476,CHEST,2017,Mirza et al. - 2017 - Diffuse Pulmonary Meningothelial-Like Nodules A Case Series.pdf,Case Series,7,"- Study type: Case series
- Total number of MPMN/DPM patients: 46
- Total number of multiple DPM patients: 7
- Number of single MPMN patients excluded: Not explicitly mentioned
- Study period/duration: 2000-2016
- Institution/geographic location: Mayo Clinic, Minnesota
- Method of patient identification: Review of medical records for incidental findings and biopsies for clinical indications","- Age: Average age at diagnosis was 61 years (range: 27-77)
- Sex distribution: 43 females (93.5%), 3 males (6.5%)
- Smoking status: Not mentioned
- E-cigarette/vape use: Not mentioned
- Relevant medical history: Not mentioned
- Social history: Not mentioned
- Environment exposures: Not mentioned
- Incidence/prevalence data: Not mentioned
- Other demographic characteristics: Not mentioned",,,,,,,,,,,,,,,,,,,,"- Concurrent lung malignancies: Adenocarcinoma in situ (1 patient)
- Other pulmonary diseases: Chronic hypersensitivity pneumonitis (3 patients), granulomas (7 patients), chronic bronchiolitis (10 patients), atypical adenomatous hyperplasia (3 patients), emphysema (4 patients)
- Other systemic associations: Possible genetic or hormonal predisposition
- Frequency of associations: Granulomas (7), chronic bronchiolitis (10), atypical adenomatous hyperplasia (3), emphysema (4)
- Temporal relationship: Hypersensitivity pneumonitis (1-6 months), atypical adenomatous hyperplasia (38 months)",,,,,,,,,,,,,,,,,,Not mentioned (no information on pulmonary function testing is included in the paper),"Not mentioned (the paper does not provide specific bronchoscopy findings or details on bronchoalveolar lavage analysis, cell count, CD4/CD8 ratio, or transbronchial lung biopsy/cryobiopsy)",,,,"- Demographics: 46 patients, predominantly female (43 females; 93.5%), average age at diagnosis 61 (range: 27-77).
- Clinical features: Micronodular disease with/without cavitation, findings suggestive of chronic hypersensitivity pneumonitis.
- Radiological findings: Micronodular disease, ground-glass opacities (GGO).
- Pathological characteristics: PMNs, granulomas, chronic bronchiolitis, atypical adenomatous hyperplasia, emphysema.
- Associations: Adenocarcinoma in situ, interstitial lung disease.
- Diagnostic approaches: Biopsy for evaluation of diffuse micronodular disease.
- Disease course and prognosis: Lack of evidence for management recommendations.
- Management strategies: Clinical judgment based on risk factors.
- Patient outcomes: Follow-up data for some patients, but comprehensive outcomes not detailed.","- Symptoms at presentation: Not mentioned
- Lung complications: Associations with chronic hypersensitivity pneumonitis, atypical adenomatous hyperplasia, and adenocarcinoma in situ
- Physical examination findings: Not mentioned
- Circumstances of discovery: Incidental detection, evaluation of diffuse micronodular disease, known or suspected malignancy, interstitial lung disease, lung surface irregularity
- Disease course and natural history: Not well-defined due to inadequate follow-up data; PMNs likely benign when detected incidentally
- Progression over time: Not mentioned
- Complications or adverse outcomes: Not mentioned
- Pulmonary function testing: Not mentioned","- Imaging modalities used: Not mentioned
- Nodule characteristics:
  - Size: Not mentioned
  - Number/innumerable: Not mentioned
  - Distribution: Not mentioned
  - Centrilobular, panlobar, or paraseptal predominance: Not mentioned
  - Upper or lower predominance: Not mentioned
  - Left or Right predominance: Not mentioned
  - Appearance: Micronodular, ground-glass opacity (GGO)
  - Other unique lung findings on CT: Cavitation
  - SUV values if PET performed: Not mentioned
  - Temporal changes on follow-up imaging: Not mentioned
  - Visibility on CT: Not mentioned
  - Other radiology studies: Not mentioned",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Nodules size between 1-6mm
- Gross anatomic location: Not mentioned
- Microscopic/Histological features and morphology: Associations with granulomas, chronic bronchiolitis, atypical adenomatous hyperplasia, and emphysema
- Microscopic location: Varies; found in association with other conditions
- Immunohistochemical markers tested and results: Not mentioned
- Molecular or genetic findings: Not mentioned
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Not explicitly mentioned",,,,,,,"- Diagnostic criteria used: Diagnosis should only be made after biopsy.
- Differential diagnoses considered: Not explicitly mentioned, but implies challenge in distinguishing from malignancy or metastatic meningioma.
- Misdiagnosis rates and types: Not mentioned.
- Diagnostic methods employed: Biopsy, imaging (for preliminary identification of micronodular disease).
- Challenges in distinguishing from malignancy or metastatic meningioma: Implied as challenging, but specific challenges not detailed.
- Recommendations for diagnosis: Diagnosis should only be made after biopsy; clinical judgment based on risk factors for follow-up and further imaging.",,,,,,,,,,,,"- Method: Biopsy (frequency not specified)
- Biopsy type: Not specified (includes bullectomy specimen)
- Biopsy site: Not specified
- Bronchoscopic biopsy: Not mentioned
- Surgical Biopsy: Mentioned in context of bullectomy specimen",Not mentioned (the paper does not provide specific immunohistochemistry results),,,,,,,,,,,,,,,,,,"- Management strategies: No specific management strategies are recommended due to lack of evidence. Clinical judgment based on risk factors is suggested for follow-up or further imaging.
- Monitoring intervals: Not mentioned.
- Recommendations for management: Diagnosis should be made after biopsy. PMNs associated with inflammation or tumors are likely markers of injury. Multiple PMNs detected incidentally are likely benign.
- Other: Clinical judgment based on risk factors should guide follow-up or further imaging.",,,,,"- Follow-up duration and methods: Follow-up periods ranged from 1 to 6 months for patients with diffuse micronodular disease; one patient had a follow-up of 38 months, and another had a follow-up of 95 months.
- Disease progression/stability: Not mentioned in detail.
- Radiological stability or progression: Not mentioned in detail.
- Symptomatic or asymptomatic: Not mentioned in detail.
- Clinical outcomes and patient status: Patients with incidental PMNs are likely benign; some had findings suggestive of chronic hypersensitivity pneumonitis or adenocarcinoma in situ.
- Survival/outcome at last follow up: Not mentioned in detail.
- Treatment effectiveness if interventions performed: Not mentioned.
- Long-term prognosis: Inadequate experience or evidence to make recommendations.",,,,,,,,,
,Diffuse Pulmonary Meningothelial-Like Nodules: A Case Series,"Shireen Mirza, Anja Roden, Charles Thomas, Mayo Clinic",10.1016/j.chest.2017.08.476,https://doi.org/10.1016/j.chest.2017.08.476,Chest,2017,Mirza et al. - 2017 - Diffuse Pulmonary Meningothelial-Like Nodules A Case Series.pdf,Case Series,7,"- Study type: Case series
- Total number of DPM patients: 46
- Total number of multiple MPMN patients: 23
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: 2000-2016
- Institution/geographic location: Mayo Clinic, Minnesota
- Method of patient identification: Incidental finding through medical records","- Age: Average age at diagnosis was 61 years, with a range of 27 to 77 years.
- Sex distribution: 43 females (93.5%) out of 46 patients had 1 or more PMNs, where 7 were actually diagnosed with DPM
- Relevant medical history: Associations with chronic hypersensitivity pneumonitis, malignancy, interstitial lung disease, and other conditions.
- Other associations: Possible genetic or hormonal predisposition to the formation of PMNs.",,,,,,,,,,,,,,,,,,,,"- Concurrent lung malignancies: Adenocarcinoma in situ
- Other pulmonary disease: Chronic hypersensitivity pneumonitis, atypical adenomatous hyperplasia, granulomas, chronic bronchiolitis, emphysema
- Other systemic associations: Possible genetic or hormonal predisposition
- Frequency of associations: Granulomas (7), chronic bronchiolitis (10), atypical adenomatous hyperplasia (3), emphysema (4)
- Temporal relationship: Follow-up periods mentioned for some conditions (e.g., 1-6 months for hypersensitivity pneumonitis)",,,,,,,,,,,,,,,,,,Not mentioned (no information on pulmonary function testing or spirometry results is included in the paper),Not mentioned (the paper does not provide specific information on bronchoscopy findings or procedures),,,,"- Epidemiology: 46 patients, predominantly female (93.5%), average age at diagnosis 61 (range: 27-77).
- Clinical features: Diffuse micronodular disease with/without cavitation.
- Radiological findings: Ground-glass opacities (GGO), micronodular disease.
- Pathological characteristics: Granulomas, chronic bronchiolitis, atypical adenomatous hyperplasia.
- Associations: Malignancy, interstitial lung disease.
- Diagnostic approaches: Biopsy for evaluation of diffuse micronodular disease.
- Disease course and prognosis: Follow-up periods (1-95 months), clinical outcomes.
- Management strategies: Clinical judgment based on risk factors.
- Patient outcomes: Clinical outcomes, follow-up data.","- Symptoms at presentation: Not mentioned
- Lung complications: Not mentioned
- Physical examination findings: Not mentioned
- Circumstances of discovery: Often incidental, found in specimens with underlying inflammation, injury, or tumor
- Disease course and natural history: Inadequate follow-up data; likely benign when found incidentally
- Progression over time: Not mentioned
- Complications or adverse outcomes: Not mentioned
- Pulmonary function testing: Not mentioned","- Imaging modalities used: Not mentioned
- Nodule characteristics:
  - Size: Not mentioned
  - Number/innumerable: Not mentioned
  - Distribution: Not mentioned
  - Centrilobular, panlobar, or paraseptal predominance: Not mentioned
  - Upper or lower predominance: Not mentioned
  - Left or Right predominance: Not mentioned
  - Appearance: Micronodular, ground-glass opacity (GGO)
  - Other unique lung findings on CT: Cavitation
  - SUV values if PET performed: Not mentioned
  - Temporal changes on follow-up imaging: Not mentioned
  - Visibility on CT: Not mentioned
  - Other radiology studies: Not mentioned",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Not mentioned
- Gross anatomic location: Not mentioned
- Microscopic/Histological features and morphology: PMNs noted on lung pathology specimens; size of nodules between 1-6mm
- Microscopic location: Not mentioned
- Immunohistochemical markers tested and results: Not mentioned
- Molecular or genetic findings: Not mentioned
- Ultrastructural features: Not mentioned
- Pathological criteria used for diagnosis: Not explicitly mentioned",,,,,,,"- Diagnostic criteria used: Biopsy is essential for diagnosis.
- Differential diagnoses considered: Distinguishing from malignancy or metastatic meningioma is challenging.
- Diagnostic methods employed: Imaging (to detect micronodular disease) followed by biopsy.
- Challenges in distinguishing from malignancy or metastatic meningioma: Not explicitly mentioned, but implied as challenging.
- Recommendations for diagnosis: Diagnosis should only be made after biopsy; clinical judgment based on risk factors is recommended for follow-up and further imaging.",,,,,,,,,,,,"- Method: Biopsy (frequency not specified)
- Biopsy type: Surgical biopsy (at least one case involved bullectomy)
- Biopsy site: Not specified
- Bronchoscopic biopsy: Not mentioned
- Surgical Biopsy: Mentioned (bullectomy)",Not mentioned (the paper does not provide information on immunohistochemistry results),,,,,,,,,,,,,,,,,,"- Management strategies: Clinical judgment based on risk factors for follow-up, oncologic work-up, or further imaging.
- Monitoring intervals: Not specified.
- Recommendations for management: Diagnosis should be made after biopsy; PMNs are likely markers of injury; clinical judgment should be used for follow-up and further imaging.
- Other: No specific treatment strategies mentioned; PMNs detected incidentally are likely benign.",,,,,"- Follow-up duration and methods: Follow-up periods range from 1 to 95 months.
- Disease progression/stability: Not explicitly detailed; some had findings suggestive of chronic hypersensitivity pneumonitis or adenocarcinoma in situ.
- Radiological stability or progression: Not explicitly mentioned; presence of micronodular disease and other pathologies.
- Symptomatic or asymptomatic: Not detailed; no specific scales or symptoms mentioned.
- Clinical outcomes and patient status: Patients with multiple PMNs detected incidentally are likely benign.
- Survival/outcome at last follow-up: Not explicitly mentioned.
- Treatment effectiveness: Not discussed.
- Long-term prognosis: Uncertain due to inadequate longitudinal follow-up data and unclear etiology and pathogenesis.",,,,,,,,,
Systematic Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
,Diffuse Pulmonary Meningotheliomatosis: A Literature Review of a Rare Diffuse Parenchymal Lung Disease with Unclear Clinical Significance,Gleason et al.,10.4103/2320-8775.196647,https://doi.org/10.4103/2320-8775.196647,CHEST,2017,diffuse_pulmonary_meningotheliomatosis__a.3.pdf,Systematic Review,25,"- Study type: Systematic review
- Total number of DPM patients: 25
- Total number of multiple MPMN patients: Not mentioned
- Number of single MPMN patients excluded: Not mentioned
- Study period/duration: Through July 2016
- Institution/geographic location: Not mentioned
- Method of patient identification: Incidental findings on imaging","- Age: Range 37 to 73 years, median age 59.5 years
- Sex distribution: 2 males (8%), 23 females (92%)
- Smoking status: Not mentioned
- E-cigarette/vape use: Not mentioned
- Relevant medical history:
  - History of malignancy: 11 patients (44%)
  - Pulmonary thromboemboli: Mentioned as a concurrent condition
  - Pulmonary cryptococcus: Mentioned as a concurrent condition
  - Hypersensitivity pneumonitis: Mentioned as a concurrent condition
  - Ulcerative colitis: Mentioned as a concurrent condition
  - Infective endocarditis: Mentioned as a concurrent condition
- Social history: Not mentioned
- Environment exposures: Not mentioned
- Incidence/prevalence data: Not mentioned
- Other demographic characteristics: Not mentioned",,,,,,,,,,,,,,,,,,,,"- History of or active malignancy: 44% of patients had a history of or active malignancy, including carcinomas of the breast, colon, liver, carcinoid tumors, and uterine leiomyosarcoma.
- Other concurrent malignancies: Not specifically detailed in the text, but implied through the mention of various carcinomas.
- Other pulmonary disease: Pulmonary embolism, pulmonary cryptococcus, hypersensitivity pneumonitis.
- History of ulcerative colitis: Yes, mentioned as a concurrent condition.
- History of cardiac disease or infective endocarditis: Yes, mentioned as a concurrent condition.
- Other systemic associations: Not specifically detailed in the text.
- Frequency of associations: 44% of patients had a history of or active malignancy.
- Temporal relationship: Not explicitly detailed in the text.",,,,,,,,,,,,,,,,,,Not mentioned (the paper does not provide information on pulmonary function testing or spirometry results for DPM),"- Bronchoscopy findings: Not mentioned
- Bronchoalveolar lavage (BAL) analysis: Not mentioned
- Cell count and predominance: Not mentioned
- CD4/CD8 ratio: Not mentioned
- Was a Transbronchial lung biopsy performed? Yes, in 3 patients (12%)
- Was a Transbronchial lung cryobiopsy performed? Not mentioned
- Was a surgical lung biopsy required to establish diagnosis due to non-diagnostic bronchoscopic biopsy? Not explicitly mentioned, but implied that surgical biopsy may be necessary in cases with history of malignancy",,,,"Not mentioned (the paper does not provide specific laboratory features such as CBC, metabolic panel, bronchoalveolar lavage, autoimmune workup, or infectious workup)","- Symptoms at presentation: Asymptomatic (60%), unexplained respiratory complaints (32%).
- Lung complications: None specifically mentioned.
- Physical examination findings: Not mentioned.
- Circumstances of discovery: Incidental findings on imaging (60%).
- Disease course and natural history: Unclear clinical significance.
- Progression over time: Not mentioned.
- Complications or adverse outcomes: Not specifically mentioned.
- Pulmonary function testing: Not mentioned.","- Imaging modalities used: CT, HRCT
- Nodule characteristics:
  - Size: Not specified
  - Number/innumerable: Innumerable
  - Distribution: Diffuse bilateral
  - Centrilobular, panlobar, or paraseptal predominance: Not specified
  - Upper or lower predominance: Apical predominance
  - Left or Right predominance: Not specified
  - Appearance: Ground glass opacity, micronodules, miliary pattern
- Other unique lung findings on CT: Interstitial pneumonia patterns, fine linear, reticular, and mixed reticulonodular patterns
- SUV values if PET performed: Not mentioned
- Temporal changes on follow-up imaging: Not mentioned
- Visibility on CT: Visible
- Other radiology studies: Not mentioned",,,,,,,,,,,,,,,,"- Macroscopic/Gross features: Disseminated bilateral minute pulmonary meningothelial-like nodules (MPMNs).
- Gross anatomic location: Not specified, but within normal pulmonary parenchyma.
- Microscopic/Histological features and morphology: Aggregates of large cells with pale pink cytoplasm, uniform oval or spindle cells with slightly indented nuclei, thin collagen fibers.
- Microscopic location: Perivenular distribution.
- Immunohistochemical markers tested and results: Positive for progesterone receptor, epithelial membrane antigen, vimentin; negative for pankeratin, synaptophysin, chromogranin, S100, TTF-1, GATA3, estrogen receptor, AE1/AE3, muscle specific actin, CD34, HMB45, CD68.
- Molecular or genetic findings: Lack of mutational damage in isolated MPMNs; greater genetic instability in diffuse cases.
- Ultrastructural features: Intercellular desmosomes; features reminiscent of meningioma cells.
- Pathological criteria used for diagnosis: Presence of characteristic nodules and their immunohistochemical profile.",,,,,,,"- Diagnostic criteria used: Diffuse bilateral pulmonary nodules on HRCT.
- Differential diagnoses considered: Not explicitly mentioned.
- Misdiagnosis rates and types: Not mentioned.
- Diagnostic methods employed: CT imaging, surgical lung biopsy, transbronchial biopsy.
- Challenges in distinguishing from malignancy or metastatic meningioma: High rates of active or historical malignancy in DPM patients; transbronchial biopsy may not be adequate to rule out metastatic spread.
- Recommendations for diagnosis: Consider DPM in patients with diffuse bilateral pulmonary nodules on HRCT; surgical lung biopsy may be more appropriate for those with a history of malignancy; transbronchial biopsy may be adequate for those with low suspicion of malignancy.",,,,,,,,,,,,"- Transbronchial biopsy (12%)
- Surgical lung biopsy (88%)
  - VATS (40%)
  - Other surgical biopsies (48%)","- Positive: progesterone receptor, epithelial membrane antigen, vimentin
- Negative: pankeratin, synaptophysin, chromogranin, S100, TTF-1, GATA3, estrogen receptor, AE1/AE3, muscle specific actin, CD34, HMB45, CD68",,,,,,,,,,,,,,,,,,"- Management strategies: Surgical lung biopsy is the preferred method for diagnosis, especially in cases with a history of malignancy. Transbronchial biopsy may be adequate in cases without a history of malignancy.
- Monitoring intervals: Not mentioned.
- Recommendations for management: Not mentioned beyond diagnostic procedures.
- Other: Additional studies are needed to better characterize the nature of DPM and its clinical scenarios.",,,,,Not mentioned (the paper does not provide specific follow-up data or outcomes at different intervals),,,,,,,,,